自律神経　初めて学ぶ方のためのマニュアル

出版社： 中外医学社
著者：
発行日： 2022-04-20
分野： 臨床医学：内科  >  脳神経科学/神経内科学
ISBN： 9784498328808
電子書籍版： 2022-04-20 （1版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

8,360 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

8,360 円(税込)

購入する

商品紹介

多系統萎縮症および生理学の第一人者がタッグを組み編集した自律神経の入門書決定版！　初学者に分かりやすく，自律神経の基礎知識や，起立性低血圧・排尿排便障害・睡眠時無呼吸はもとより，こころに由来する内臓症状とその治療についても解説．様々な疾患に関わる自律神経のすべてをこの1冊で網羅した役立つ1冊．

目次

  • I章　自律神経：初めて学ぶ方へ！

    A．基礎編
    　　　1．自律神経系の働き
    　　　2．自律神経系の基本的構成
    　　　3．自律神経遠心路による内臓機能の調節
    　　　4．自律神経調節の特徴
    　　　5．局所性・ホルモン性・自律神経性の協調的な調節
    　　　6．内臓求心性線維の経路と働き
    　　　7．関連痛とその仕組み
    　　　8．ホメオスタシスの維持に働く自律神経系

    B．臨床編
    　　　1．からだ（脳神経内科）からみた自律神経
    　　　2．脳と臓器障害
    　　　3．神経チームの歴史
    　　　4．こころ（精神科）からみた自律神経

    II章　自律神経：もっと知りたい！

    A 概括編

    　1．末梢自律神経―神経伝達物質を中心に
    　　　1．末梢自律神経と神経伝達物質
    　　　2．アセチルコリン
    　　　3．モノアミン
    　　　4．プリン化合物
    　　　5．アミノ酸・ペプチド
    　　　6．NO
    　　　7．腸管神経系の伝達物質

    　2．自律機能の中枢調節
    　　　1．中枢自律神経系とは？
    　　　2．中枢自律神経ネットワーク（CAN）
    　　　（コラム1）自律神経機能の左右差
    　　　（コラム2）脳の大規模ネットワーク
    　　　3．自律機能の中枢性調節機構
    　　　（コラム3）mPFCと自律神経調節

    　3．内分泌機能の自律神経系調節
    　　　1．膵内分泌と自律神経系
    　　　2．脂肪組織からのレプチン放出
    　　　3．副腎皮質からの糖質コルチコイド放出

    　4．免疫機能の自律神経性調節
    　　　1．伝達物質と受容体
    　　　2．神経系と免疫系の相互作用に関与する求心性感覚神経
    　　　3．交感神経を介する免疫機能調節
    　　　4．迷走神経系を介する免疫機能調節

    　5．生体リズムと自律神経
    　　　1．概日リズム制御系
    　　　2．睡眠・覚醒の概日リズム
    　　　3．概日時計による自律神経制御
    　　　4．概日リズム攪乱の自律神経系への影響

    　6．体温の調節機構
    　　　1．体温調節の基礎
    　　　2．体温を調節する自律神経メカニズム
    　　　3．まとめ

    　7．脳循環の調節機構
    　　　1．脳への血液供給の経路
    　　　2．脳血管調節のしくみ
    　　　3．体位変換（起立）に伴う脳血流調節
    　　　4．睡眠時の脳血流調節
    　　　5．日常生活動作に伴うNBM賦活と脳血流増加

    　8．体性感覚刺激による自律神経機能の反射性調節
    　　　1．体性—内臓反射の特徴
    　　　2．体性—内臓反射の例

    B　症候と臓器編

    　9．起立性低血圧の生体防止機構と循環調節
    　　　1．起立性低血圧の生体防止機構
    　　　2．起立性低血圧の診断および症状
    　　　3．起立性低血圧の疫学研究

    　10．起立性低血圧をきたす疾患と治療
    　　　1．起立性低血圧（OH）をきたす疾患
    　　　2．OHの治療

    　11．頻尿・尿失禁・尿閉の生体防止機構と下部尿路機能・性機能の調節
    　　　1．下部尿路機能の神経調節機構
    　　　2．男性機能の神経調節機構

    　12．頻尿・尿失禁・尿閉をきたす疾患と治療
    　　　1．下部尿路症状とは
    　　　2．神経疾患での下部尿路症状問診における注意点
    　　　3．下部尿路機能検査
    　　　4．ヒト自律神経障害における研究の歴史
    　　　5．疾患
    　　　6．過活動膀胱（OAB）：パーキンソン病など
    　　　7．高齢者の白質型多発脳梗塞（かくれ脳梗塞）
    　　　8．DHIC：多系統萎縮症，脊髄疾患など
    　　　9．排尿筋低活動（DU）：腰椎症など
    　　　10．排尿筋低活動（DU）：糖尿病性ニューロパチー
    　　　11．治療
    　　　12．過活動膀胱（OAB）治療
    　　　（コラム1）抗コリン薬の副作用
    　　　（コラム2）ポリファーマシー
    　　　13．排尿筋低活動（DU）治療
    　　　14．DHIC治療
    　　　（コラム3）排尿失神
    　　　（コラム4）α交感神経遮断薬による起立性低血圧

    　13．自律神経と摂食・消化器機能調節
    　　　1．摂食中枢
    　　　2．末梢情報を脳へ伝達する2つの経路：液性経路と神経経路
    　　　3．胃腸伸展刺激
    　　　4．栄養素（グルコース）
    　　　5．グレリン
    　　　6．コレシストキニン
    　　　7．グルカゴン様ペプチド—1（GLP—1）
    　　　8．その他ホルモン

    　14．食思不振・嘔吐・便秘・便失禁をきたす疾患と治療
    　　　1．食思不振
    　　　2．嘔吐
    　　　3．便秘
    　　　4．便失禁

    　15．睡眠時無呼吸の生体防止機構と呼吸の調節
    　　　1．睡眠とは
    　　　2．呼吸とは
    　　　3．神経による呼吸関連筋収縮の調節
    　　　4．睡眠時無呼吸とは
    　　　5．呼吸の睡眠に伴う変化
    　　　6．睡眠による呼吸調節の変化

    　16．睡眠時無呼吸をきたす疾患と治療
    　　　1．睡眠時無呼吸の特徴と診断
    　　　2．睡眠時無呼吸をきたす疾患や病態
    　　　3．睡眠時無呼吸の中枢神経への影響
    　　　4．OSAにおける自律神経の変化
    　　　5．CSAにおける自律神経障害
    　　　6．脳卒中と睡眠時無呼吸
    　　　7．治療

    C　疾患編

    　17．自律神経不全をきたす疾患：糖尿病と自己免疫性自律神経ニューロパチー・アミロイドーシス
    　　　1．糖尿病
    　　　2．自己免疫性自律神経ニューロパチー
    　　　3．アミロイドーシス

    　18．自律神経不全をきたす疾患：脊髄損傷・脊髄炎（脊髄の病気）
    　　　1．脊髄を介する自律神経調節機構
    　　　2．脊髄の各障害部位での徴候
    　　　3．原因疾患

    　19．自律神経不全をきたす疾患：パーキンソン病と類縁疾患（脳・末梢神経の病気）
    　　　1．パーキンソン病の自律神経不全
    　　　2．レビー小体型認知症の自律神経不全
    　　　3．純粋型自律神経不全症の自律神経不全
    　　　4．その他のレビー小体病の自律神経不全

    　20．自律神経不全をきたす疾患：多系統萎縮症（脳・脊髄の病気）
    　　　1．多系統萎縮症について
    　　　2．MSAの診断基準や臨床症状
    　　　3．多系統萎縮症における自律神経症状
    　　　4．MSAで主に用いる自律神経系検査
    　　　5．治療
    　　　6．遺伝子レベルの研究や動物モデルなど

    　21．自律神経不全をきたす疾患：脳梗塞と高齢者のかくれ脳梗塞（脳の病気）
    　　　1．脳梗塞

    　22．自律神経不全をきたす疾患：多発性硬化症その他（脳の病気）
    　　　1．中枢自律神経ネットワーク
    　　　2．各疾患

    　23．認知症高齢者で自律神経障害がみられる場合
    　　　1．疫学
    　　　2．発生機序
    　　　3．影響
    　　　4．注意点と対処法

    　24．脳局所病変による二次性情動障害と自律神経症状
    　　　1．脳局所病変による二次性情動障害
    　　　2．脳局所病変による自律神経障害
    　　　3．脳局所病変による二次性情動障害と自律神経障害の合併

    　25．情動障害と脳病変の合併
    　　　1．情動障害と神経疾患
    　　　2．うつとアパシー
    　　　3．うつに関連する神経回路
    　　　4．パーキンソン病とうつ
    　　　5．認知症とうつ
    　　　6．てんかんとうつ

    III章　脳と臓器障害って？

    　1．急性脳疾患によるCushing潰瘍，胃排出障害，下痢便秘イレウス，非閉塞性腸管虚血症（NOMI）
    　　　1．胃腸粘膜の虚血に伴ったストレス潰瘍もしくは消化管出血
    　　　2．消化管運動障害に起因した胃排泄障害，下痢，便秘，イレウス
    　　　3．腸管粘膜の萎縮に伴ったbacterial translocation，endotoxin translocation
    　　　4．非閉塞性腸管虚血症

    　2．神経原性肺水腫と急性脳疾患
    　　　1．神経原性肺水腫の臨床的特徴
    　　　2．神経原生肺水腫の発生機序
    　　　3．NPE発症予測
    　　　4．神経原生肺水腫の治療
    　　　5．予後

    　3．タコツボ症候群他と急性脳疾患（およびその他の疾患）
    　　　1．タコツボ症候群の概念と病因
    　　　2．臨床症状・検査
    　　　3．診断
    　　　4．予後
    　　　5．急性期治療法
    　　　6．再発
    　　　7．まとめ

    IV章　こころが出す症状って？

    　1．こころ・情動のとらえ方：精神医学入門
    　　　1．精神医学・医療とは
    　　　2．わが国における精神医療
    　　　3．精神疾患の分類
    　　　4．外因性精神障害
    　　　5．統合失調症
    　　　6．気分障害
    　　　7．神経症性障害

    　2．こころ・情動の病気：身体症状症
    　　　1．疫学
    　　　2．病因・病態
    　　　3．典型的な症状と診断
    　　　（コラム　

    　3．こころ・情動と自律神経・内分泌・免疫系―ストレス負荷時の反応を中心に
    　　　1．ストレスとは
    　　　2．ストレス反応
    　　　3．ストレスと自律神経・内分泌系
    　　　4．ストレスと免疫機能
    　　　5．痛みとストレス
    　　　6．ストレスへの積極的対応

    　4．神経調節性（反射性）失神と治療
    　　　1．血管迷走性失神
    　　　2．状況性失神
    　　　3．頸動脈洞症候群
    　　　4．治療

    　5．こころ・情動と消化管症状：過敏性腸症候群と治療
    　　　1．過敏性腸症候群
    　　　2．自律神経と脳—腸相関
    　　　3．IBSの自律神経機能不全
    　　　4．IBSの治療

    　6．こころ・情動と膀胱症状：心因性排尿障害と治療
    　　　1．下部尿路の神経支配
    　　　2．心因性排尿障害の症状
    　　　3．心因性排尿障害の評価
    　　　4．心因性排尿障害における心理的要因
    　　　5．心因性尿閉
    　　　6．過活動膀胱と不安やうつの関係

    7．身体症状症型の神経症の治療
    　　　1．身体症状症の概要・症状
    　　　2．身体症状症の治療
    　　　3．各疾患に対する治療

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I章 自律神経 : 初めて学ぶ方へ !

P.11 掲載の参考文献
1) 佐藤昭夫, 佐藤優子, 五嶋摩理. 自律機能生理学. 京都 : 金芳堂 ; 1995. p.1-435.
 
2) 鈴木郁子, 編著. やさしい自律神経生理学 命を支える仕組み. 東京 : 中外医学社 ; 2015. p.1-247.
 
3) Sato A, Sato Y, Schmidt RF. The impact of somatosensory input on autonomic functions. Rev Physiol Biochem Pharmacol. 1997 ; 130 : 1-328.
PubMed
4) Gibbons CH. Chapter 27. Basics of autonomic nervous system function. In : Levin KH, et al. editors. Handbook of Clinical Neurology. Vol. 160. Clinical Neurophysiology : Basics and Technical Aspects. Elsevier. 2019. p.407-18.
 
5) Wehrwein EA, Orer HS, Barman SM. Overview of the anatomy, physiology, and pharmacology of the autonomic nervous system. Compr Physiol. 2016 ; 6 : 1239-78.
PubMed
6) Benarroch EE. 中枢性自律神経統御. In : Robertson D, et al. editors. (高橋昭, 間野忠明, 監訳). ロバートソン自律神経学 原著第3版. 東京 : エルゼビア・ジャパン ; 2015. p.3-7.
 
7) Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 2012 ; 9 : 286-94.
PubMed
8) Schmidt RF. 神経生理学. 京都 : 金芳堂 ; 1988. p.1-325.
 
9) McLachlan E. Autonomic ganglia. In : Binder MD, et al. editors. Encyclopedia of Neuroscience, vol. 1. Heidelberg : Springer ; 2009. p.261-6.
 
10) Yamamoto K, Ando J. New molecular mechanisms for cardiovascular disease : blood flow sensing mechanism in vascular endothelial cells. J Pharmacol Sci. 2011 ; 116 : 323-31.
PubMed
11) Janig W. Integrative action of the autonomic nervous system : Neurobiology of homeostasis. London : Cambridge University Press ; 2006. p.1-610.
 
12) Grundy L, Erickson A, Brierley SM. Visceral pain. Annu Rev Physiol. 2019 ; 81 : 261-84.
PubMed
13) Foreman RD, Garrett KM, Blair RW. Mechanisms of cardiac pain. Compr Physiol. 2015 ; 5 : 929-60.
PubMed
P.58 掲載の参考文献
1) Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019 ; 5 : 42.
 
2) Sharma JK, Rohatgi A, Sharma D. Diabetic autonomic neuropathy : a clinical update. J R Coll Physicians Edinb. 2020 ; 50 : 269-73.
PubMed
3) Coon EA, Mandrekar JN, Berini SE, et al. Predicting phenoconversion in pure autonomic failure. Neurology. 2020 ; 95 : e889-97.
PubMed
4) Kabir MA, Chelimsky TC. Pure autonomic failure. Handb Clin Neurol. 2019 ; 161 : 413-22.
PubMed
5) Vallelonga F, Maule S. Diagnostic and therapeutical management of supine hypertension in autonomic failure : a review of the literature. J Hypertens. 2019 ; 37 : 1102-11.
PubMed
6) Anjum A, Yazid MD, Fauzi Daud M, et al. Spinal cord injury : pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int J Mol Sci. 2020 ; 21 : 7533.
 
7) Ong B, Wilson JR, Henzel MK. Management of the patient with chronic spinal cord injury. Med Clin North Am. 2020 ; 104 : 263-78.
PubMed
8) Bragge P, Guy S, Boulet M, et al. A systematic review of the content and quality of clinical practice guidelines for management of the neurogenic bladder following spinal cord injury. Spinal Cord. 2019 ; 57 : 540-9.
 
9) Fanciulli A, Stankovic I, Krismer F, et al. Multiple system atrophy. Int Rev Neurobiol. 2019 ; 149 : 137-92.
PubMed
10) Pellecchia MT, Stankovic I, Fanciulli A, et al ; Members of the Movement Disorder Society Multiple System Atrophy Study Group are listed in the appendix. Can autonomic testing and imaging contribute to the early diagnosis of multiple system atrophy? a systematic review and recommendations by the movement disorder society multiple system atrophy study group. Mov Disord Clin Pract. 2020 ; 7 : 750-62.
 
11) 日本自律神経学会, 編. 自律神経機能検査 第5版. 東京 : 文光堂 ; 2015.
 
12) Cushing H. Peptic ulcers and the interbrain. Surgical Publishing Company, 1932.
 
13) Kemp WJ, Bashir A, Dababneh H, et al. Cushing's ulcer : Further reflections. Asian J Neurosurg. 2015 ; 10 : 87-94.
 
14) 川口実. 全身性疾患と消化管病変, 各論 2. 神経系疾患 1) Cushing潰瘍. 胃と腸. 2003 ; 38 : 501-5.
 
15) Yang X, Ren W, Zu H, et al. Evaluate the serum cortisol in patients with intracerebral hemorrhage. Clin Neurol Neurosurg. 2014 ; 123 : 127-30.
PubMed
16) Barugh AJ, Gray P, Shenkin SD, et al. Cortisol levels and the severity and outcomes of acute stroke : a systematic review. J Neurol. 2014 ; 261 : 533-45.
PubMed
17) Li ZM, Wang LX, Jiang LC, et al. Relationship between plasma cortisol levels and stress ulcer following acute and severe head injury. Med Princ Pract. 2010 ; 19 : 17-21.
 
18) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-4). Washington, DC : American Psychiatric Association Press, 1994.
 
19) Eus J W, Van Someren EJW. Brain mechanisms of insomnia : new perspectives on causes and consequences. Physiol Rev. 2020 Aug 13. doi : 10.1152/physrev.00046.2019. Online ahead of print.
 
20) Ryznar E, Wilcox D. Functional coma : two case reports and a review of the literature. Psychosomatics. 2019 ; 60 : 343-51.
 
21) Nora S, Stefan K, Klaus S, et al. functional cognitive disorder in subjective cognitive decline- a ten-year follow-up. Int J Geriatr Psychiatry. 2020 Nov 9. doi : 10.1002/gps.5466. Online ahead of print. PMID : 33166421.
 
22) Mendez MF. Non-neurogenic language disorders : a preliminary classification. Psychosomatics. 2018 ; 59 : 28-35.
PubMed
23) Vuilleumier P. Brain circuits implicated in psychogenic paralysis in conversion disorders and hypnosis. Neurophysiol Clin. 2014 ; 44 : 323-37.
PubMed
24) Winterdahl M, Miani A, Vercoe MJH, et al. Vulnerability to psychogenic non-epileptic seizures is linked to low neuropeptide Y levels. Stress. 2017 ; 20 : 589-97.
PubMed
25) Popkirov S, Enax-Krumova EK, Mainka T, et al. Functional pain disorders- more than nociplastic pain. NeuroRehabilitation. 2020 Sep 20. doi : 10.3233/NRE-208007. Online ahead of print. PMID : 32986624.
 
26) Ferrari S, Monzani D, Baraldi S, et al. Vertigo "in the pink" : The impact of female gender on psychiatric-psychosomatic comorbidity in benign paroxysmal positional vertigo patients. Psychosomatics. 2014 ; 55 : 280-8.
PubMed
27) Rafanelli C, Gostoli S, Roncuzzi R, et al. Psychological correlates of vasovagal versus medically unexplained syncope. Gen Hosp Psychiatry. 2013 ; 35 : 246-52.
PubMed
28) Ristiniemi H, Perski A, Lyskov E, et al. Hyperventilation and exhaustion syndrome. Scand J Caring Sci. 2014 ; 28 : 657-64.
PubMed
29) Seidel M, Geisler D, Borchardt V, et al. Evaluation of spontaneous regional brain activity in weight-recovered anorexia nervosa. Transl Psychiatry. 2020 ; 10 : 395.
PubMed
30) Asiedu K, Dzasimatu SK, Kyei S. Impact of dry eye on psychosomatic symptoms and quality of life in a healthy youthful clinical sample. Eye Contact Lens. 2018 ; 44 Suppl 2 : S404-9.
 
31) Kano M, Grinsvall C, Ran Q, et al. Resting state functional connectivity of the pain matrix and default mode network in irritable bowel syndrome : a graph theoretical analysis. Sci Rep. 2020 ; 10 : 11015.
PubMed
32) Sakakibara R, Ito T, Yamamoto T, et al. Depression, anxiety and the bladder. Low Urin Tract Symptoms. 2013 ; 5 : 109-20.
PubMed
33) Farrell MJ, Trevaks D, Taylor NA, et al. Regional brain responses associated with thermogenic and psychogenic sweating events in humans. J Neurophysiol. 2015 ; 114 : 2578-87.
PubMed
34) Finch A, Metcalfe KA, Chiang JK, et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol. 2011 ; 121 : 163-8.
PubMed
35) Kotsopoulos J, Gronwald J, Lubinski J, et al ; Hereditary Breast Cancer Clinical Study Group. Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers? Menopause. 2020 ; 27 : 156-61.
PubMed
36) Kalia M. Neurobiological basis of depression : an update. Metabolism. 2005 ; 54 (Suppl 1) : 24-7.
 
37) Kavia RB, Dasgupta R, Fowler CJ. Functional imaging and the central control of the bladder. J Comp Neurol. 2005 ; 493 : 27-32.
PubMed
38) Malizia AL, Cunningham VJ, Bell CJ, et al. Decreased brain GABA (A) -benzodiazepine receptor binding in panic disorder : preliminary results from a quantitative PET study. Arch Gen Psychiatry. 1998 ; 55 : 715-20.
 
39) de Groat WC. Influence of central serotonergic mechanisms on lower urinary tract function. Urology. 2002 ; 59 (Suppl 5A) : 30-6.
 
40) Supprian T, Reiche W, Schmitz B, et al. MRI of the brainstem in patients with major depression, bipolar affective disorder and normal controls. Psychiatry Res. 2004 ; 131 : 269-76.
PubMed
41) Yuvari P, Vogel GW, Neill DB. Decreased raphe unit activity in a rat model of endogenous depression. Brain Res. 1993 ; 611 : 31-6.
 
42) Neumeister A, Bain E, Nugent AC, et al. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci. 2004 ; 24 : 589-91.
PubMed
43) Ito T, Sakakibara R, Nakazawa K, et al. Effects of electrical stimulation of the raphe area on the micturition reflex in cats. Neuroscience. 2006 ; 142 : 1273-80.
PubMed
44) Ito T, Sakakibara R, Uchiyama T, et al. The effect of milnaciplan hydrochloride on urge incontinence due to neurogenic diseases. J Japan Neurogenic Bladder Society. 2005 ; 16 : 208-12.
 
45) Klausner AP, Streng T, Na YG, et al. The role of corticotrophin releasing factor and its antagonist, astressin, on micturition in the rat. Auton Neurosci Basic Clin. 2005 ; 123 : 26-35.
 
46) Sagami Y, Shimada Y, Tayama J, et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut. 2004 ; 53 : 919-21.
 
47) Goekoop JG, de Winter RF, Wolterbeek R, et al. Increased plasma norepinephrine concentration in psychotic depression. Ther Adv Psychopharmacol. 2012 ; 2 : 51-63.
PubMed
48) Ullas Kamath S, Chaturvedi A, Bhaskar Yerrapragada D, et al. Increased levels of acetylcholinesterase, paraoxonase 1, and copper in patients with moderate depression-a preliminary study. Rep Biochem Mol Biol. 2019 ; 7 : 174-80.
PubMed
49) Sakakibara R, Ogata T, Aiba Y, et al. Does depression contribute to the bladder and bowel complaint in Parkinson's disease patients? Movement Disorders Clinical Practice 2020 : in press.
 
50) Kimura M, Tateno A, Robinson RG. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression : merged analysis of nortriptyline trials. Am J Geriatr Psychiatry. 2003 ; 11 : 320-7.
PubMed
51) Gobbi C, Rocca MA, Riccitelli G, et al. Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. Mult Scler. 2014 ; 20 : 192-201.
PubMed
52) Gulyayeva NA, Massie MJ, Duhamel KN. Anti-NMDA receptor encephalitis : psychiatric presentation and diagnostic challenges from psychosomatic medicine perspective. Palliat Support Care. 2014 ; 12 : 159-63.
PubMed
53) Corsi N, Colloca L. Placebo and nocebo effects : the advantage of measuring expectations and psychological factors. Front Psychol. 2017 ; 8 : 308.
PubMed
54) Ito E, Shima R, Yoshioka T. A novel role of oxytocin : Oxytocin-induced well-being in humans. Biophys Physicobiol. 2019 ; 16 : 132-9.
PubMed
55) Colloca L, Akintola T, Haycock NR, et al. Prior therapeutic experiences, not expectation ratings, predict placebo effects : an experimental study in chronic pain and healthy participants. Psychother Psychosom. 2020 ; 89 : 371-8.
 

II章 自律神経 : もっと知りたい !

P.72 掲載の参考文献
1) Horn JP. The sacral autonomic outflow is parasympathetic : Langley got it right. Basics of autonomic nervous system function. Clinical Autonomic Res. 2018 ; 28 : 181-85.
 
2) Gibbons CH. Handb Clin Neurol. 2019 ; 160 : 407-18.
PubMed
3) Comroe JH. 諏訪邦夫 (訳). 心臓をめぐる発見の物語. 東京 : 中外医学社 ; 1987.
 
4) Otsuka M, et al. Proc Natl Acad Sci. 1966 ; 56 : 1110-5.
PubMed
5) Konishi S, Otsuka M. Actions of certain polypeptides on frog spinal neurons. Jpn J Pharmacol. 1971 ; 21 ; 685-87.
PubMed
6) Burnstock G. Brain Res Bull. 1999 ; 50 : 355-7.
PubMed
7) Costa M, et al. In : Hokfelt T et al. editors. Progress in brain research 68. Amsterdam : Elsevier 1986, p.217-39.
 
8) Morris JL, Gibbins H. Co-transission and neuromodulation. In : Burnstock G, Hoyle CHV, editors. Autonomic neuroeffector mechanisms. Chur : Harwood Academic Publishers : 1992. p33-119.
 
9) Gershon MD. 古川奈々子 (訳) セカンドブレイン 腸にも脳がある. 東京. 小学館. 2000.
 
10) Spencer NJ, Hu H. Nat Rev Gastroenterol Hepatol. 2020 ; 17 : 338-51.
PubMed
11) Rao M, Gershon MD. Enteric nervous system development : what could possibly go wrong? Nat Rev Neurosci. 2018 ; 19 ; 552-65.
 
12) 井村徹也. 消化管神経システムの整理と病理. 北部医療センター誌 ; 2020, p2-9.
 
13) Mayer E. 高橋洋 (訳). 腸と脳 内臓感覚は強し. 東京 : 紀伊国屋書店 ; 2018.
 
14) 鈴木郁子, 編著. やさしい自律神経生理学 命を支える仕組み. 東京 : 中外医学社 ; 2015.
 
P.79 掲載の参考文献
1) Critchley HD, Wiens S, Rotshtein P, et al. Neural systems supporting interoceptive awareness. Nat Neurosci. 2004 ; 7 : 189-95.
PubMed
2) Craig AD. How do you feel? Interoception : the sense of the physiological condition of the body. Nat Rev Neurosci. 2002 ; 3 : 655-66.
 
3) Craig AD. Forebrain emotional asymmetry : a neuroanatomical basis? Trends Cogn Sci. 2005 ; 9 : 566-71.
PubMed
4) Craig AD. How do you feel---now? The anterior insula and human awareness. Nature Rev Neurosci. 2009 ; 10 : 59-70.
 
P.82 掲載の参考文献
1) Smith EE, Jonides J. Storage and executive processes in the frontal lobes. Science. 1999 ; 283 : 1657-61.
PubMed
2) Raichle ME, MacLeod AM, Snyder AZ, et al. A default mode of brain function. Proc Natl Acad Sci USA. 2001 ; 98 : 676-82.
PubMed
3) Seeley WW, Menon V, Schatzberg AF, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. 2007 ; 27 : 2349-56.
PubMed
4) Sridharan D, Levitin DJ, Menon V. A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks. Proc Natl Acad Sci USA. 2008 ; 105 : 12569-574.
 
5) Craig AD. How do you feel---now? The anterior insula and human awareness. Nature Rev Neurosci. 2009 ; 10 : 59-70.
 
P.85 掲載の参考文献
1) McKlveen JM, Myers B, Herman JP. The medial prefrontal cortex : Coordinator of autonomic, neuroendocrine and behavioural responses to stress. J Neuroendocrinol. 2015 ; 27 : 446-56.
PubMed
2) Verberne AJ. Medullary sympathoexcitatory neurons are inhibited by activation of the medial prefrontal cortex in the rat. Am J Physiol. 1996 ; 270 : R713-9.
PubMed
3) Tavares RF, Correa FMA, Resstel LBM. Opposite role of infralimbic and prelimbic cortex in the tachycardiac response evoked by acute restraint stress in rats. J Neurosci Res. 2009 ; 87 : 2601-7.
 
4) Zhang S, Hu S, Chao HH, et al. Ventromedial prefrontal cortex and the regulation of physiological arousal. Soc Cogn Affect Neurosci. 2014 ; 9, 900-8.
PubMed
P.92 掲載の参考文献
1) Craig AD. How do you feel? Interoception : the sense of the physiological condition of the body. Nat Rev Neurosci. 2002 ; 3 : 655-66.
 
2) Craig AD. Pain mechanisms : labeled lines versus convergence in central processing. Annu Rev Neurosci. 2003 ; 26 : 1-30.
PubMed
3) Benarroch EE. The central autonomic network : functional organization, dysfunction, and perspective. Mayo Clin Proc. 1993 ; 68 : 988-1001.
PubMed
4) Altman J, Bayer SA. The development of the rat spinal cord. Adv Anat Embryol Cell Biol. 1984 ; 85 : 1-164.
PubMed
5) Cortelli P, Giannini G, Favoni V, et al. Nociception and autonomic nervous system. Neurol Sci. 2013 ; 34 (Suppl 1) : S41-6.
 
6) Benarroch EE. Pain-autonomic interactions. Neurol Sci. 2006 ; 27 : S130-3.
PubMed
7) Benarroch EE. Periaqueductal gray : an interface for behavioral control. Neurology. 2012 ; 78 : 210-7.
PubMed
8) Dampney RA. Central neural control of the cardiovascular system : current perspectives. Adv Physiol Educ. 2016 ; 40 : 283-96.
PubMed
9) Beissner F, Meissner K, Bar KJ, et al. The autonomic brain : an activation likelihood estimation meta-analysis for central processing of autonomic function. J Neurosci. 2013 ; 33 : 10503-11.
 
10) Critchley HD, Eccles J, Garfinkel SN. Interaction between cognition, emotion, and the autonomic nervous system. Handb Clin Neurol. 2013 ; 117 : 59-77.
PubMed
11) Benarroch EE. Insular cortex : Functional complexity and clinical correlations. Neurology. 2019 ; 93 : 932-8.
PubMed
12) Kurth F, Zilles K, Fox PT, et al. A link between the systems : functional differentiation and integration within the human insula revealed by meta-analysis. Brain Struct Funct. 2010 ;.214 :.519-34.
PubMed
13) Seeley WW, Menon V, Schatzberg AF, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. 2007 ; 27 : 2349-56.
PubMed
14) Kimmerly DS, Wong S, Menon R, et al. Forebrain neural patterns associated with sex differences in autonomic and cardiovascular function during baroreceptor unloading. Am J Physiol Regul Integr Comp Physiol. 2007 ; 292 : R715-22.
PubMed
15) Macey PM, Rieken NS, Kumar R, et al. Sex differences in insular cortex gyri responses to the Valsalva maneuver. Front Neurol. 2016 ; 7 : 87.
 
16) Kuo TB, Lin T, Yang CC, et al. Effect of aging on gender differences in neural control of heart rate. Am J Physiol. 1999 ; 277 : H2233-9.
PubMed
17) Liu CC, Kuo TB, Yang CC. Effects of estrogen on gender related autonomic differences in humans. Am J Physiol Heart Circ Physiol. 2003 ; 285 : H2188-93.
PubMed
18) Biswal BB, Mennes M, Zuo XN, et al. Toward discovery science of human brain function. Proc Natl Acad Sci USA. 2010 ; 107 : 4734-9.
PubMed
19) Filippi M, Valsasina P, Misci P, et al. The organization of intrinsic brain activity differs between genders : a restingstate fMRI study in a large cohort of young healthy subjects. Hum Brain Mapp. 2013 ; 34 : 1330-43.
 
20) Sie J-H, Chen Y-H, Shiau Y-H, et al. Gender- and age-specific differences in resting-state functional connectivity of the central autonomic network in adulthood. Frontiers in Human Neuroscience. 2019 ; 13 : 369.
PubMed
21) Kimmerly DS, O'leary DD, Menon RS, et al. Cortical regions associated with autonomic cardiovascular regulation during lower body negative pressure in humans. J Physiol. 2005 ; 569 : 331-45.
 
22) Critchley HD, Corfield DR, Chandler MP, et al. Cerebral correlates of autonomic cardiovascular arousal : a functional neuroimaging investigation in humans. J Physiol. 2000 ; 523 (Pt 1), 259-70.
PubMed
23) Oppenheimer SM, Gelb A, Girvin JP, et al. Cardiovascular effects of human insular cortex stimulation. Neurology. 1992 ; 42, 1727-32.
PubMed
24) Critchley HD. The human cortex responds to an interoceptive challenge. Proc Natl Acad Sci USA. 2004 ; 101 : 6333-4.
 
25) Verberne AJ, Owens NC. Cortical modulation of the cardiovascular system. Prog Neurobiol. 1998 ; 54 : 149-68.
PubMed
26) Bandler R, Keay KA, Floyd N, et al. Central circuits mediating patterned autonomic activity during active vs. passive emotional coping. Brain Res Bull. 2000 ; 53 : 95-104.
PubMed
27) Keay KA, Bandler R. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev. 2001 ; 25 : 669-78.
PubMed
28) Dampney RA, Furlong TM, Horiuchi J, et al. Role of dorsolateral periaqueductal grey in the coordinated regulation of cardiovascular and respiratory function. Auton Neurosci. 2013 ; 175 : 17-25.
PubMed
29) Horiuchi J, McDowall LM, Dampney RA. Vasomotor and respiratory responses evoked from the dorsolateral periaqueductal grey are mediated by the dorsomedial hypothalamus. J Physiol. 2009 ; 587 (Pt 21) : 5149-62.
 
30) Barna BF, Takakura AC, Moreira TS. Acute exercise-induced activation of Phox2b-expressing neurons of the retrotrapezoid nucleus in rats may involve the hypothalamus. Neuroscience. 2014 ; 258 : 355-63.
PubMed
31) Kuwaki T, Zhang W. Orexin neurons as arousal-associated modulators of central cardiorespiratory regulation. Resp Physiol Neurobiol. 2010 ; 174 : 43-54.
 
32) Bastide L, Herbaut A-G. Cerebellum and micturition : what do we know? A systematic review. Cerebellum & Ataxias. 2020 ; 7 : 9.
 
33) Roy HA, Green AL. The central autonomic network and regulation of bladder function. Front Neuroscience. 2019 ; 13 : 535.
 
P.100 掲載の参考文献
1) Alonge KM, D'Alessio DA, Schwartz MW. Brain control of blood glucose levels : implications for the pathogenesis of type 2 diabetes. Diabetologia. 2021 ; 64 : 5-14.
 
2) Faber CL, Deem JD, Campos CA, et al. CNS control of the endocrine pancreas. Diabetologia. 2020 ; 63 : 2086-94.
PubMed
3) Rodriguez-Diaz R, Caicedo A. Neural control of the endocrine pancreas. Best Pract Res Clin Endocrinol Metab. 2014 ; 28 : 745-56.
PubMed
4) Tarussio D, Metref S, Seyer P, et al. Nervous glucose sensing regulates postnatal beta cell proliferation and glucose homeostasis. J Clin Invest. 2014 ; 124 : 413-24.
PubMed
5) Osundiji MA, Lam DD, Shaw J, et al. Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion. Diabetes. 2012 ; 61 : 321-8.
PubMed
6) De Backer I, Hussain SS, Bloom SR, et al. Insights into the role of neuronal glucokinase. Am J Physiol Endocrin Metab. 2016 ; 311 : E42-55.
 
7) Kruyt ND, Musters A, Biessels GJ, et al. Beta-cell dysfunction and insulin resistance after subarachnoid haemorrhage. Neuroendocrinology. 2011 ; 93 : 126-32.
PubMed
8) Harvengt J, Gernay C, Mastouri M, et al. ROHHAD (NET) syndrome : Systematic review of the clinical timeline and recommendations for diagnosis and prognosis. J Clini Endocrinol Metab. 2020 ; 105 : dgaa 247.
 
9) Chow C, Fortier MV, Das L, et al. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome may have a hypothalamus-periaqueductal gray localization. Pediatr Neurol. 2015 ; 52 : 521-5.
PubMed
10) Geha P, Cecchi G, Todd Constable R, et al. Reorganization of brain connectivity in obesity. Hum Brain Map. 2017 ; 38 : 1403-20.
PubMed
11) Legget KT, Wylie KP, Cornier MA, et al. Altered between-network connectivity in individuals prone to obesity. Physiology & behavior. 2021 ; 229 : 113242.
PubMed
12) Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2013 ; 369 : 362-72.
PubMed
13) Campbell-Thompson M, Butterworth EA, Boatwright JL, et al. Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes. Sci Rep. 2021 ; 11 : 6562.
PubMed
14) Lin EE, Scott-Solomon E, Kuruvilla R. Peripheral innervation in the regulation of glucose homeostasis. Trends Neurosci. 2021 ; 44 : 189-202.
PubMed
15) Ahren B. Autonomic regulation of islet hormone secretion-Implications for health and disease. Diabetologia. 2000 ; 43 : 393-410.
PubMed
16) Devedjian JC, Pujol A, Cayla C, et al. Transgenic mice overexpressing α2A-adrenoceptors in pancreatic beta-cells show altered regulation of glucose homeostasis. Diabetologia. 2000 ; 43 : 899-906.
 
17) Rosengren AH, Jokubka R, Tojjar D, et al. Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science. 2010 ; 327 : 217-20.
PubMed
18) Morton GJ, Muta K, Kaiyala KJ, et al. Evidence that the sympathetic nervous system elicits rapid, coordinated, and reciprocal adjustments of insulin secretion and insulin sensitivity during cold exposure. Diabetes. 2017 ; 66 : 823-34.
PubMed
19) Brown JM, Scarlett JM, Schwartz MW. Rethinking the role of the brain in glucose homeostasis and diabetes pathogenesis. J Clini Invest. 2019 ; 129 : 3035-7.
 
20) Mundinger TO, Taborsky GJ, Jr. Early sympathetic islet neuropathy in autoimmune diabetes : lessons learned and opportunities for investigation. Diabetologia. 2016 ; 59 : 2058-67.
PubMed
21) Gilon P. The role of alpha-cells in islet function and glucose homeostasis in health and type 2 diabetes. J Mol Biol. 2020 ; 432 : 1367-94.
PubMed
22) Borden P, Houtz J, Leach Steven D, et al. Sympathetic innervation during development Is necessary for pancreatic islet architecture and functional maturation. Cell Rep. 2013 ; 4 : 287-301.
PubMed
23) D'Alessio DA, Kieffer TJ, Taborsky GJ, Jr, et al. Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques. J Clini Endocrinol Metab. 2001 ; 86 : 1253-9.
 
24) Skvortsova A, Veldhuijzen DS, Kloosterman IEM, et al. Food anticipatory hormonal responses : A systematic review of animal and human studies. Neurosci Biobehav Rev. 2021 ; 126 : 447-64.
PubMed
25) Strubbe JH. Parasympathetic involvement in rapid meal-associated conditioned insulin secretion in the rat. Am J Physiol-Regul, Integ Comp Physiol. 1992 ; 263 : R615-8.
 
26) Taylor IL, Feldman M. Effect of cephalic-vagal stimulation on insulin, gastric inhibitory polypeptide, and pancreatic polypeptide release in humans. J Clini Endocrinol Metab. 1982 ; 55 : 1114-7.
 
27) Blackman JD, Polonsky KS, Jaspan JB, et al. Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation. Diabetes. 1992 ; 41 : 1346-54.
 
28) Becker HD, Borger HW, Schafmayer A. Effect of vagotomy on gastrointestinal hormones. World J Surg. 1979 ; 3 : 615-22.
PubMed
29) Veedfald S, Plamboeck A, Deacon CF, et al. Cephalic phase secretion of insulin and other enteropancreatic hormones in humans. Am J Physiol Gastrointest Liver Physiol. 2016 ; 310 : G43-51.
PubMed
30) Rodriguez-Diaz R, Dando R, Jacques-Silva MC, et al. Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans. Nat Med. 2011 ; 17 : 888-92.
PubMed
31) Gautam D, Han SJ, Hamdan FF, et al. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab. 2006 ; 3 : 449-61.
PubMed
32) Guo Y, Traurig M, Ma L, et al. CHRM3 gene variation is associated with decreased acute insulin secretion and increased risk for early-onset type 2 diabetes in Pima Indians. Diabetes. 2006 ; 55 : 3625-9.
PubMed
33) Noguchi GM, Huising MO. Integrating the inputs that shape pancreatic islet hormone release. Nat Metab. 2019 ; 1 : 1189-201.
PubMed
34) Lamy CM, Sanno H, Labouebe G, et al. Hypoglycemia-activated GLUT2 neurons of the nucleus tractus solitarius stimulate vagal activity and glucagon secretion. Cell Metab. 2014 ; 19 : 527-38.
 
35) Makhmutova M, Weitz J, Tamayo A, et al. Pancreatic beta-cells communicate with vagal sensory neurons. Gastroenterology. 2021 ; 160 : 875-888 e811.
 
36) Bou Karam J, Cai W, Mohamed R, et al. TRPV1 neurons regulate beta-cell function in a sex-dependent manner. Mol Metab. 2018 ; 18 : 60-7.
 
37) Kiba T, Tanaka K, Numata K, et al. Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation. Gastroenterology. 1996 ; 110 : 885-93.
PubMed
38) Edvell A, Lindstrom P. Vagotomy in young obese hyperglycemic mice : effects on syndrome development and islet proliferation. A J Physiol Endocrinol Metab. 1998 ; 274 : E1034-9.
 
39) Townsend KL. The re-emergence of adipose innervation as a research focus. Nat Rev Endocrinol. 2020 ; 16 : 127-8.
PubMed
40) Zeng W, Pirzgalska RM, Pereira MM, et al. Sympathetic neuro-adipose connections mediate leptin-driven lipolysis. Cell. 2015 ; 163 : 84-94.
PubMed
41) Caron A, Lee S, Elmquist JK, et al. Leptin and brain-adipose crosstalks. Nat Rev Neurosci. 2018 ; 19 : 153-65.
 
42) Raff H, Lee JJ, Widmaier EP, et al. Basal and adrenocorticotropin-stimulated corticosterone in the neonatal rat exposed to hypoxia from birth : modulation by chemical sympathectomy. Endocrinology. 2004 ; 145 : 79-86.
PubMed
43) Dickmeis T. Glucocorticoids and the circadian clock. J Endocrinol. 2009 ; 200 : 3-22.
PubMed
44) Ottenweller JE, Meier AH. Adrenal innervation may be an extrapituitary mechanism able to regulate adrenocortical rhythmicity in rats. Endocrinology. 1982 ; 111 : 1334-8.
PubMed
45) Ulrich-Lai YM, Arnhold MM, Engeland WC. Adrenal splanchnic innervation contributes to the diurnal rhythm of plasma corticosterone in rats by modulating adrenal sensitivity to ACTH. Am J Physiol Regul Integr Comp Physiol. 2006 ; 290 : R1128-35.
 
46) Edwards AV, Jones CT. Autonomic control of adrenal function. J Anat. 1993 ; 183 (Pt 2) : 291-307.
 
47) Lightman SL, Birnie MT, Conway-Campbell BL. Dynamics of ACTH and cortisol secretion and implications for disease. Endocr Rev. 2020.
 
48) Jasper MS, Engeland WC. Splanchnic neural activity modulates ultradian and circadian rhythms in adrenocortical secretion in awake rats. Neuroendocrinology. 1994 ; 59 : 97-109.
PubMed
49) Jasper MS, Engeland WC. Splanchnicotomy increases adrenal sensitivity to ACTH in nonstressed rats. Am J physiol. 1997 ; 273 (2 Pt 1) : E363-8.
PubMed
50) Pruss H, Tedeschi A, Thiriot A, et al. Spinal cord injury-induced immunodeficiency is mediated by a sympathetic-neuroendocrine adrenal reflex. Nat Neurosci. 2017 ; 20 : 1549-59.
PubMed
P.114 掲載の参考文献
1) Ishigami T. The influence of psychic acts on the progress of pulmonary tuberculosis. Am Rev Tuberc. 1919 ; 2 : 470-84.
 
2) Padro CJ, Sanders VM. : Neuroendocrine regulation of inflammation. Semin Immunol. 2014 ; 26 : 357-68.
 
3) Selye H. The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol Metab. 1946 ; 6 : 117-230.
PubMed
4) Solomon GF, Moos RH. The relationship of personality to the presence of rheumatoid factor in asymptomatic relatives of patients with rheumatoid arthritis. Psychosom Med. 1965 ; 27 : 350-60.
 
5) Chavan SS, Pavlov VA, Tracey KJ. Mechanisms and therapeutic relevance of neuro-immune communication. Immunity. 2017 ; 46 : 927-42.
PubMed
6) Pavlov VA, Tracey KJ. Neural regulation of immunity : molecular mechanisms and clinical translation. Nat Neurosci. 2017 ; 20 : 156-66.
PubMed
7) Fujii YX, Tashiro A, Arimoto K, et al. Diminished antigen-specific IgG1 and interleukin-6 production and acetylcholinesterase expression in combined M1 and M5 muscarinic acetylcholine receptor knockout mice. J Neuroimmunol. 2007 ; 188 : 80-5.
PubMed
8) Grando SA, Kawashima K, Kirkpatrick CJ, et al. Recent progress in revealing the biological and medical significance of the non-neuronal cholinergic system. Int Immunopharmacol. 2015 ; 29 : 1-7.
PubMed
9) Fujii T, Mashimo M, Moriwaki Y, et al. Expression and function of the cholinergic system in immune cells. Front Immunol. 2017 ; 8 : 1085.
PubMed
10) King JR, Ullah A, Bak E, et al. Ionotropic and metabotropic mechanisms of allosteric modulation of α7 nicotinic receptor intracellular calcium. Mol Pharmacol. 2018 ; 93 : 601-11.
 
11) Grau V, Richter K, Hone AJ, et al. Conopeptides [V11L ; V16D] ArIB and RgIA4 : Powerful tools for the identification of novel nicotinic acetylcholine receptors in monocytes. Front Pharmacol. 2018 ; 9 : 1499.
PubMed
12) Flierl MA, Rittirsch D, Huber-Lang M, et al. Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora's box? Mol Med. 2008 ; 14 : 195-204.
PubMed
13) Matt SM, Gaskill PJ. Where is dopamine and how do immune cells see it? : Dopamine-mediated immune cell function in health and disease. J Neuroimmune Pharmacol. 2020 ; 15 : 114-64.
 
14) 川島紘一郎. アセチルコリンのルーツと非神経性アセチルコリン. 基礎老化研究. 2010 ; 34 : 12-24.
 
15) Fujii T, Yamada S, Misawa H, et al. Expression of choline acetyltransferase mRNA and protein in T-lymphocytes. Proc Japan Acad. 1995 ; 71B : 231-5.
 
16) Mashimo M, Fujii T, Ono S, et al. Divergent roles of α7 nicotinic acetylcholine receptors expressed on antigen-presenting cells and CD4+ T cells in the regulation of T cell differentiation. Int Immunopharmacol. 2020 ; 82 : 106306.
 
17) Berthoud HR, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci. 2000 ; 85 : 1-17.
PubMed
18) Besedovsky H, del Rey A, Sorkin E, et al. The immune response evokes changes in brain noradrenergic neurons. Science. 1983 ; 221 : 564-6.
PubMed
19) Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions : facts and hypotheses. Endocr Rev. 1996 ; 17 : 64-102.
PubMed
20) Felten SY, Olschowka J. Noradrenergic sympathetic innervation of the spleen : II. Tyrosine hydroxylase (TH) -positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp. J Neurosci Res. 1987 ; 18 : 37-48.
 
21) Springer, TA. Adhesion receptors of the immune system. Nature. 1990 ; 346 : 425-34.
PubMed
22) Felten SY, Housel J, Felten DL. Use of in vivo dialysis for evaluation of splenic norepinephrine and serotonin. Soc Neurosci Abstr. 1986 ; 12 : 1065.
 
23) Wijesinghe M, Perrin K, Harwood M, et al. The risk of asthma mortality with inhaled long acting beta-agonists. Postgrad Med J. 2008 ; 84 : 467-72.
PubMed
24) Hubner G, Brauchle M, Smola H, et al. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine. 1996 ; 8 : 548-56.
PubMed
25) Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000 ; 405 : 458-62.
PubMed
26) Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003 ; 421 : 384-8.
 
27) Tracey KJ. The inflammatory reflex. Nature. 2002 ; 420 : 853-9.
PubMed
28) Rosas-Ballina M, Ochani M, Parrish WR, et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA. 2008 ; 105 : 11008-13.
PubMed
29) Rosas-Ballina M, Olofsson PS, Ochani M, et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science. 2011 ; 334 : 98-101.
 
30) Koopman FA, Chavan SS, Miljko S, et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci USA. 2016 ; 113 : 8284-9.
PubMed
31) Bonaz B, Sinniger V, Hoffmann D, et al. Chronic vagus nerve stimulation in Crohn's disease : a 6-month follow-up pilot study. Neurogastroenterol Motil. 2016 ; 28 : 948-53.
PubMed
P.123 掲載の参考文献
1) Koronowski KB, Sassone-Corsi P. Communicating clocks shape circadian homeostasis. Science. 2021 ; 371 : eabd0951.
 
2) Takahashi JS. Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet. 2017 ; 18 : 164-79.
PubMed
3) Welz PS, Zinna VM, Symeonidi A, et al. BMAL1-driven tissue clocks respond independently to light to maintain homeostasis. Cell. 2019 ; 177 : 1436-47.e12.
 
4) Koronowski KB, Kinouchi K, Welz PS, et al. Defining the independence of the liver circadian clock. Cell. 2019 ; 177 : 1448-62.e14.
 
5) Borbely AA. A two process model of sleep regulation. Hum Neurobiol. 1982 ; 1 : 195-204.
PubMed
6) Peng W, Wu Z, Song K, et al. Regulation of sleep homeostasis mediator adenosine by basal forebrain glutamatergic neurons. Science. 2020 ; 369 : eabb0556.
PubMed
7) Wang Z, Ma J, Miyoshi C, et al. Quantitative phosphoproteomic analysis of the molecular substrates of sleep need. Nature. 2018 ; 558 : 435-39.
PubMed
8) Saito YC, Maejima T, Nishitani M, et al. Monoamines inhibit GABAergic neurons in ventrolateral preoptic area that make direct synaptic connections to hypothalamic arousal neurons. J Neurosci. 2018 ; 38 : 6366-78.
PubMed
9) Tsuneki H, Sasaoka T, Sakurai T. Sleep control, GPCRs, and glucose metabolism. Trends Endocrinol Metab. 2016 ; 27 : 633-42.
PubMed
10) Buijs RM, Wortel J, Van Heerikhuize JJ, et al. Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur J Neurosci. 1999 ; 11 : 1535-44.
PubMed
11) Akselrod S, Gordon D, Ubel FA, et al. Power spectrum analysis of heart rate fluctuation : a quantitative probe of beat-to-beat cardiovascular control. Science. 1981 ; 213 : 220-2.
PubMed
12) Akselrod S, Gordon D, Madwed JB, et al. Hemodynamic regulation : investigation by spectral analysis. Am J Physiol. 1985 ; 249 : H867-75.
PubMed
13) Vandewalle G, Middleton B, Rajaratnam SM, et al. Robust circadian rhythm in heart rate and its variability : influence of exogenous melatonin and photoperiod. J Sleep Res. 2007 ; 16 : 148-55.
PubMed
14) Leach S, Suzuki K. Adrenergic signaling in circadian control of immunity. Front Immunol. 2020 ; 11 : 1235.
PubMed
15) Buijs RM, Escobar C, Swaab DF. The circadian system and the balance of the autonomic nervous system. Handb Clin Neurol. 2013 ; 117 : 173-91.
PubMed
16) American Academy of Sleep Medicine. The International Classification of Sleep Disorders-Third Edition (ICSD-3). 2014.
 
17) Knutsson A. Health disorders of shift workers. Occup Med (Lond). 2003 ; 53 : 103-8.
PubMed
18) Inokawa H, Umemura Y, Shimba A, et al. Chronic circadian misalignment accelerates immune senescence and abbreviates lifespan in mice. Sci Rep. 2020 ; 10 : 2569.
PubMed
19) Lee S, Donehower LA, Herron AJ, et al. Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS One. 2010 ; 5 : e10995.
PubMed
20) Kettner NM, Voicu H, Finegold MJ, et al. Circadian homeostasis of liver metabolism suppresses hepatocarcinogenesis. Cancer Cell. 2016 ; 30 : 909-24.
PubMed
P.131 掲載の参考文献
1) 入來正躬. 体温生理学テキスト. 東京 : 文光堂 ; 2003.
 
2) 中村和弘. 体温調節の中枢神経機構. 日本臨牀. 2012 ; 70 : 922-6.
Medical*Online
3) Smith CJ, Johnson JM. Responses to hyperthermia. Optimizing heat dissipation by convection and evaporation : Neural control of skin blood flow and sweating in humans. Auton Neurosci. 2016 ; 196 : 25-36.
PubMed
4) Cannon B, Nedergaard J. Brown adipose tissue : function and physiological significance. Physiol Rev. 2004 ; 84 : 277-359.
PubMed
5) Tikuisis P, Bell DG, Jacobs I. Shivering onset, metabolic response, and convective heat transfer during cold air exposure. J Appl Physiol. 1991 ; 70 : 1996-2002.
PubMed
6) Kanosue K, Crawshaw LI, Nagashima K, et al. Concepts to utilize in describing thermoregulation and neurophysiological evidence for how the system works. Eur J Appl Physiol. 2010 ; 109 : 5-11.
PubMed
7) Nakamura K. Central circuitries for body temperature regulation and fever. Am J Physiol Regul Integr Comp Physiol. 2011 ; 301 : R1207-28.
PubMed
8) Nakamura K, Matsumura K, Hubschle T, et al. Identification of sympathetic premotor neurons in medullary raphe regions mediating fever and other thermoregulatory functions. J Neurosci. 2004 ; 24 : 5370-80.
PubMed
9) Stornetta RL, Rosin DL, Simmons JR, et al. Coexpression of vesicular glutamate transporter-3 and gamma-aminobutyric acidergic markers in rat rostral medullary raphe and intermediolateral cell column. J Comp Neurol. 2005 ; 492 : 477-94.
PubMed
10) Nakamura K, Morrison SF. Central efferent pathways mediating skin cooling-evoked sympathetic thermogenesis in brown adipose tissue. Am J Physiol Regul Integr Comp Physiol. 2007 ; 292 : R127-36.
PubMed
11) Nakamura K, Morrison SF. Central efferent pathways for cold-defensive and febrile shivering. J Physiol. 2011 ; 589 : 3641-58.
PubMed
12) Kataoka N, Hioki H, Kaneko T, et al. Psychological stress activates a dorsomedial hypothalamus-medullary raphe circuit driving brown adipose tissue thermogenesis and hyperthermia. Cell Metab. 2014 ; 20 : 346-58.
PubMed
13) Morrison SF, Nakamura K. Central mechanisms for thermoregulation. Annu Rev Physiol. 2019 ; 81 : 285-308.
PubMed
14) Rathner JA, Madden CJ, Morrison SF. Central pathway for spontaneous and prostaglandin E2-evoked cutaneous vasoconstriction. Am J Physiol Regul Integr Comp Physiol. 2008 ; 295 : R343-54.
PubMed
15) Nakamura Y, Nakamura K, Morrison SF. Different populations of prostaglandin EP3 receptor-expressing preoptic neurons project to two fever-mediating sympathoexcitatory brain regions. Neuroscience. 2009 ; 161 : 614-20.
PubMed
16) Tanaka M, McKinley MJ, McAllen RM. Preoptic-raphe connections for thermoregulatory vasomotor control. J Neurosci. 2011 ; 31 : 5078-88.
PubMed
17) da Conceicao EPS, Morrison SF, Cano G, et al. Median preoptic area neurons are required for the cooling and febrile activations of brown adipose tissue thermogenesis in rat. Sci Rep. 2020 ; 10 : 18072.
PubMed
18) Nakamura K, Morrison SF. A thermosensory pathway that controls body temperature. Nat Neurosci. 2008 ; 11 : 62-71.
PubMed
19) Nakamura K, Morrison SF. A thermosensory pathway mediating heat-defense responses. Proc Natl Acad Sci U S A. 2010 ; 107 : 8848-53.
PubMed
20) Nakayama T, Eisenman JS, Hardy JD. Single unit activity of anterior hypothalamus during local heating. Science. 1961 ; 134 : 560-1.
PubMed
21) Matsumura K, Cao C, Ozaki M, et al. Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever : light and electron microscopic immunocytochemical studies. J Neurosci. 1998 ; 18 : 6279-89.
PubMed
22) Yamagata K, Matsumura K, Inoue W, et al. Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J Neurosci. 2001 ; 21 : 2669-77.
PubMed
23) Nakamura K, Matsumura K, Kaneko T, et al. The rostral raphe pallidus nucleus mediates pyrogenic transmission from the preoptic area. J Neurosci. 2002 ; 22 : 4600-10.
PubMed
24) Lazarus M, Yoshida K, Coppari R, et al. EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses. Nat Neurosci. 2007 ; 10 : 1131-3.
PubMed
25) Tanaka M, McKinley MJ, McAllen RM. Roles of two preoptic cell groups in tonic and febrile control of rat tail sympathetic fibers. Am J Physiol Regul Integr Comp Physiol. 2009 ; 296 : R1248-57.
PubMed
26) Kataoka N, Shima Y, Nakajima K, et al. A central master driver of psychosocial stress responses in the rat. Science. 2020 ; 367 : 1105-12.
PubMed
27) Nakamura Y, Yanagawa Y, Morrison SF, et al. Medullary reticular neurons mediate neuropeptide Y-induced metabolic inhibition and mastication. Cell Metab. 2017 ; 25 : 322-34.
PubMed
28) Nakamura Y, Nakamura K. Central regulation of brown adipose tissue thermogenesis and energy homeostasis dependent on food availability. Pflugers Arch. 2018 ; 470 : 823-37.
PubMed
29) Nakamura K, Nakamura Y. Hunger and satiety signaling : modeling two hypothalamomedullary pathways for energy homeostasis. BioEssays. 2018 ; 40 : e1700252.
PubMed
P.141 掲載の参考文献
1) 松本美志也, 坂部武史. 脳循環・代謝の生理. 坂部武史, 編. 脳保護・脳蘇生. 東京 : 克誠堂出版 ; 2008. p.15-30.
 
2) 棚橋紀夫. 脳血管の支配領域と脳循環の生理. 矢崎義雄, 赤司浩一, 渥美達也, 他編. 内科學. 分冊版 第11版. 東京 : 朝倉書店 ; 2017. p.2100-2.
 
3) 菅野巌. 脳血流量は語る : かくれた謎をひも解く : 東京 : 中外医学社 ; 2020.
 
4) Hotta H. Neurogenic control of parenchymal arterioles in the cerebral cortex. Prog Brain Res. 2016 ; 225 : 3-39.
PubMed
5) 堀田晴美, 鈴木はる江. 脳血管の神経性調節. Clinical Neuroscience. 2014 ; 32 : 1345-8.
 
6) 鈴木郁子, 内田さえ, 鍵谷方子, 他. 局所循環の調節 : 脳循環. 鈴木郁子, 編. やさしい自律神経生理学 : 命を支える仕組み=Physiology of autonomic nervous system. 東京 : 中外医学社 ; 2015. p.100-4.
 
7) Goadsby PJ. Autonomic nervous system control of the cerebral circulation. In : Buijs RM, Swaab DF, editors. Handbook of clinical neurology. vol. 117. Amsterdam : Elsevier ; 2013. p.193-201.
 
8) Hamel E. Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol (1985). 2006 ; 100 : 1059-64.
 
9) Saeki Y, Sato A, Sato Y, et al. Effects of stimulation of cervical sympathetic trunks with various frequencies on the local cortical cerebral blood flow measured by laser Doppler flowmetry in the rat. Jpn J Physiol. 1990 ; 40 : 15-32.
PubMed
10) Sato A, Sato Y. Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain. Neurosci Res. 1992 ; 14 : 242-74.
PubMed
11) Levi H, Schoknecht K, Prager O, et al. Stimulation of the sphenopalatine ganglion induces reperfusion and blood-brain barrier protection in the photothrombotic stroke model. PLoS One. 2012 ; 7 : e39636.
PubMed
12) Toda N, Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev. 2003 ; 55 : 271-324.
PubMed
13) Morita-Tsuzuki Y, Hardebo JE, Bouskela E. Inhibition of nitric oxide synthase attenuates the cerebral blood flow response to stimulation of postganglionic parasympathetic nerves in the rat. J Cereb Blood Flow Metab. 1993 ; 13 : 993-7.
 
14) 鈴木則宏. 脳血管疾患病態の多様性と神経伝達物質機能の解析を目指して. 臨床神経学. 2012 ; 52 : 819-24.
 
15) Nieuwenhuys R, Voogd J, van Huijzen C. The human central nervous system. 4th ed : Springer ; 2008.
 
16) Adachi T, Chan SHH, Sato A, et al. Regulation of norepinephrine release and cerebral blood flow in the parietal cortex by locus coeruleus in the rat. Biogenic Amines. 1991 ; 8 : 19-31.
 
17) Cao WH, Sato A, Yusof A, et al. Regulation of regional blood flow in cerebral cortex by serotonergic neurons originating in the dorsal raphe nucleus in the rat. Biogenic Amines. 1992 ; 8 : 351-60.
 
18) Biesold D, Inanami O, Sato A, et al. Stimulation of the nucleus basalis of Meynert increases cerebral cortical blood flow in rats. Neurosci Lett. 1989 ; 98 : 39-44.
PubMed
19) Hamner JW, Tan CO. Relative contributions of sympathetic, cholinergic, and myogenic mechanisms to cerebral autoregulation. Stroke. 2014 ; 45 : 1771-7.
PubMed
20) White RP, Vallance P, Markus HS. Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans. Clin Sci (Lond). 2000 ; 99 : 555-60.
PubMed
21) Cassaglia PA, Griffiths RI, Walker AM. Cerebral sympathetic nerve activity has a major regulatory role in the cerebral circulation in REM sleep. J Appl Physiol (1985). 2009 ; 106 : 1050-6.
 
22) Loos N, Grant DA, Wild J, et al. Sympathetic nervous control of the cerebral circulation in sleep. J Sleep Res. 2005 ; 14 : 275-83.
 
23) Beaudin AE, Waltz X, Hanly PJ, et al. Impact of obstructive sleep apnoea and intermittent hypoxia on cardiovascular and cerebrovascular regulation. Exp Physiol. 2017 ; 102 : 743-63.
PubMed
24) Watanabe N, Sasaki S, Masamoto K, et al. Vascular gap junctions contribute to forepaw stimulation-induced vasodilation differentially in the pial and penetrating arteries in isoflurane-anesthetized rats. Front Mol Neurosci. 2018 ; 11 : 446.
PubMed
25) Hosford PS, Gourine AV. What is the key mediator of the neurovascular coupling response? Neurosci Biobehav Rev. 2019 ; 96 : 174-81.
PubMed
26) Piche M, Uchida S, Hara S, et al. Modulation of somatosensory-evoked cortical blood flow changes by GABAergic inhibition of the nucleus basalis of Meynert in urethane-anaesthetized rats. J Physiol. 2010 ; 588 : 2163-71.
PubMed
27) Hotta H, Suzuki H, Inoue T, et al. Involvement of the basal nucleus of Meynert on regional cerebral cortical vasodilation associated with masticatory muscle activity in rats. J Cereb Blood Flow Metab. 2020 ; 40 : 2416-28.
PubMed
28) Kimura A, Okada K, Sato A, et al. Regional cerebral blood flow in the frontal, parietal and occipital cortices increases independently of systemic arterial pressure during slow walking in conscious rats. Neurosci Res. 1994 ; 20 : 309-15.
PubMed
29) Chen YS, Shu K, Kang HC. Deep brain stimulation in Alzheimer's disease : targeting the nucleus basalis of Meynert. J Alzheimers Dis. 2021 ; 80 : 53-70.
PubMed
P.149 掲載の参考文献
1) 黒澤美枝子, 第19章 自律神経系. 本間研一, 監修. 標準生理学 第9版. 東京 : 医学書院 ; 2019.
 
2) 黒澤美枝子. 第1章 神経 IV 自律神経系. 黒澤美枝子, 長谷川薫, 編. 生理学 第3版. 東京 : 中外医学社 ; 2012.
 
3) Sato A, Sato Y, Schmidt RF. The impact of somatosensory input on autonomic functions. Rev Phywiol Biochem Harmacol. 1997 ; 130 : 1-328.
PubMed
4) Sato A, Schmidt RF. Somatosympathetic reflexes : afferent fibers, central pathways, discharge characteristics. Physiol Rev. 1973 ; 53 : 916-47.
PubMed
5) Hines EA Jr, Brown GE. The cold pressor test for measuring the reactivity of the blood pressure : data concerning 571 normal and hypertensive subjects. Am Heart J. 1936 ; 11 : 1-9.
 
6) Moyer CA, Rounds J, Hannum JW. A meta-analysis of massage therapy research. Psychol Bull. 2004 ; 130 : 3-18.
PubMed
7) 今井樹, 下重里江, 徳永亮太, 他. ラットの腹部皮膚触刺激時の動脈圧・心拍数低下反応における自律神経性機序. 自律神経. 2016 ; 53 : 253-9.
Medical*Online
8) Uchida S, Kagitani F, Suzuki A, et al. Effect of acupuncture-like stimulation on cortical cerebral blood flow in anesthetized rats. Jpn J Physiol. 2000 ; 50 : 495-507.
PubMed
9) Kurosawa M, Watanabe O, Maruyama H, et al. Responses of dorsal spinal cord blood flow to innocuous cutaneous stimulation in anesthetized rats. Auton Neurosci. 2006 ; 126-7 : 185-92.
 
10) Kurosawa M, Enomoto K, Aikawa Y, et al. Hepatic blood flow responses to mechanical stimulation of the skin in anaesthetised rats. Auton Neurosci. 2002 ; 99 : 40-6.
PubMed
11) Iimura K, Watanabe N, Masunaga K, et al. Effects of a gentle, self-administered stimulation of perineal skin for nocturia in elderly women : A randomized, placebo-controlled, double-blind crossover trial. PLoS One. 2016 ; 11 : e0151726.
PubMed
12) Yamanishi T, Yasuda K, Sakakibara R, et al. Urinary retention due to herpes virus infects. Neurourol Urodyn. 1998 ; 17 : 613-9.
 
13) Hosoe N, Sakakibara R, Yoshida M, et al. Acute, severe constipation in a 58-year-old Japanese patient. Gut. 2011 ; 60 : 1059, 1093.
 
14) Higashimura Y, Shimoju R, Maruyama H, et a. Electro-acupuncture improves responsiveness to insulin via excitation of somatic afferent fibers in diabetic rats. Auton Neurosci. 2009 ; 150 : 100-3.
PubMed
15) Kurosawa M, Niijima A. Noxious and innocuous mechanical cutaneous stimulation increase the sympathetic efferent nerve activity innervating the interscapular brown adipose tissue in anesthetized rats. J Auton Nerv Syst. 1991 ; 32 : 47-52.
PubMed
16) Shimoju-Kobayashi R, Maruyama H, Yoneda M, et al. Responses of hepatic glucose output to electro-acupuncture stimulation of the hindlimb in anaesthetized rats. Auton Neurosci. 2004 ; 115 : 7-14.
PubMed
P.155 掲載の参考文献
1) Kaufmann H, Norcliffe-Kaufmann L, et al. Baroreflex dysfunction. N Engl J Med. 2020 ; 382 : 163-78.
PubMed
2) Heesch CM. Reflexes that control cardiovascular function. Am J Physiol. 1999 ; 277 (6 Pt 2) : S234-43.
 
3) Zeng WZ, Marshall KL, Min S, et al. PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex. Science. 2018 ; 362 : 464-7.
PubMed
4) Ciriello J. Brainstem projections of aortic baroreceptor afferent fibers in the rat. Neurosci Lett. 1983 ; 36 : 37-42.
PubMed
5) Lenard Z, Studinger P, Kovats Z, et al. Comparison of aortic arch and carotid sinus distensibility in humans--relation to baroreflex sensitivity. Auton Neurosci. 2001 ; 92 (1-2) : 92-9.
PubMed
6) Hainsworth R. Cardiovascular control from cardiac and pulmonary vascular receptors. Exp Physiol. 2014 ; 99 : 312-9.
PubMed
7) Jeske I, Reis DJ, Milner TA. Neurons in the barosensory area of the caudal ventrolateral medulla project monosynaptically on to sympathoexcitatory bulbospinal neurons in the rostral ventrolateral medulla. Neuroscience. 1995 ; 65 : 343-53.
PubMed
8) Sved AF, Ito S, Madden CJ, et al. Excitatory inputs to the RVLM in the context of the baroreceptor reflex. Ann N Y Acad Sci. 2001 ; 940 : 247-58.
 
9) Wang J, Irnaten M, Neff RA, et al. Synaptic and neurotransmitter activation of cardiac vagal neurons in the nucleus ambiguus. Ann N Y Acad Sci. 2001 ; 940 : 237-46.
PubMed
10) Thrasher TN. Baroreceptor regulation of vasopressin and renin secretion : low-pressure versus high-pressure receptors. Front Neuroendocrinol. 1994 ; 15 : 157-96.
PubMed
11) Freeman R, Abuzinadah AR, Gibbons C, et al. Orthostatic hypotension : JACC State-of-the-Art Review. J Am Coll Cardiol. 2018 ; 72 : 1294-309.
PubMed
12) Jacob G, Ertl AC, Shannon JR, et al. Effect of standing on neurohumoral responses and plasma volume in healthy subjects. J Appl Physiol (1985). 1998 ; 84 : 914-21.
PubMed
13) 井上博, 他. 失神の診断・治療ガイドライン (2012年改訂版) 循環器病の診断と治療に関するガイドライン. http://www.j-circ.or.jp/guideline/index.htm
 
14) Gibbons CH, Freeman R. Clinical implications of delayed orthostatichypotension : A 10-year follow-up study. Neurology. 2015 ; 85 : 1362-7.
 
15) Gilani A, Juraschek SP, Belanger MJ, et al. Postural hypotension. BMJ. 2021 ; 373 : n922.
PubMed
16) Mann S, Altman DG, Raftery EB, et al. Circadian variation of blood pressure in autonomic failure. Circulation. 1983 ; 68 : 477-83.
PubMed
17) Kapoor WN, Peterson J, Karpf M. Defecation syncope. A symptom with multiple etiologies. Arch Intern Med. 1986 ; 146 : 2377-9.
PubMed
18) Luciano GL, Brennan MJ, Rothberg MB. Postprandial hypotension. Am J Med. 2010 ; 123 : 281. e1-6.
PubMed
19) Narkiewicz K, Cooley RL, Somers VK. Alcohol potentiates orthostatic hypotension : implications for alcohol-related syncope. Circulation. 2000 ; 101 : 398-402.
PubMed
20) Sugawara J, Tomoto T. Effects of short-term warm water immersion on cardiac baroreflex sensitivity in healthy men. J Physiol Sci. 2020 ; 70 : 34.
 
21) Juraschek SP, Daya N, Appel LJ, et al. Orthostatic hypotension in middle-age and risk of falls. Am J Hypertens. 2017 ; 30 : 188-95.
PubMed
22) Shin C, Abbott RD, Lee H, et al. Prevalence and correlates of orthostatic hypotension in middle-aged men and women in Korea : the Korean Health and Genome Study. J Hum Hypertens. 2004 ; 18 : 717-23.
PubMed
23) Gaspar L, Kruzliak P, Komornikova A, et al. Orthostatic hypotension in diabetic patients-10-year follow-up study. J Diabetes Complications. 2016 ; 30 : 67-71.
PubMed
24) Rose KM, Eigenbrodt ML, Biga RL, et al. Orthostatic hypotension predicts mortality in middle-aged adults : the Atherosclerosis Risk In Communities (ARIC) Study. Circulation. 2006 ; 114 : 630-6.
PubMed
25) Fedorowski A, Stavenow L, Hedblad B, et al. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J. 2010 ; 31 : 85-91.
PubMed
26) Weiss A, Beloosesky Y, Kornowski R, et al. Influence of orthostatic hypotension on mortality among patients discharged from an acute geriatric ward. J Gen Intern Med. 2006 ; 21 : 602-6.
 
27) Raiha I, Luutonen S, Piha J, et al. Prevalence, predisposing factors, and prognostic importance of postural hypotension. Arch Intern Med. 1995 ; 155 : 930-5.
PubMed
28) Ricci F, Fedorowski A, Radico F, et al. Cardiovascular morbidity and mortality related to orthostatic hypotension : a meta-analysis of prospective observational studies. Eur Heart J. 2015 ; 36 : 1609-17.
PubMed
P.166 掲載の参考文献
1) Gibbons CH, Schmidt P, Biaggioni I, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017 ; 264 : 1567-82.
PubMed
2) Baker J, Kimpinski K. Reduced brainstem functional connectivity in patients with peripheral autonomic failure. Neuroimage Clin. 2019 ; 23 : 101924.
PubMed
3) Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011 ; 21 : 69-72.
PubMed
4) Norcliffe-Kaufmann L, Kaufmann H, Palma JA, et al. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol. 2018 ; 83 : 522-31.
PubMed
5) Shaw BH, Garland EM, Black BK, et al. Optimal diagnostic thresholds for diagnosis of orthostatic hypotension with a'sit-to-stand test'. J Hypertens. 2017 ; 35 : 1019-25.
 
6) Fedorowski A, Melander O. Syndromes of orthostatic intolerance : a hidden danger. J Intern Med. 2013 ; 273 : 322-35.
 
7) Pavy-Le Traon A, Piedvache A, Perez-Lloret S, et al. New insights into orthostatic hypotension in multiple system atrophy : a European multicentre cohort study. J Neurol Neurosurg Psychiatry. 2016 ; 87 : 554-61.
PubMed
8) Gibbons CH, Freeman R. Clinical implications of delayed orthostatic hypotension : A 10-year follow-up study. Neurology. 2015 ; 85 : 1362-7.
PubMed
9) 出口一志. head-up tilt試験および起立試験-起立性低血圧の評価. 日本自律神経学会, 編. 自律神経機能検査. 5版. 東京 : 文光堂 ; 2015. p.141-5.
 
10) Deguchi K, Sasaki I, Touge T, et al. Abnormal baroreceptor-mediated vasopressin release as possible marker in early diagnosis of multiple system atrophy. J Neurol Neurosurg Psychiatry. 2004 ; 75 : 110-5.
PubMed
11) Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, et al. Orthostatic hypotension in Parkinson disease : how much you fall or how low you go? Mov Disord. 2015 ; 30 : 639-45.
PubMed
12) Hiorth YH, Pedersen KF, Dalen I, et al. Orthostatic hypotension in Parkinson disease : A 7-year prospective population-based study. Neurology. 2019 ; 93 : e1526-34.
PubMed
13) Goldstein DS. Orthostatic hypotension as an early finding in Parkinson's disease. Clin Auton Res. 2006 ; 16 : 46-54.
PubMed
14) Kaufmann H, Norcliffe-Kaufmann L, Palma JA, et al. Natural history of pure autonomic failure : A United States prospective cohort. Ann Neurol. 2017 ; 81 : 287-97.
PubMed
15) Goldstein DS, Sharabi Y, Karp BI, et al. Cardiac sympathetic denervation preceding motor signs in Parkinson disease. Clin Auton Res. 2007 ; 17 : 118-21.
PubMed
16) Merola A, Romagnolo A, Rosso M, et al. Autonomic dysfunction in Parkinson's disease : A prospective cohort study. Mov Disord. 2018 ; 33 : 391-7.
PubMed
17) Udow SJ, Robertson AD, MacIntosh BJ, et a'l. Under pressure' : is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies? J Neurol Neurosurg Psychiatry. 2016 ; 87 : 1311-21.
 
18) Goldstein DS, Holmes C, Sharabi Y, et al. Survival in synucleinopathies : A prospective cohort study. Neurology. 2015 ; 85 : 1554-61.
PubMed
19) Fereshtehnejad SM, Romenets SR, Anang JB, et al. New clinical subtypes of Parkinson disease and their longitudinal progression : A prospective cohort comparison with other phenotypes. JAMA Neurol. 2015 ; 72 : 863-73.
PubMed
20) Palma JA, Norcliffe-Kaufmann L, Kaufmann H. An orthostatic hypotension mimic : The inebriation-like syndrome in Parkinson disease. Mov Disord. 2016 ; 31 : 598-600.
PubMed
21) McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies : Fourth consensus report of the DLB Consortium. Neurology. 2017 ; 89 : 88-100.
PubMed
22) Horimoto Y, Matsumoto M, Akatsu H, et al. Autonomic dysfunctions in dementia with Lewy bodies. J Neurol. 2003 ; 250 : 530-3.
PubMed
23) Fujishiro H, Iseki E, Nakamura S, et al. Dementia with Lewy bodies : early diagnostic challenges. Psychogeriatrics. 2013 ; 13 : 128-38.
PubMed
24) Thaisetthawatkul P, Boeve BF, Benarroch EE, et al. Autonomic dysfunction in dementia with Lewy bodies. Neurology. 2004 ; 62 : 1804-9.
PubMed
25) Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008 ; 71 : 670-6.
PubMed
26) Yamamoto T, Asahina M, Yamanaka Y, et al. Postvoid residual predicts the diagnosis of multiple system atrophy in Parkinsonian syndrome. J Neurol Sci. 2017 ; 381 : 230-4.
 
27) Wenning GK, Granata R, Krismer F, et al. Orthostatic hypotension is differentially associated with the cerebellar versus the parkinsonian variant of multiple system atrophy : a comparative study. Cerebellum. 2012 ; 11 : 223-6.
PubMed
28) Wecht JM, Bauman WA. Implication of altered autonomic control for orthostatic tolerance in SCI. Auton Neurosci. 2018 ; 209 : 51-8.
PubMed
29) Illman A, Stiller K, Williams M. The prevalence of orthostatic hypotension during physiotherapy treatment in patients with an acute spinal cord injury. Spinal Cord. 2000 ; 38 : 741-7.
PubMed
30) Cariga P, Ahmed S, Mathias CJ, et al. The prevalence and association of neck (coat-hanger) pain and orthostatic (postural) hypotension in human spinal cord injury. Spinal Cord. 2002 ; 40 : 77-82.
PubMed
31) Wecht JM, Weir JP, Galea M, et al. Prevalence of abnormal systemic hemodynamics in veterans with and without spinal cord injury. Arch Phys Med Rehabil. 2015 ; 96 : 1071-9.
PubMed
32) Pop-Busui R. Cardiac autonomic neuropathy in diabetes : a clinical perspective. Diabetes Care. 2010 ; 33 : 434-41.
PubMed
33) Fleg JL, Evans GW, Margolis KL, et al. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) blood pressure trial : Prevalence, incidence, and prognostic significance. Hypertension. 2016 ; 68 : 888-95.
PubMed
34) Palma JA, Gonzalez-Duarte A, Kaufmann H. Orthostatic hypotension in hereditary transthyretin amyloidosis : epidemiology, diagnosis and management. Clin Auton Res. 2019 ; 29 (Suppl 1) : 33-44.
 
35) Gonzalez-Duarte A, Barroso F, Mundayat R, et al. Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS). Auton Neurosci. 2019 ; 222 : 102590.
PubMed
36) Golden EP, Vernino S. Autoimmune autonomic neuropathies and ganglionopathies : epidemiology, pathophysiology, and therapeutic advances. Clin Auton Res. 2019 ; 29 : 277-88.
PubMed
37) Mtinangi BL, Hainsworth R. Early effects of oral salt on plasma volume, orthostatic tolerance, and baroreceptor sensitivity in patients with syncope. Clin Auton Res. 1998 ; 8 : 231-5.
PubMed
38) Deguchi K, Ikeda K, Sasaki I, et al. Effects of daily water drinking on orthostatic and postprandial hypotension in patients with multiple system atrophy. J Neurol. 2007 ; 254 : 735-40.
PubMed
39) Newton JL, Frith J. The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging. Neurology. 2018 ; 91 : e652-e6.
PubMed
40) Freeman R, Abuzinadah AR, Gibbons C, et al. Orthostatic Hypotension : JACC State-of-the-Art Review. J Am Coll Cardiol. 2018 ; 72 : 1294-309.
PubMed
41) Low DA, da Nobrega AC, Mathias CJ. Exercise-induced hypotension in autonomic disorders. Auton Neurosci. 2012 ; 171 : 66-78.
PubMed
42) Fanciulli A, Goebel G, Metzler B, et al. Elastic abdominal binders attenuate orthostatic hypotension in Parkinson's disease. Mov Disord Clin Pract. 2016 ; 3 : 156-60.
PubMed
43) Okamoto LE, Diedrich A, Baudenbacher FJ, et al. Efficacy of servo-controlled splanchnic venous compression in the treatment of orthostatic hypotension : A randomized comparison with midodrine. Hypertension. 2016 ; 68 : 418-26.
PubMed
44) Ten Harkel AD, Van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Intern Med. 1992 ; 232 : 139-45.
PubMed
45) Ando Y, Asahara K, Obayashi K, et al. Autonomic dysfunction and anemia in neurologic disorders. J Auton Nerv Syst. 1996 ; 61 : 145-8.
PubMed
46) Beitzke M, Pfister P, Fortin J, et al. Autonomic dysfunction and hemodynamics in vitamin B12 deficiency. Auton Neurosci. 2002 ; 97 : 45-54.
PubMed
47) Skrabal F. Syncope, falls and cobalamin deficiency in the old population. Clin Auton Res. 2004 ; 14 : 60-6.
PubMed
48) Parsaik AK, Singh B, Altayar O, et al. Midodrine for orthostatic hypotension : a systematic review and meta-analysis of clinical trials. J Gen Intern Med. 2013 ; 28 : 1496-503.
PubMed
49) Chen JJ, Hewitt LA. Comparison of the pharmacokinetics of droxidopa after dosing in the fed versus fasted state and with 3-times-daily dosing in healthy elderly subjects. Drugs R D. 2018 ; 18 : 77-86.
PubMed
50) Park JW, Okamoto LE, Shibao CA, et al. Pharmacologic treatment of orthostatic hypotension. Auton Neurosci. 2020 ; 229 : 102721.
PubMed
51) Biaggioni I, Arthur Hewitt L, Rowse GJ, et al. Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension. BMC Neurol. 2017 ; 17 : 90.
PubMed
52) Kurihara J, Takata Y, Suzuki S, et al. Effect of midodrine on chlorpromazine-induced orthostatic hypotension in rabbits : comparison with amezinium, etilefrine and droxidopa. Biol Pharm Bull. 2000 ; 23 : 1445-9.
PubMed
53) Sakakibara R, Uchiyama T, Asahina M, et al. Amezinium metilsulfate, a sympathomimetic agent, may increase the risk of urinary retention in multiple system atrophy. Clin Auton Res. 2003 ; 13 : 51-3.
PubMed
54) Singer W, Sandroni P, Opfer-Gehrking TL, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006 ; 63 : 513-8.
PubMed
55) Schreglmann SR, Buchele F, Sommerauer M, et al. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease-a randomized controlled trial. Eur J Neurol. 2017 ; 24 : 545-51.
PubMed
56) Fanciulli A, Jordan J, Biaggioni I, et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res. 2018 ; 28 : 355-62.
PubMed
57) Palma JA, Kaufmann H. Orthostatic hypotension in Parkinson disease. Clin Geriatr Med. 2020 ; 36 : 53-67.
PubMed
P.186 掲載の参考文献
1) de Groat WC, Griffiths D, Yoshimura N. Neural control of the lower urinary tract. Compr Physiol. 2015 ; 5 : 327-96.
PubMed
2) Miyazato M, Kadekawa K, Kitta T, et al. New frontiers of basic science research in neurogenic lower urinary tract dysfunction. Urol Clin North Am. 2017 ; 44 : 491-505.
PubMed
3) Andersson KE, Garcia Pascual A, Persson K, et al. Electrically-induced, nerve-mediated relaxation of rabbit urethra involves nitric oxide. J Urol. 1992 ; 147 : 253-59.
PubMed
4) de Groat WC, Nadelhaft I, Milne RJ, et al. Organization of the sacral parasympathetic reflex pathways to the urinary bladder and large intestine. J Auton Nerv Syst. 1981 ; 3 : 135-60.
 
5) Callsen-Cencic P, Mense S. Expression of neuropeptides and nitric oxide synthase in neurones innervating the inflamed rat urinary bladder. J Auton Nerv Syst. 1997 ; 65 : 33-44.
PubMed
6) Vizzard MA. Alterations in neuropeptide expression in lumbosacral bladder pathways following chronic cystitis. J Chem Neuroanat. 2001 ; 21 : 125-38.
PubMed
7) Birder L, Andersson KE. Urothelial signaling. Physiol Rev. 2013 ; 93 : 653-80.
PubMed
8) Hashitani H. Interaction between interstitial cells and smooth muscles in the lower urinary tract and penis. J Physiol. 2006 ; 576 : 707-14.
PubMed
9) 日本泌尿器科学会. 男性下部尿路症状・前立腺肥大症診療ガイドライン. 男性下部尿路症状・前立腺肥大症診療ガイドライン作成委員会, 編. RichHill Medical ; 2017.
 
10) Hirayama A, Fujimoto K, Matsumoto Y, et al. Positive response to ice water test associated with high-grade bladder outlet obstruction in patients with benign prostatic hyperplasia. Urology. 2003 ; 62 : 909-13.
PubMed
11) Yokoyama O, Miwa Y, Oyama N, et al. Urethral sensations are related to the development of detrusor overactivity. Low Urin Tract Symptoms. 2011 ; 3 : 59-63.
 
12) 吉村直樹, 橘田岳也, 嘉手川豪心, 他. 中枢神経系における排尿薬理機構の概説. 日本薬理学雑誌. 2020 ; 155 : 4-9.
Medical*Online
13) Holstege G, Griffiths D, de Wall H, et al. Anatomical and physiological observations on supraspinal control of bladder and urethral sphincter muscles in the cat. J Comp Neurol. 1986 ; 250 : 449-61.
 
14) Nishizawa O, Sugaya K, Noto H, et al. Pontine urine storage center in the dog. Tohoku J Exp Med. 1987 ; 153 : 77-8.
PubMed
15) Holstege G. The emotional motor system and micturition control. Neurourol Urodyn. 2010 ; 29 : 42-8.
PubMed
16) Tye KM, Deisseroth K. Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat Rev Neurosci. 2012 ; 13 : 251-66.
PubMed
17) Sternson SM, Roth BL. Chemogenetic tools to interrogate brain functions. Annu Rev Neurosci. 2014 ; 37 : 387-407.
PubMed
18) Hou XH, Hyun M, Taranda J, et al. Central Control Circuit for Context-Dependent Micturition. Cell. 2016 ; 167 : 73-86. e12.
 
19) Keller JA, Chen J, Simpson S, et al. Voluntary urination control by brainstem neurons that relax the urethral sphincter. Nat Neurosci. 2018 ; 21 : 1229-38.
PubMed
20) Yao J, Zhang Q, Liao X, et al. A corticopontine circuit for initiation of urination. Nat Neurosci. 2018 ; 21 : 1541-50.
PubMed
21) Blok BF, Willemsen AT, Holstege G. A PET study on brain control of micturition in humans. Brain. 1997 ; 120 : 111-21.
 
22) Griffiths D, Derbyshire S, Stenger A, et al. Brain control of normal and overactive bladder. J Urol. 2005 ; 174 : 1862-7.
PubMed
23) Nour S, Svarer C, Kristensen JK, et al. Cerebral activation during micturition in normal men. Brain. 2000 ; 123 : 781-9.
PubMed
24) Griffiths D. Neural control of micturition in humans : a working model. Nat Rev Urol. 2015 ; 12 : 695-705.
PubMed
25) Tanaka H, Kakizaki H, Shibata T, et al. Effects of a selective metabotropic glutamate receptor agonist on the micturition reflex pathway in urethane-anesthetized rats. Neurourol Urodyn. 2003 ; 22 : 611-6.
PubMed
26) Yoshiyama M, de Groat WC. Role of spinal metabotropic glutamate receptors in regulation of lower urinary tract function in the decerebrate unanesthetized rat. Neurosci Lett. 2007 ; 420 : 18-22.
PubMed
27) Miyazato M, Kaiho Y, Kamo I, et al. Role of spinal serotonergic pathways in sneeze-induced urethral continence reflex in rats. Am J Physiol Renal Physiol. 2009 ; 297 : F1024-31.
PubMed
28) Suzuki T, Shimizu T, Kwon J, et al. Role of the serotonergic system in urethral continence reflexes during sneezing in rats. Am J Physiol Renal Physiol. 2018 ; 315 : F79-85.
PubMed
29) Chiba H, Kitta T, Ohmura Y, et al. Serotonin in the rat prefrontal cortex controls the micturition reflex through 5-hydroxytryptamine 2A and 5-hydroxytryptamine 7 receptors. Int J Urol. 2020 ; 27 : 684-9.
PubMed
30) Kaiho Y, Kamo I, Chancellor MB, et al. Role of noradrenergic pathways in sneeze-induced urethral continence reflex in rats. Am J Physiol Renal Physiol. 2007 ; 292 : F639-46.
PubMed
31) Kitta T, Miyazato M, Chancellor MB, et al. Alpha2-adrenoceptor blockade potentiates the effect of duloxetine on sneeze induced urethral continence reflex in rats. J Urol. 2010 ; 184 : 762-8.
PubMed
32) Ogawa T, Sakakibara R, Kuno S, et al. Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy. Nat Rev Urol. 2017 ; 14 : 79-89.
PubMed
33) Yokoyama O, Ootsuka N, Komatsu K, et al. Forebrain muscarinic control of micturition reflex in rats. Neuropharmacology. 2001 ; 41 : 629-38.
PubMed
34) Masuda H, Hayashi Y, Chancellor MB, et al. Roles of peripheral and central nicotinic receptors in the micturition reflex in rats. J Urol. 2006 ; 176 : 374-9.
PubMed
35) Lee SJ, Nakamura Y, de Groat WC. Effect of (+/-) -epibatidine, a nicotinic agonist, on the central pathways controlling voiding function in the rat. Am J Physiol Regul Integr Comp Physiol. 2003 ; 285 : R84-90.
PubMed
36) Shimizu Y, Shimizu T, Zou S, et al. Stimulation of brain α7-nicotinic acetylcholine receptors suppresses the rat micturition through brain GABAergic receptors. Biochem Biophys Res Commun. 2021 ; 548 : 84-90.
 
37) Giuliano F, Rampin O. Neural control of erection. Physiol Behav. 2004 ; 83 : 189-201.
PubMed
38) Andersson KE. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev. 2011 ; 63 : 811-59.
PubMed
39) Coolen LM, Allard J, Truitt WA, et al. Central regulation of ejaculation. Physiol Behav. 2004 ; 83 : 203-15.
PubMed
40) Vaughan E, Fisher AE. Male sexual behavior induced by intracranial electrical stimulation. Science. 1962 ; 137 : 758-60.
PubMed
41) Heimer L, Larsson K. Impairment of mating behavior in male rats following lesions in the preoptic-anterior hypothalamic continuum. Brain Research. 1967 ; 3 : 248-63.
 
42) Sato Y, Christ GJ. Differential ICP responses elicited by electrical stimulation of medial preoptic area. Am J Physiol Heart Circ Physiol. 2000 ; 278 : H964-70.
PubMed
43) Marson L. Lesions of the periaqueductal gray block the medial preoptic area-induced activation of the urethrogenital reflex in male rats. Neurosci Lett. 2004 ; 367 : 278-82.
PubMed
P.214 掲載の参考文献
1) 失神の診断・治療ガイドライン (2012年改訂版).
Medical*Online
2) Sakakibara R, et al. Urodynamic and cardiovascular measurements in patients with micturition syncope. Clin Auton Res. 1997 ; 7 : 219-21.
PubMed
3) Uchiyama T, Sakakibara R. Post-micturitional hypotension in patients with multiple system atrophy. J Neurol Neurosurg Psychiatry. 2005 ; 76 : 186-90.
PubMed
P.216 掲載の参考文献
1) Kawabe K, Yoshida M, Homma Y. Silodosin, a new alpha 1A-adrenoceptorselective antagonist for treating benign prostatic hyperplasia : results of a phase III randomized, placebo-controlled, double-blind study in Japanese men. BJU Int. 2006 ; 98 : 1019-24.
 
1) 日本排尿機能学会 過活動膀胱ガイドライン作成委員会, 編. 過活動膀胱診療ガイドライン [第2版]. 東京 : リッチヒルメディカル ; 2015.
 
2) Masumori N. Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia. Therapeutics and Clinical Risk Management. 2011 : 7 ; 227-238.
PubMed
2) Uchiyama T, Sakakibara R, Yamamoto T, et al. Urinary dysfunction in early and untreated Parkinson's disease. J Neurol Neurosurg Psychiatry. 2011 ; 82 : 1382-8.
PubMed
3) Gomes CM, Sammour ZM, Junior JDB, et al. Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson's disease. Clinics. 2014 : 69 : 817-22.
 
3) Winge K, Fowler CJ. Bladder dysfunction in Parkinsonism : mechanisms, prevalence, symptoms, and management. Mov Disord. 2006 ; 21 : 737-45. Review.
PubMed
4) Kaufmann H, Goldstein DS. Autonomic dysfunction in Parkinson disease. Handb Clin Neurol. 2013 ; 117 : 259-78.
PubMed
4) 内山智之, 榊原隆次, 山本達也, 他. パーキンソン病の排泄障害update. 自律神経 2013 ; 50 : 205-7.
 
5) Takahashi O, Sakakibara R, Tateno F, et al. Overactive bladder may precede motor disorder in Parkinson's disease : A urodynamic study. Parkinsonism Relat Disord. 2014 : S1353-8020 (14) 00229-6. doi : 10.1016/j.parkreldis.2014.06.009. [Epub ahead of print]
 
5) Sakakibara R, Hattori T, Uchiyama T, et al. Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte J Auton Nerv Syst. 2000 : 15 ; 191-5.
 
6) Sakakibara R, Hattori T, Uchiyama T, et al. Urinary dysfunction and orthostatic hypotension in multiple system atrophy : which is the more common and earlier manifestation? J Neurol Neurosurg Psychiatry. 2000 ; 68 : 65-9.
PubMed
7) パーキンソン病における下部尿路機能障害診療ガイドライン. 東京 : 中外医学社 ; 2017.
 
8) Lim CS, Abrams P. The Abrams-Griffiths nomogram. World J Urol. 1995 ; 13 : 34-9.
PubMed
9) Schafer W. Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction : from complex to simple.
 
10) 日本排尿機能学会 女性下部尿路症状診療ガイドライン作成委員会, 編. 女性下部尿路症状診療ガイドライン. 東京 : リッチヒルメディカル ; 2013.
 
11) Abrams P, Cardozo L, Fall M, et al ; Standardisation Sub-committee of the International Continence Society. The Standardisation of terminology of lower urinary tract function : report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002 ; 21 : 167-78.
 
12) Abrams P, Cardozo L, Fall M, et al ; Standardisation Sub-committee of the International Continence Society. The Standardisation of terminology of lower urinary tract function : report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002 ; 21 : 167-78.
 
13) Sakakibara R, Uchiyama T, Yamanishi T, et al. Sphincter EMG as a diagnostic tool in autonomic disorders. Clin Auton Res. 2009 ; 19 : 20-31.
 
14) Yamamoto T, Sakakibara R, Uchiyama T, et al. Receiver operating characteristic analysis of sphincter electromyography for parkinsonian syndrome. Neurourol Urodyn. 2012 ; 31 : 1128-1134.
PubMed
15) Gilad R, Giladi N, Korczyn AD, et al. Quantitative anal sphincter EMG in multisystem atrophy and 100 controls. J Neurol Neurosurg Psychiatry. 2001 ; 71 : 596-9.
PubMed
16) パーキンソン病における下部尿路機能障害診療ガイドライン. 東京 : 中外医学社 ; 2017.
 
17) Andrew J, Nathan PW. Lesions of the anterior frontal lobes and disturbances of micturition and defaecation. Brain. 1964 ; 87 : 233-62.
PubMed
18) 植木幸明. 脳腫瘍患者よりみた排尿障害. 綜合臨床. 1960 ; 9 : 1361-70.
 
19) Fukuyama H, Matsuzaki S, Ouchi Y, et al. Neural control of micturition in man examined with single photon emission computed tomography using 99mTc-HMPAO. Neuroreport. 1996 ; 7 : 3009-12.
PubMed
20) Matsuura S, Kakizaki H, Mitsui T, et al. Human brain region response to distention or cold stimulation of the bladder : a positron emission tomography study. J Urol. 2002 ; 168 : 2035-9.
PubMed
21) Kavia RB, Dasgupta R, Fowler CJ. Functional imaging and the central control of the bladder. J Comp Neurol. 2005 ; 493 : 27-32.
PubMed
22) DasGupta R, Kavia RB, Fowler CJ. Cerebral mechanisms and voiding function. BJU Int. 2007 ; 99 : 731-4.
PubMed
23) Tadic SD, Griffiths D, Schaefer W, et al. Abnormal connections in the supraspinal bladder control network in women with urge urinary incontinence. Neuroimage. 2008 ; 39 : 1647-53.
PubMed
24) Fowler CJ, Griffiths DJ. A decade of functional brain imaging applied to bladder control. Neurourol Urodyn. 2010 ; 29 : 49-55.
PubMed
25) Griffiths D, Derbyshire S, Stenger A, et al. Brain control of normal and overactive bladder. J Urol. 2005 ; 174 : 1862-7.
PubMed
26) Sakakibara R, Tsunoyama K, Takahashi O, et al. Real-time measurement of oxyhemoglobin concentration changes in the frontal micturition area : an fNIRS study. Neurourol Urodyn. 2010 ; 29 : 757-64.
PubMed
27) Tadic SD, Griffiths D, Schaefer W, Murrin A, Clarkson B, Resnick NM : Brain activity underlying impaired continence control in older women with overactive bladder. Neurourol Urodyn. 2012 ; 31 : 652-8.
PubMed
28) 日本排尿機能学会 過活動膀胱ガイドライン作成委員会編. 過活動膀胱診療ガイドライン [第2版]. 東京 : リッチヒルメディカル ; 2015.
 
29) 榊原隆次, 舘野冬樹, 岸雅彦, 他. 高齢者における脳疾患と排尿機能障害, 日本老年医学会雑誌. 2013 ; 50 : 446-52.
 
30) Sakakibara R, Panicker J, Fowler CJ, et a"l. Vascular incontinence" : incontinence in the elderly due to ischemic white matter changes. Neurology International. 2012 ; 4 : e13.
 
31) Sakakibara R, Hattori T, Uchiyama T, et al. Urinary function in the elderly with and without leukoaraiosis ; in relation to cognitive and gait function. J Neurol Neurosurg Psychiatry. 1999 ; 67 : 658-60.
PubMed
32) Yamaguchi C, Sakakibara R, Uchiyama T, et al. Overactive bladder in diabetes : a peripheral or central mechanism? Neurourol Urodyn. 2007 ; 26 : 807-13.
PubMed
33) 過活動膀胱診療ガイドライン. 第2版. 東京 : リッチヒルメディカル ; 2015.
 
34) 女性下部尿路症状診療ガイドライン. 第2版, 東京 : リッチヒルメディカル ; 2019.
 
35) 男性下部尿路症状・前立腺肥大症診療ガイドライン. 東京 : リッチヒルメディカル ; 2017.
 
36) Sakakibara R, Yamaguchi C, Yamamoto T, et al. Imidapril, an angiotensin-converting enzyme inhibitor, can reverse loss of bladder sensation. J Neurol Neurosurg Psychiatry. 2006 ; 77 : 1100-1.
PubMed
37) Fowler CJ, Panicker JN, Drake M, et al. A UK consensus on the management of the bladder in multiple sclerosis. Postgrad Med J. 2009 ; 85 : 552-9.
 
38) Takeda M, Homma Y, Araki I, et al. Predictive factors for the effect of the a1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogeniclower urinary tract dysfunction. BJU Int. 2011 ; 108 : 100-7.
 
39) Sakakibara R, Uchiyama T, Asahina M, et al. Amezinium metilsulfate, a sympathomimetic agent, may increase the risk of urinary retention in multiple system atrophy. Clin Auton Res. 2003 ; 13 : 51-3.
PubMed
40) Yamanishi T, Yasuda K, Kamai T, et al. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol. 2004 ; 11 : 88-96.
 
41) Yamamoto T, Sakakibara R, Yamanaka Y, et al. Pyridostigmine in autonomic failure : can we treat postural hypotension and bladder dysfunction with one drug? Clin Auton Res 2006 ; 16 : 296-8.
PubMed
42) Yamamoto T, Sakakibara R, Uchiyama T, et al. Neurological diseases that cause detrusor hyperactivity with impaired contractile function. Neurourol Urodyn. 2006 ; 25 : 356-60.
PubMed
43) Ito T, Sakakibara R, Yasuda K, et al. Incomplete emptying and urinary retention in multiple system atrophy : when does it occur and how do we manage it? Mov Disord. 2006 ; 21 : 816-23.
PubMed
44) Sakakibara R, Uchiyama T, Yamanishi T, et al. Sphincter EMG as a diagnostic tool in autonomic disorders. Clin Auton Res. 2009 ; 19 : 20-31.
 
P.229 掲載の参考文献
1) Cannon WB, Washburn AL. An explanation of hunger. Am J Physiol. 1912 ; 29 : 441-54.
 
2) Lashley KS : Experimental analysis of instinctive behavior. Psychological Review. 1938 ; 45 : 445-71.
 
3) Hetherington AW, Ranson SW. The spontaneous activity and food intake of rats with hypothalamic lesions. Am J Physiol. 1942 ; 136 : 609-17.
 
4) Anand BK, Brobeck JR. Hypothalamic control of food intake in rats and cats. Yale J Biol Med. 1951 ; 24 : 123-40.
PubMed
5) Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest. 2007 ; 117 : 13-23.
PubMed
6) Lemmens SG, Martens EA, Kester AD, et al. Changes in gut hormone and glucose concentrations in relation to hunger and fullness. Am J Clin Nutr. 2011 ; 94 : 717-25.
PubMed
7) Berthoud HR. Anatomy and function of sensory hepatic nerves. Anat Rec A Discov Mol Cell Evol Biol. 2004 ; 280 : 827-35.
PubMed
8) Berthoud HR, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci. 2000 ; 85 (1-3) : 1-17.
 
9) Berthoud HR and Neuhuber WL. Vagal mechanisms as neuromodulatory targets for the treatment of metabolic disease. Ann N Y Acad Sci. 2019 ; 1454 : 42-55.
PubMed
10) Williams EK, Chang RB, Strochlic DE, et al. Sensory neurons that detect stretch and nutrients in the digestive system. Cell. 2016 ; 166 : 209-21.
PubMed
11) Bai L, Mesgarzadeh S, Ramesh KS, et al. Genetic identification of vagal sensory neurons that control feeding. Cell. 2019 ; 179 : 1129-43 e1123.
 
12) Han W, Tellez LA, Perkins MH, et al. A neural circuit for gut-induced reward. Cell. 2018 ; 175 : 665-78 e623.
 
13) Prechtl JC, Powley TL. The fiber composition of the abdominal vagus of the rat. Anat Embryol (Berl). 1990 ; 181 : 101-15.
PubMed
14) Paintal AS. Vagal afferent fibres. Ergeb Physiol. 1963 ; 52 : 74-156.
PubMed
15) Powley TL, Berthoud HR, Prechtl JC, et al. Fibers of the vagus regulating gastrointestinal function. In : Tache Y, Wingate D, editors. Brain-gut interactions. Boca Ratan, FL : CRC Press ; 1991. p.73-82.
 
16) Brookes SJ, Spencer NJ, Costa M, et al. Extrinsic primary afferent signalling in the gut. Nat Rev Gastroenterol Hepatol. 2013 ; 10 : 286-96.
PubMed
17) Berthoud HR. The vagus nerve, food intake and obesity. Regul Pept. 2008 ; 149 (1-3) : 15-25.
 
18) Kaelberer MM, Buchanan KL, Klein ME, et al. A gut-brain neural circuit for nutrient sensory transduction. Science. 2018 ; 361 (6408) : eaat5236.
PubMed
19) Bohorquez DV, Shahid RA, Erdmann A, et al. Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells. J Clin Invest. 2015 ; 125 : 782-6.
PubMed
20) Phillips RJ, Powley TL. Gastric volume rather than nutrient content inhibits food intake. Am J Physiol. 1996 ; 271 (3 Pt 2) : R766-9.
PubMed
21) Deutsch JA. Dietary control and the stomach. Prog Neurobiol. 1983 ; 20 (3-4) : 313-32.
 
22) Berthoud HR, Blackshaw LA, Brookes SJ, et al. Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol Motil. 2004 ; 16 Suppl 1 : 28-33.
 
23) Wang YB, de Lartigue G, Page AJ. Dissecting the role of subtypes of gastrointestinal vagal afferents. Front Physiol. 2020 ; 11 : 643.
PubMed
24) Kim DY, Heo G, Kim M, et al. A neural circuit mechanism for mechanosensory feedback control of ingestion. Nature. 2020 ; 580 : 376-80.
 
25) Deutsch JA, Gonzalez MF. Gastric nutrient content signals satiety. Behav Neural Biol. 1980 ; 30 : 113-6.
PubMed
26) Feinle C, Grundy D, Read NW. Effects of duodenal nutrients on sensory and motor responses of the human stomach to distension. Am J Physiol. 1997 ; 273 (3 Pt 1) : G721-6.
 
27) Ritter RC. Gastrointestinal mechanisms of satiation for food. Physiol Behav. 2004 ; 81 : 249-73.
PubMed
28) Kaplan JM, Spector AC, Grill HJ. Dynamics of gastric emptying during and after stomach fill. Am J Physiol. 1992 ; 263 (4 Pt 2) : R813-9.
PubMed
29) Ohbayashi K, Oyama Y, Yamaguchi C, et al. Gastrointestinal distension by pectin-containing carbonated solution suppresses food intake and enhances glucose tolerance via GLP-1 secretion and vagal afferent activation. Front Endocrinol. 2021 ; 12 : 676869.
PubMed
30) Grabauskas G, Song I, Zhou S, et al. Electrophysiological identification of glucose-sensing neurons in rat nodose ganglia. J Physiol. 2010 ; 588 (Pt 4) : 617-32.
PubMed
31) Raybould HE. Gut chemosensing : interactions between gut endocrine cells and visceral afferents. Auton Neurosci. 2010 ; 153 (1-2) : 41-6.
 
32) Niijima A, Torii K, Uneyama H. Role played by vagal chemical sensors in the hepato-portal region and duodeno-intestinal canal : an electrophysiological study. Chem Senses. 2005 ; 30 (Suppl 1) : i178-9.
 
33) Tan HE, Sisti AC, Jin H, et al. The gut-brain axis mediates sugar preference. Nature. 2020 ; 580 : 511-6.
PubMed
34) Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999 ; 402 : 656-60.
PubMed
35) Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 2001 ; 86 : 4753-8.
PubMed
36) Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001 ; 409 : 194-8.
PubMed
37) Masuda Y, Tanaka T, Inomata N et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000 ; 276 : 905-8.
PubMed
38) Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000 ; 407 : 908-13.
PubMed
39) Yada T, Damdindorj B, Rita RS, et al. Ghrelin signalling in beta-cells regulates insulin secretion and blood glucose. Diabetes Obes Metab. 2014 ; 16 (Suppl 1) : 111-7.
 
40) Kojima M, Kangawa K. Drug insight : The functions of ghrelin and its potential as a multitherapeutic hormone. Nat Clin Pract Endocrinol Metab. 2006 ; 2 : 80-8.
PubMed
41) Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001 ; 50 : 1714-9.
PubMed
42) Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes. 2001 ; 50 : 2540-7.
PubMed
43) Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001 ; 86 : 5992.
PubMed
44) Akamizu T, Takaya K, Irako T, et al. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol. 2004 ; 150 : 447-55.
PubMed
45) Banks WA, Tschop M, Robinson SM, et al. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther. 2002 ; 302 : 822-7.
PubMed
46) Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology. 2002 ; 123 : 1120-8.
PubMed
47) Grabauskas G, Wu X, Lu Y, et al. KATP channels in the nodose ganglia mediate the orexigenic actions of ghrelin. J Physiol. 2015 ; 593 : 3973-89.
PubMed
48) Date Y, Toshinai K, Koda S, et al. Peripheral interaction of ghrelin with cholecystokinin on feeding regulation. Endocrinology. 2005 ; 146 : 3518-25.
PubMed
49) Iwasaki Y, Dezaki K, Kumari P, et al. Ghrelin counteracts insulin-induced activation of vagal afferent neurons via growth hormone secretagogue receptor. Neuropeptides. 2015 ; 52 : 55-60.
PubMed
50) Date Y, Shimbara T, Koda S, et al. Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus. Cell Metab. 2006 ; 4 : 323-31.
 
51) Wang L, Saint-Pierre DH, Tache Y. Peripheral ghrelin selectively increases Fos expression in neuropeptide Y- synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett. 2002 ; 325 : 47-51.
PubMed
52) Sun Y, Wang P, Zheng H, et al. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A. 2004 ; 101 : 4679-84.
PubMed
53) Davis EA, Wald HS, Suarez AN, et al. Ghrelin signaling affects feeding behavior, metabolism, and memory through the vagus nerve. Curr Biol. 2020 ; 30 : 4510-8 e4516.
 
54) Miller LJ, Gao F. Structural basis of cholecystokinin receptor binding and regulation. Pharmacol Ther. 2008 ; 119 : 83-95.
PubMed
55) Karhunen LJ, Juvonen KR, Huotari A, et al. Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans. Regul Pept. 2008 ; 149 (1-3) : 70-8.
 
56) Passaro E Jr, Debas H, Oldendorf W, et al. Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation. Brain Res. 1982 ; 241 : 335-40.
PubMed
57) Zhu XG, Greeley GH Jr, Lewis BG, et al. Blood-CSF barrier to CCK and effect of centrally administered bombesin on release of brain CCK. J Neurosci Res. 1986 ; 15 : 393-403.
 
58) Simasko SM, Wiens J, Karpiel A, et al. Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons. Am J Physiol Regul Integr Comp Physiol. 2002 ; 283 : R1303-13.
 
59) Peters JH, Ritter RC, Simasko SM. Leptin and CCK selectively activate vagal afferent neurons innervating the stomach and duodenum. Am J Physiol Regul Integr Comp Physiol. 2006 ; 290 : R1544-9.
PubMed
60) Iwasaki Y, Yada T. Vagal afferents sense meal-associated gastrointestinal and pancreatic hormones : mechanism and physiological role. Neuropeptides. 2012 ; 46 : 291-7.
PubMed
61) Raybould HE, Tache Y. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am J Physiol. 1988 ; 255 (2 Pt 1) : G242-6.
 
62) Cheung GW, Kokorovic A, Lam CK, et al. Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab. 2009 ; 10 : 99-109.
PubMed
63) Smith GP, Jerome C, Cushin BJ, et al. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science. 1981 ; 213 : 1036-7.
PubMed
64) Heldsinger A, Lu Y, Zhou SY, et al. Cocaine- and amphetamine-regulated transcript is the neurotransmitter regulating the action of cholecystokinin and leptin on short-term satiety in rats. Am J Physiol Gastrointest Liver Physiol. 2012 ; 303 : G1042-51.
PubMed
65) Cawston EE, Miller LJ. Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor. Br J Pharmacol. 2010 ; 159 : 1009-21.
PubMed
66) Bodnaruc AM, Prud'homme D, Blanchet R, et al. Nutritional modulation of endogenous glucagon-like peptide-1 secretion : a review. Nutr Metab (Lond). 2016 ; 13 : 92.
 
67) Orskov C, Wettergren A, Holst JJ. Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day. Scand J Gastroenterol. 1996 ; 31 : 665-70.
PubMed
68) Muller TD, Finan B, Bloom SR, et al. Glucagon-like peptide 1 (GLP-1). Mol Metab. 2019 ; 30 : 72-130.
PubMed
69) Kakei M, Yada T, Nakagawa A, et al. Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons. Auton Neurosci. 2002 ; 102 (1-2) : 39-44.
 
70) Iwasaki Y, Goswami C, Yada T. Glucagon-like peptide-1 and insulin synergistically activate vagal afferent neurons. Neuropeptides. 2017 ; 65 : 77-82.
PubMed
71) Abbott CR, Monteiro M, Small CJ, et al. The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 2005 ; 1044 : 127-31.
PubMed
72) Talsania T, Anini Y, Siu S, et al. Peripheral exendin-4 and peptide YY3-36 synergistically reduce food intake through different mechanisms in mice. Endocrinology. 2005 ; 146 : 3748-56.
PubMed
73) Krieger JP, Arnold M, Pettersen KG, et al. Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia. Diabetes. 2016 ; 65 : 34-43.
PubMed
74) Iwasaki Y, Sendo M, Dezaki K, et al. GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose. Nat Commun. 2018 ; 9 : 113.
PubMed
75) Smith EP, An Z, Wagner C, et al. The role of beta cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs. Cell Metab. 2014 ; 19 : 1050-7.
 
76) Nakabayashi H, Nishizawa M, Nakagawa A, et al. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol. 1996 ; 271 (5 Pt 1) : E808-13.
 
77) Nishizawa M, Nakabayashi H, Uehara K, et al. Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways. Am J Physiol Endocrinol Metab. 2013 ; 305 : E376-87.
PubMed
78) Zhou SY, Lu Y, Song I, et al. Inhibition of gastric motility by hyperglycemia is mediated by nodose ganglia KATP channels. Am J Physiol Gastrointest Liver Physiol. 2011 ; 300 : G394-400.
PubMed
79) Darling RA, Zhao H, Kinch D, et al. Mercaptoacetate and fatty acids exert direct and antagonistic effects on nodose neurons via GPR40 fatty acid receptors. Am J Physiol Regul Integr Comp Physiol. 2014 ; 307 : R35-43.
PubMed
80) Iwasaki Y, Nakabayashi H, Kakei M, et al. Nesfatin-1 evokes Ca2+ signaling in isolated vagal afferent neurons via Ca2+ influx through N-type channels. Biochem Biophys Res Commun. 2009 ; 390 : 958-62.
PubMed
81) Peters JH, Karpiel AB, Ritter RC, et al. Cooperative activation of cultured vagal afferent neurons by leptin and cholecystokinin. Endocrinology. 2004 ; 145 : 3652-7.
PubMed
82) Peters JH, McKay BM, Simasko SM et al. Leptin-induced satiation mediated by abdominal vagal afferents. Am J Physiol Regul Integr Comp Physiol. 2005 ; 288 : R879-84.
PubMed
83) Malone HM, Peters JA, Lambert JJ. Physiological and pharmacological properties of 5-HT3 receptors--a patch clamp-study. Neuropeptides. 1991 ; 19 (Suppl) : 25-30.
 
84) Lankisch TO, Tsunoda Y, Lu Y, et al. Characterization of CCKA receptor affinity states and Ca2+ signal transduction in vagal nodose ganglia. Am J Physiol Gastrointest Liver Physiol. 2002 ; 282 : G1002-8.
 
85) Iwasaki Y, Kakei M, Nakabayashi H, et al. Pancreatic polypeptide and peptide YY3-36 induce Ca2+ signaling in nodose ganglion neurons. Neuropeptides. 2013 ; 47 : 19-23.
 
86) Koda S, Date Y, Murakami N, et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology. 2005 ; 146 : 2369-75.
PubMed
87) Goswami C, Iwasaki Y, Yada T. Short-chain fatty acids suppress food intake by activating vagal afferent neurons. J Nutr Biochem. 2018 ; 57 : 130-5.
PubMed
88) Wu X, Li JY, Lee A, et al. Satiety induced by bile acids is mediated via vagal afferent pathways. JCI Insight. 2020 ; 5 : e132400.
PubMed
89) Iwasaki Y, Shimomura K, Kohno D, et al. Insulin activates vagal afferent neurons including those innervating pancreas via insulin cascade and Ca2+ influx : Its dysfunction in IRS2-KO mice with hyperphagic obesity. PLoS One. 2013 ; 8 : e67198.
 
90) VanderWeele DA. Insulin is a prandial satiety hormone. Physiol Behav. 1994 ; 56 : 619-22.
PubMed
91) Ayush EA, Iwasaki Y, Iwamoto S, et al. Glucagon directly interacts with vagal afferent nodose ganglion neurons to induce Ca2+ signaling via glucagon receptors. Biochem Biophys Res Commun. 2015 ; 456 : 727-32.
 
92) Geary N, Smith GP. Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect. Physiol Behav. 1983 ; 31 : 391-4.
PubMed
93) Asakawa A, Inui A, Yuzuriha H, et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology. 2003 ; 124 : 1325-36.
PubMed
94) Iwasaki Y, Kumari P, Wang L, et al. Relay of peripheral oxytocin to central oxytocin neurons via vagal afferents for regulating feeding. Biochem Biophys Res Commun. 2019 ; 519 : 553-8.
PubMed
95) Iwasaki Y, Maejima Y, Suyama S, et al. Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice : a route for ameliorating hyperphagia and obesity. Am J Physiol Regul Integr Comp Physiol. 2015 ; 308 : R360-9.
PubMed
P.242 掲載の参考文献
1) Morley JE. Anorexia of aging : physiologic and pathologic. Am J Clin Nutr. 1997 ; 66 : 760-73.
PubMed
2) Langston JW. The Parkinson's complex : parkinsonism is just the tip of the iceberg. Annals of neurology. 2006 ; 59 : 591-6.
 
3) Reijnders JS, Ehrt U, Weber WE, et al. A systematic review of prevalence studies of depression in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 2008 ; 23 : 183-9 ; quiz 313.
 
4) Suttrup I, Warnecke T. Dysphagia in Parkinson's disease. Dysphagia. 2016 ; 31 : 24-32.
PubMed
5) Ehrt U, Broich K, Larsen JP, et al. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease : a cohort study. Journal of neurology, neurosurgery, and Psychiatry. 2010 ; 81 : 160-5.
PubMed
6) Sakakibara Y, Asahina M, Suzuki A, et al. Gastric myoelectrical differences between Parkinson's disease and multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society. 2009 ; 24 : 1579-86.
PubMed
7) Araki N, Yamanaka Y, Poudel A, et al. Electrogastrography for diagnosis of early-stage Parkinson's disease. Parkinsonism Relat Disord. 2021 ; 86 : 61-6.
PubMed
8) Arai E, Arai M, Uchiyama T, et al. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. Brain : a journal of neurology. 2012 ; 135 (Pt 5) : 1478-85.
PubMed
9) 新井英二, 新井誠人, 横須賀収. 胃排出機能検査. 日本自律神経学会, 編. 自律神経機能検査 第5版. 東京 : 文光堂 ; 2015. p.357-60.
 
10) 山中義崇, 朝比奈正人. 胃電図検査. 日本自律神経学会, 編. 自律神経機能検査 第5版. 東京 : 文光堂 ; 2015. p.361-4.
 
11) 鮫島奈々美, 乾明夫. 【高齢者の栄養】臨床に役立つQ&A 高齢者の食欲調節メカニズムと食思不振に対するアプローチについて教えてください. Geriatric Medicine. 2017 ; 55 : 781-5.
 
12) 加藤士郎. これからの高齢者地域医療と介護における課題 漢方の効果的な運用 消化器疾患 食欲不振と胃炎, 便秘と下痢. Geriatric Medicine. 2018 ; 56 : 787-93.
 
13) 三木一正. 悪心, 嘔吐. 島田馨, 編. 内科学書 全訂第5版. 東京 : 中山書店 ; 1999. p.225-7.
 
14) Saito R, Takano Y, Kamiya H. Roles of Substance P and NK1 Receptor in the Brainstem in the Development of Emesis. Journal of Pharmacological Sciences. 2003 ; 91 : 87-94.
 
15) 佐伯俊昭. 【制吐療法Up to Date】制吐薬適正使用ガイドライン (2018 ver. 2.0) と標準的治療. 癌と化学療法. 2019 ; 46 : 1683-5.
 
16) 便秘の定義. 日本消化器学会関連研究会慢性便秘の診断・治療研究会, 編. 慢性便秘症診療ガイドライン 2017. 東京 : 南江堂 ; 2017. p.2.
 
17) 朝倉均. 便通異常. 島田馨, 編. 内科学書. 東京 : 中山書店 ; 1999. p.1615-8.
 
18) 慢性便秘 (症) の分類. 日本消化器病学会関連研究会慢性便秘の診断・治療研究会, 編. 慢性便秘症ガイドライン 2017. 東京 : 南江堂 ; 2017.
 
19) 慢性便秘症を起こす基礎疾患. 日本消化器病学会関連研究会慢性便秘の診断・治療研究会, 編. 慢性便秘症ガイドライン 2017. 東京 : 南江堂 ; 2017.
 
20) 問診票. 日本消化器病学会関連研究会慢性便秘の診断・治療研究会, 編. 慢性便秘症ガイドライン 2017. 東京 : 南江堂 ; 2017. p.42-6.
 
21) Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology. 2016.
PubMed
22) 鳥居明. 【慢性便秘症の診療の進歩】浸透圧性下剤. 日本内科学会雑誌. 2019 ; 108 : 36-9.
 
23) 尾高健夫. 【これでスッキリ! 便秘治療薬の悩みを解決】作用機序別 使用のポイント・注意点 刺激性下剤. 薬事. 2017 ; 59 : 2233-6.
 
24) 二神生爾, 山脇博. 【これでスッキリ! 便秘治療薬の悩みを解決】作用機序別 使用のポイント・注意点 上皮機能変容薬. 薬事. 2017 ; 59 : 2228-32.
 
25) 榊原隆次, 岸雅彦, 舘野冬樹, 他. 排便機能検査. 日本自律神経学会, 編. 自律神経機能検査 第5版. 東京 : 文光堂 ; 2015. p.368-40.
 
26) 便失禁の定義. 日本大腸肛門病学会, 編. 便失禁診療ガイドライン 2017年度版. 東京 : 南江堂 ; 2017. p.1-3.
 
27) 便失禁の病態と原因. 日本大腸肛門病学会, 編. 便失禁診療ガイドライン 2017年度版. 東京 : 南江堂 ; 2017. p.9-11.
 
28) Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993 ; 36 : 77-97.
PubMed
29) Vaizey CJ, Carapeti E, Cahill JA, et al. Prospective comparison of faecal incontinence grading systems. Gut. 1999 ; 44 : 77-80.
PubMed
30) Fox M, Stutz B, Menne D, et al. The effects of loperamide on continence problems and anorectal function in obese subjects taking orlistat. Digestive diseases and sciences. 2005 ; 50 : 1576-83.
PubMed
31) Omar MI, Alexander CE. Drug treatment for faecal incontinence in adults. The Cochrane database of systematic reviews. 2013 ; 2013 : Cd002116.
PubMed
32) 薬物療法. 日本大腸肛門病学会, 編. 便失禁診療ガイドライン 2017年度版. 東京 : 南江堂 ; 2017. p.52-3.
 
33) 藤村昭夫. 頻用薬 処方の作法 Common Diseaseと臨床薬理学 (File No. 22) 過敏性腸症候群 高分子重合体など. 日本医事新報. 2018 : 12-3.
 
P.255 掲載の参考文献
1) 安垣進之助, 林悠. 睡眠の動態. 日本睡眠学会, 編. 睡眠学第2版. 東京 : 朝倉書店 ; 2020. p.11-9.
 
2) McCormick DA, Bal T. Sensory gating mechanisms of the thalamus. Curr Opin Neurobiol. 1994 ; 4 : 550-6.
PubMed
3) 桑木共之. 攻撃行動と呼吸. 有田秀穂, 編. 呼吸の事典. 東京 : 朝倉書店 ; 2006. p.347-54.
 
4) 西野卓. 上気道の調節. 有田秀穂, 編. 呼吸の事典. 東京 : 朝倉書店 ; 2006. p.186-98.
 
5) 桑木共之. 睡眠と生理機能, 呼吸器. 日本睡眠学会, 編. 睡眠学 第2版. 東京 : 朝倉書店 ; 2020. p.135-9.
 
6) Nakamura A, et al. Sleep apnea and effect of chemostimulation on breathing instability in mice. J Appl Physiol. 2003 ; 94 : 525-32.
PubMed
7) 磯野史朗. 閉塞性睡眠時無呼吸, 病態生理. 日本睡眠学会, 編. 睡眠学 第2版. 東京 : 朝倉書店 ; 2020. p.540-3.
 
8) Inui K, et al. Nasal TRPA1 mediates irritant-induced bradypnea in mice. Physiol Rep. 2016 ; 4 : e13098.
PubMed
9) Yonemitsu T, et al. TRPA1 detects environmental chemicals and induces avoidance behavior and arousal from sleep. Sci Rep. 2013 ; 3 : 3100.
PubMed
10) Chen S, et al. Transient receptor potential ankyrin 1 mediates hypoxic responses in mice. Front Physiol. 2020 ; 11 ; 576209.
PubMed
11) Nakamura A, et al. Vigilance state-dependent attenuation of hypercapnic chemoreflex and exaggerated sleep apnea in orexin knockout mice. J Appl Physiol. 2007 ; 102 : 241-8.
PubMed
12) Kuwaki T. Thermoregulation under pressure : a role for orexin neurons. Temperature 2015 ; 2 : 379-91.
PubMed
13) Iwakawa S, et al. Orexin receptor blockade-induced sleep preserves the ability to wake in the presence of threat in mice. Front Behav Neurosci. 2019 ; 12 : 327.
PubMed
14) 陳和夫. 睡眠時無呼吸症候群. 有田秀穂, 編. 呼吸の事典. 東京 : 朝倉書店 ; 2006. p.292-312.
 
P.266 掲載の参考文献
1) Cheng S, Stark CD, Stark RJ. Sleep apnoea and the neurologist. Pract Neurol. 2017 ; 17 : 21-7.
PubMed
2) Sakakibara R, Hattori T, Hirayama K. Sleep apnea associated with diabetic automic neurpathy. The Autonomic Nervous System. 1990 ; 27 : 646-51.
 
3) Guilleminault C, Lin CM, Goncalves MA, et al. A prospective study of nocturia and the quality of life of elderly patients with obstructive sleep apnea or sleep onset insomnia. J Psychosom Res. 2004 ; 56 : 511-5.
PubMed
4) Gulur DM, Mevcha AM, Drake MJ. Nocturia as a manifestation of systemic disease. BJU Int. 2011 ; 107 : 702-13.
PubMed
5) Huang X, Tang S, Lyu X, et al. Structural and functional brain alterations in obstructive sleep apnea : a multimodal meta-analysis. Sleep Med. 2019 ; 54 : 195-204.
PubMed
6) Jensen MLF, Vestergaard MB, Tonnesen P, et al. Cerebral blood flow, oxygen metabolism, and lactate during hypoxia in patients with obstructive sleep apnea. Sleep. 2018 ; 41.
PubMed
7) Baril AA, Gagnon K, Brayet P, et al. Obstructive sleep apnea during REM sleep and daytime cerebral functioning : A regional cerebral blood flow study using high-resolution SPECT. J Cereb Blood Flow Metab. 2020 ; 40 : 1230-41.
PubMed
8) Miglis MG. Autonomic dysfunction in primary sleep disorders. Sleep Med. 2016 ; 19 : 40-9.
 
9) Balfors EM, Franklin KA. Impairment of cerebral perfusion during obstructive sleep apneas. Am J Respir Crit Care Med. 1994 ; 150 : 1587-91.
PubMed
10) Hilton MF, Chappell MJ, Bartlett WA, et al. The sleep apnoea/hypopnoea syndrome depresses waking vagal tone independent of sympathetic activation. Eur Respir J. 2001 ; 17 : 1258-66.
PubMed
11) Palma JA, Iriarte J, Fernandez S, et al. Long-term continuous positive airway pressure therapy improves cardiac autonomic tone during sleep in patients with obstructive sleep apnea. Clin Auton Res. 2015 ; 25 : 225-32.
PubMed
12) Bradicich M, Sievi NA, Grewe FA, et al. Nocturnal heart rate variability in obstructive sleep apnoea : a cross-sectional analysis of the Sleep Heart Health Study. J Thorac Dis. 2020 ; 12 : S129-38.
PubMed
13) Gapelyuk A, Riedl M, Suhrbier A, et al. Cardiovascular regulation in different sleep stages in the obstructive sleep apnea syndrome. Biomed Tech (Berl). 2011 ; 56 : 207-13.
PubMed
14) Lombardi C, Pengo MF, Parati G. Obstructive sleep apnea syndrome and autonomic dysfunction. Auton Neurosci. 2019 ; 221 : 102563.
PubMed
15) Dimsdale JE, Coy T, Ziegler MG, et al. The effect of sleep apnea on plasma and urinary catecholamines. Sleep. 1995 ; 18 : 377-81.
PubMed
16) Gilardini L, Lombardi C, Redaelli G, et al. Effect of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea and high urinary metanephrines. J Hypertens. 2018 ; 36 : 199-204.
PubMed
17) Matsuzawa Y, Kwon TG, Lennon RJ, et al. Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events : A systematic review and meta-analysis. J Am Heart Assoc. 2015 ; 4 : 1-15.
PubMed
18) Azuma M, Chihara Y, Yoshimura C, et al. Association between endothelial function (assessed on reactive hyperemia peripheral arterial tonometry) and obstructive sleep apnea, visceral fat accumulation, and serum adiponectin. Circ J. 2015 ; 79 : 1381-9.
PubMed
19) Izzi F, Placidi F, Liguori C, et al. Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? Sleep Med. 2018 ; 42 : 68-72.
PubMed
20) Kheirandish-Gozal L, Gozal D. Obstructive sleep apnea and inflammation : proof of concept based on two illustrative cytokines. Int J Mol Sci. 2019 ; 20.
PubMed
21) Herlenius E. An inflammatory pathway to apnea and autonomic dysregulation. Respir Physiol Neurobiol. 2011 ; 178 : 449-57.
PubMed
22) Hetland A, Vistnes M, Haugaa KH, et al. Obstructive sleep apnea versus central sleep apnea : prognosis in systolic heart failure. Cardiovasc Diagn Ther. 2020 ; 10 : 396-404.
PubMed
23) Mansfield D, Kaye DM, Brunner La Rocca H, et al. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation. 2003 ; 107 : 1396-400.
PubMed
24) Tung P, Levitzky YS, Wang R, et al. Obstructive and central sleep apnea and the risk of incident atrial fibrillation in a community cohort of men and women. J Am Heart Assoc. 2017 ; 6 : 1-10.
 
25) Spicuzza L, Bernardi L, Calciati A, et al. Autonomic modulation of heart rate during obstructive versus central apneas in patients with sleep-disordered breathing. Am J Respir Crit Care Med. 2003 ; 167 : 902-10.
PubMed
26) Nasr N, Pavy-Le Traon A, Larrue V. Baroreflex sensitivity is impaired in bilateral carotid atherosclerosis. Stroke. 2005 ; 36 : 1891-5.
PubMed
27) Rupprecht S, Hoyer D, Hagemann G, et al. Central sleep apnea indicates autonomic dysfunction in asymptomatic carotid stenosis : a potential marker of cerebrovascular and cardiovascular risk. Sleep. 2010 ; 33 : 327-33.
PubMed
28) Seiler A, Camilo M, Korostovtseva L, et al. Prevalence of sleep-disordered breathing after stroke and TIA : A meta-analysis. Neurology. 2019 ; 92 : e648-54.
 
29) Siarnik P, Jurik M, Klobucnikova K, et al. Sleep apnea prediction in acute ischemic stroke (SLAPS score) : a derivation study. Sleep Med. 2020 ; 77 : 23-8.
 
30) Hermann DM, Bassetti CL. Sleep-related breathing and sleep-wake disturbances in ischemic stroke. Neurology. 2009 ; 73 : 1313-22.
PubMed
31) Lipford MC, Flemming KD, Calvin AD, et al. Associations between cardioembolic stroke and obstructive sleep apnea. Sleep. 2015 ; 38 : 1699-705.
PubMed
32) Duss SB, Brill AK, Bargiotas P, et al. Sleep-wake disorders in stroke-increased stroke risk and deteriorated recovery? An evaluation on the necessity for prevention and treatment. Curr Neurol Neurosci Rep. 2018 ; 18 : 72.
PubMed
33) Boulos MI, Dharmakulaseelan L, Brown DL, et al. Trials in sleep apnea and stroke : Learning from the past to direct future approaches. Stroke. 2021 ; 52 : 366-72.
PubMed
34) Peppard PE, Young T. Exercise and sleep-disordered breathing : an association independent of body habitus. Sleep. 2004 ; 27 : 480-4.
PubMed
35) Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea : A review. JAMA. 2020 ; 323 : 1389-400.
PubMed
36) Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep. 2007 ; 30 : 711-9.
PubMed
37) Cistulli PA, Armitstead J, Pepin JL, et al. Short-term CPAP adherence in obstructive sleep apnea : a big data analysis using real world data. Sleep Med. 2019 ; 59 : 114-6.
PubMed
38) Askland K, Wright L, Wozniak DR, et al. Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev. 2020 ; 4 : Cd007736.
PubMed
39) Yu J, Zhou Z, McEvoy RD, et al. Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea : a systematic review and meta-analysis. JAMA. 2017 ; 318 : 156-66.
 
40) Ramar K, Dort LC, Katz SG, et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy : an update for 2015. J Clin Sleep Med. 2015 ; 11 : 773-827.
PubMed
41) Browaldh N, Nerfeldt P, Lysdahl M, et al. SKUP3 randomised controlled trial : polysomnographic results after uvulopalatopharyngoplasty in selected patients with obstructive sleep apnoea. Thorax. 2013 ; 68 : 846-53.
PubMed
42) Zaghi S, Holty JE, Certal V, et al. Maxillomandibular advancement for treatment of obstructive sleep apnea : a meta-analysis. JAMA Otolaryngol Head Neck Surg. 2016 ; 142 : 58-66.
PubMed
43) Strollo PJ, Jr, Soose RJ, Maurer JT, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. 2014 ; 370 : 139-49.
PubMed
44) Woodson BT, Strohl KP, Soose RJ, et al. Upper airway stimulation for obstructive sleep apnea : 5-year outcomes. Otolaryngol Head Neck Surg. 2018 ; 159 : 194-202.
PubMed
P.276 掲載の参考文献
1) Spallone V. Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes : What is defined, What is new, and what is unmet. Diabetes Metab J. 2019 ; 43 : 3-30.
PubMed
2) Spallone V, Ziegler D, Freeman R, et al. Cardiovascular autonomic neuropathy in diabetes : clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011 ; 27 : 639-53.
PubMed
3) Aune D, Sen A, o'Hartaigh B, et al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality-A systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 2017 ; 27 : 504-17.
 
4) Fleg JL, Evans GW, Margolis KL, et al. Orthostatic hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) blood pressure trial : Prevalence, incidence, and prognostic significance. Hypertension. 2016 ; 68 : 888-95.
PubMed
5) Spallone V. Blood pressure variability and autonomic dysfunction. Curr Diab Rep. 2018 ; 18 : 137.
PubMed
6) Deli G, Bosnyak E, Pusch G, et al. Diabetic neuropathies : diagnosis and management. Neuroendocrinology. 2013 ; 98 : 267-80.
PubMed
7) Kebapci N, Yenilmez A, Efe B, et al. Bladder dysfunction in type 2 diabetic patients. Neurourol Urodyn. 2007 ; 26 : 814-9.
PubMed
8) Yamaguchi C, Sakakibara R, Uchiyama T, et al. Overactive bladder in diabetes : a peripheral or central mechanism? Neurourol Urodyn. 2007 ; 26 : 807-13.
PubMed
9) Wang R, Lefevre R, Hacker MR, et al. Diabetes, glycemic control, and urinary incontinence in women. Female Pelvic Med Reconstr Surg. 2015 ; 21 : 293-7.
PubMed
10) Bacon CG, Hu FB, Giovannucci E, et al. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care. 2002 ; 25 : 1458-63.
 
11) Zhao J, Gregersen H. Diabetes-induced mechanophysiological changes in the esophagus. Ann N Y Acad Sci. 2016 ; 1380 : 139-54.
PubMed
12) Monreal-Robles R, Remes-Troche JM. Diabetes and the esophagus. Curr Treat Options Gastroenterol. 2017 ; 15 : 475-89.
PubMed
13) Kinekawa F, Kubo F, Matsuda K, et al. Esophageal function worsens with long duration of diabetes. J Gastroenterol. 2008 ; 43 : 338-44.
PubMed
14) Phillips LK, Deane AM, Jones KL, et al. Gastric emptying and glycaemia in health and diabetes mellitus. Nat Rev Endocrinol. 2015 ; 11 : 112-28.
PubMed
15) Vanormelingen C, Tack J, Andrews CN. Diabetic gastroparesis. Br Med Bull. 2013 ; 105 : 213-30.
PubMed
16) Azpiroz F, Malagelada C. Diabetic neuropathy in the gut : pathogenesis and diagnosis. Diabetologia. 2016 ; 59 : 404-8.
PubMed
17) Phillips LK, Rayner CK, Jones KL, et al. An update on autonomic neuropathy affecting the gastrointestinal tract. Curr Diab Rep. 2006 ; 6 : 417-23.
PubMed
18) Ogbonnaya KI, Arem R. Diabetic diarrhea. Pathophysiology, diagnosis, and management. Arch Intern Med. 1990 ; 150 : 262-7.
PubMed
19) Rosa-e-Silva L, Troncon LE, Oliveira RB, et al. Rapid distal small bowel transit associated with sympathetic denervation in type I diabetes mellitus. Gut. 1996 ; 39 : 748-56.
PubMed
20) Horvath VJ, Putz Z, Izbeki F, et al. et al. Diabetes-related dysfunction of the small intestine and the colon : focus on motility. Curr Diab Rep. 2015 ; 15 : 94.
PubMed
21) Gatopoulou A, Papanas N, Maltezos E. Diabetic gastrointestinal autonomic neuropathy : current status and new achievements for everyday clinical practice. Eur J Intern Med. 2012 ; 23 : 499-505.
PubMed
22) Rayner CK, Samsom M, Jones KL, et al. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001 ; 24 : 371-81.
PubMed
23) Chandrasekharan B, Anitha M, Blatt R, et al. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil. 2011 ; 23 : 131-8, e26.
 
24) Taba Taba Vakili S, Nezami BG, Shetty A, et al. Association of high dietary saturated fat intake and uncontrolled diabetes with constipation : evidence from the National Health and Nutrition Examination Survey. Neurogastroenterol Motil. 2015 ; 27 : 1389-97.
PubMed
25) Reutrakul S, Mokhlesi B. Obstructive sleep apnea and diabetes : A state of the art review. Chest. 2017 ; 152 : 1070-86.
PubMed
26) Strand LB, Carnethon M, Biggs ML, et al. Sleep disturbances and glucose metabolism in older adults : The cardiovascular health study. Diabetes Care. 2015 ; 38 : 2050-8.
PubMed
27) Ota H, Fujita Y, Yamauchi M, et al. Relationship between intermittent hypoxia and type 2 diabetes in sleep apnea syndrome. Int J Mol Sci. 2019 ; 20 : 4756.
 
28) Reutrakul S, Thakkinstian A, Anothaisintawee T, et al. Sleep characteristics in type 1 diabetes and associations with glycemic control : systematic review and meta-analysis. Sleep Med. 2016 ; 23 : 26-45.
PubMed
29) Banghoej AM, Nerild HH, Kristensen PL, et al. Obstructive sleep apnoea is frequent in patients with type 1 diabetes. J Diabetes Complications. 2017 ; 31 : 156-61.
PubMed
30) Arrellano-Valdez F, Urrutia-Osorio M, Arroyo C, et al. A comprehensive review of urologic complications in patients with diabetes. Springerplus. 2014 ; 3 : 549.
 
31) Wittig L, Carlson KV, Andrews JM, et al. Diabetic bladder dysfunction : A review. Urology. 2019 ; 123 : 1-6.
PubMed
32) Dandona P, Chaudhuri A. Sodium-glucose co-transporter 2 inhibitors for type 2 diabetes mellitus : An overview for the primary care physician. Int J Clin Pract. 2017 ; 71 : e12937.
 
33) Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes : an acute, iatrogenic complication of diabetes. Brain. 2015 ; 138 (Pt 1) : 43-52.
 
34) Klein CM, Vernino S, Lennon VA, et al. The spectrum of autoimmune autonomic neuropathies. Ann Neurol. 2003 ; 53 : 752-8.
PubMed
35) Koike H, Koyano S, Morozumi S, et al. Slowly progressive autonomic neuropathy with antiganglionic acetylcholine receptor antibody. J Neurol Neurosurg Psychiatry. 2010 ; 81 : 586-7.
PubMed
36) Koike H, Hashimoto R, Tomita M, et al. The spectrum of clinicopathological features in pure autonomic neuropathy. J Neurol. 2012 ; 259 : 2067-75.
PubMed
37) Koike H, Watanabe H, Sobue G. The spectrum of immune-mediated autonomic neuropathies : insights from the clinicopathological features. J Neurol Neurosurg Psychiatry. 2013 ; 84 : 98-106.
PubMed
38) Nakane S, Mukaino A, Maeda Y, et al. Extra-autonomic manifestations in autoimmune autonomic ganglionopathy : a Japanese survey. J Neurol Neurosurg Psychiatry. 2017 ; 88 : 367-8.
PubMed
39) Muppidi S, Scribner M, Gibbons CH, et al. A unique manifestation of pupillary fatigue in autoimmune autonomic ganglionopathy. Arch Neurol. 2012 ; 69 : 644-8.
PubMed
40) Vernino S, Sandroni P, Singer W, et al. Invited article : Autonomic ganglia : target and novel therapeutic tool. Neurology. 2008 ; 70 : 1926-32.
PubMed
41) Golden EP, Bryarly MA, Vernino S. Seronegative autoimmune autonomic neuropathy : a distinct clinical entity. Clin Auton Res. 2018 ; 28 : 115-23.
PubMed
42) Golden EP, Vernino S. Autoimmune autonomic neuropathies and ganglionopathies : epidemiology, pathophysiology, and therapeutic advances. Clin Auton Res. 2019 ; 29 : 277-88.
PubMed
43) Koike H, Atsuta N, Adachi H, et al. Clinicopathological features of acute autonomic and sensory neuropathy. Brain. 2010 ; 133 : 2881-96.
PubMed
44) Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998 ; 50 : 652-7.
PubMed
45) Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody : marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001 ; 49 : 146-54.
PubMed
46) Li Y, Jammoul A, Mente K, et al. Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center. Muscle Nerve. 2015 ; 52 : 386-91.
 
47) Kesner VG, Oh SJ, Dimachkie MM, et al. Lambert-Eaton myasthenic syndrome. Neurol Clin. 2018 ; 36 : 379-94.
PubMed
48) Zaeem Z, Siddiqi ZA, Zochodne DW. Autonomic involvement in Guillain-Barre syndrome : an update. Clin Auton Res. 2019 ; 29 : 289-99.
PubMed
49) Shimazaki C, Hata H, Iida S, et al. Nationwide survey of 741 patients with systemic amyloid light-chain amyloidosis in Japan. Intern Med. 2018 ; 57 : 181-7.
PubMed
50) Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL) : a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005 ; 79 : 319-28.
PubMed
51) Bodez D, Guellich A, Kharoubi M, et al. Prevalence, severity, and prognostic value of sleep apnea syndromes in cardiac amyloidosis. Sleep. 2016 ; 39 : 1333-41.
PubMed
52) Mahmood S, Sovani M, Smith P, et al. High prevalence of recurrent nocturnal desaturations in systemic AL amyloidosis : a cross-sectional pilot study. Sleep Med. 2017 ; 32 : 191-7.
PubMed
53) Matsuda M, Gono T, Morita H, et al. Peripheral nerve involvement in primary systemic AL amyloidosis : a clinical and electrophysiological study. Eur J Neurol. 2011 ; 18 : 604-10.
PubMed
54) Koike H, Misu K, Ikeda S, et al. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan : early- vs late-onset form. Arch Neurol. 2002 ; 59 : 1771-6.
PubMed
55) Palma JA, Gonzalez-Duarte A, Kaufmann H. Orthostatic hypotension in hereditary transthyretin amyloidosis : epidemiology, diagnosis and management. Clin Auton Res. 2019 ; 29 (Suppl 1) : 33-44.
 
56) Gonzalez-Duarte A, Barroso F, Mundayat R, et al. Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS). Auton Neurosci. 2019 ; 222 : 102590.
PubMed
57) Loavenbruck AJ, Singer W, Mauermann ML, et al. Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart : an answer to the paradox? Ann Neurol. 2016 ; 80 : 401-11.
 
58) Hita Villaplana G, Hita Rosino E, Lopez Cubillana P, et al. Corino-Andrade disease (familial amyloidotic polineuropathy type I) in Spain : urological and andrological disorders. Neurourol Urodyn. 1997 ; 16 : 55-61.
 
59) Andrade MJ. Lower urinary tract dysfunction in familial amyloidotic polyneuropathy, Portuguese type. Neurourol Urodyn. 2009 ; 28 : 26-32.
PubMed
60) Wada Y, Ando Y, Kai N, et al. Lower urinary tract dysfunction in type 1 familial amyloidotic polyneuropathy in Kumamoto, Japan. Int J Urol. 2006 ; 13 : 1475-8.
PubMed
61) Carr AS, Pelayo-Negro AL, Evans MR, et al. A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK. J Neurol Neurosurg Psychiatry. 2016 ; 87 : 620-7.
 
62) Oliveira-e-Silva T, Campos Pinheiro L, Rocha Mendes J, et al. Peripheral polyneuropathy and female sexual dysfunction-familial amyloidotic polyneuropathy as an example besides diabetes mellitus. J Sex Med. 2013 ; 10 : 430-8.
PubMed
63) Wixner J, Mundayat R, Karayal ON, et al. THAOS : gastrointestinal manifestations of transthyretin amyloidosis-common complications of a rare disease. Orphanet J Rare Dis. 2014 ; 9 : 61.
PubMed
64) Obici L, Suhr OB. Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis. Clin Auton Res. 2019 ; 29 (Suppl 1) : 55-63.
 
65) Ito T, Sakakibara R, Ito S, et al. Mechanism of constipation in familial amyloid polyneuropathy : a case report. Intern Med. 2006 ; 45 : 1173-5.
PubMed
66) Guirl MJ, Hogenauer C, Santa Ana CA, et al. Rapid intestinal transit as a primary cause of severe chronic diarrhea in patients with amyloidosis. Am J Gastroenterol. 2003 ; 98 : 2219-25.
PubMed
67) Wixner J, Suhr OB, Anan I. Management of gastrointestinal complications in hereditary transthyretin amyloidosis : a single-center experience over 40 years. Expert Rev Gastroenterol Hepatol. 2018 ; 12 : 73-81.
PubMed
68) Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl. 1976 ; 590 : 1-64.
PubMed
69) Podboy A, Anderson BW, Sweetser S. 61-year-old man with chronic diarrhea. Mayo Clin Proc. 2016 ; 91 : e23-8.
PubMed
70) Ikegawa S, Araki S, Nagata J, et a [l. Review of clinical records and therapeutic trials to familial amyloidotic polyneuropathy-study of 50 cases in Kumamoto (1967-1984)]. Rinsho Shinkeigaku. 1986 ; 26 : 175-9.
 
71) Bergethon PR, Sabin TD, Lewis D, et al. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology. 1996 ; 47 : 944-51.
PubMed
72) Takei Y, Ikeda S, Hashikura Y, et al. Partial-liver transplantation to treat familial amyloid polyneuropathy : follow-up of 11 patients. Ann Intern Med. 1999 ; 131 : 592-5.
PubMed
73) Sharma P, Perri RE, Sirven JE, et al. Outcome of liver transplantation for familial amyloidotic polyneuropathy. Liver Transpl. 2003 ; 9 : 1273-80.
PubMed
74) Wixner J, Sundstrom T, Karling P, et al. Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis. BMC Gastroenterol. 2015 ; 15 : 51.
PubMed
75) Lozeron P, Theaudin M, Mincheva Z, et al. Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy. Eur J Neurol. 2013 ; 20 : 1539-45.
PubMed
76) Adams D, Gonzalez-Duarte A, O'Riordan WD, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018 ; 379 : 11-21.
PubMed
P.293 掲載の参考文献
1) Biering-Sorensen F, Biering-Sorensen T, Liu N, et al. Alterations in cardiac autonomic control in spinal cord injury. Auton Neurosci 2018 ; 209 : 4-18
 
2) Furlan JC, Verocai F, Palmares X, et al. Electrocardiographic abnormalities in the early stage following traumatic spinal cord injury. Spinal Cord 2016 ; 54 (10) : 872-77.
PubMed
3) Lehmann KG, Lane JG, Piepmeier JM, et al. Cardiovascular abnormalities accompanying acute spinal cord injury in humans : incidence, time course and severity. J Am Coll Cardiol 1987 ; 10 : 46-52.
PubMed
4) Ditunno JF, Little JW, Tessler A, et al. Spinal shock revisited : a four-phase model. Spinal Cord. 2004 ; 42, 383-95.
PubMed
5) Bilello JF, Davis JW, Cunningham MA, et al. Cervical spinal cord injury and the need for cardiovascular intervention. Arch. Surg. 2003 ; 138, 127-9.
 
6) Krassioukov AV, Furlan JC, Fehlings MG. Autonomic dysreflexia in acute spinal cord injury : an under-recognized clinical entity. J Neurotrauma. 2003 ; 20 : 707-16.
PubMed
7) Liu N, Zhou MW, Biering-Sorensen, F, et al. Cardiovascular response during urodynamics in individuals with spinal cord injury. Spinal Cord. 2016 ; http://dx.doi.org/10.1038/sc.2016.110.
 
8) Weaver LC, Fleming JC, Mathias CJ, et al. Disordered cardiovascular control after spinal cord injury. Handb Clin Neurol 2012 ; 109 : 213-33.
PubMed
9) Wan D, Krassioukov AV. Life-threatening outcomes associated with autonomic dysreflexia : a clinical review. J Spinal Cord Med. 2014 ; 37 : 2-10.
PubMed
10) Courtois F, Rodrigue X, Cote I, et al. Sexual function and autonomic dysreflexia inmen with spinal cord injuries : how should we treat? Spinal Cord. 2012 ; 50 : 869-77.
 
11) Liu N, Zhou M, Biering-Sorensen F, et al. Iatrogenic urological triggers of autonomic dysreflexia : a systematic review. Spinal Cord. 2015 ; 53 : 500-9.
PubMed
12) McGillivray CF, Hitzig SL, Craven BC, et al. Evaluating knowledge of autonomic dysreflexia among individuals with spinal cord injury and their families. J Spinal Cord Med. 2009 ; 32 : 54-62.
PubMed
13) Consortium for Spinal Cord Medicine, 2001. Acute management of autonomic dysreflexia : Individuals with spinal cord injury presenting to health care facilities, 2001. second ed. Paralyzed Veterans of America, Washington (DC).
 
14) Aiba Y, Sakakibara R, Tateno F. Chest pain and hypertension from the spinal cord. Intern Med. 2020 ; doi : 10.2169/internalmedicine.5692-20
 
15) Oka H, Toyoda C, Yogo M, et al. Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson's disease. J Neural Transm. 2011 ; 118 : 1323-7.
PubMed
16) Claydon VE, Krassioukov AV. Orthostatic hypotension and autonomic pathways after spinal cord injury. J Neurotrauma. 2006 ; 23 : 1713-25.
PubMed
17) Claydon VE, Steeves JD, Krassioukov A. Orthostatic hypotension following spinal cord injury : understanding clinical pathophysiology. Spinal Cord. 2006 ; 44 : 341-51.
PubMed
18) Ishikawa J, Watanabe S, Harada K. Awakening blood pressure rise in a patient with spinal cord injury. Am J Case Rep. 2016 ; 17 : 177-81.
 
19) Schwab JM, Zhang Y, Kopp MA, et al. The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Exp Neurol. 2014 ; 258 : 121-9.
PubMed
20) Nash MS, Tractenberg RE, Mendez AJ, et al. Cardiometabolic syndrome in people with spinal cord injury/disease : guideline derived and nonguideline risk components in a pooled sample. Arch Phys Med Rehabil. 2016 ; 97 : 1696-705.
 
21) Wu JC, Chen YC, Liu L, et al. Increased risk of stroke after spinal cord injury : a nationwide 4-year follow-up cohort study. Neurology. 2012 ; 78 : 1051-7.
PubMed
22) Wecht JM, BaumanWA. Decentralized cardiovascular autonomic control and cognitive deficits in personswith spinal cord injury. J Spinal Cord Med. 2013 ; 36 : 74-81.
 
23) Chaparro RE, Quiroga C, Bosco G, et al. Hippocampal cellular loss after brief hypotension. Springerplus. 2013 ; 2 : 23.
PubMed
24) Nightingale TE, Zheng MMZ, Sachdeva R, et al. Diverse cognitive impairment after spinal cord injury is associated with orthostatic hypotension symptom burden. Physiol Behav. 2020 ; 213 : 112742.
PubMed
25) West CR, Campbell IG, Shave RE, et al. Effects of abdominal binding on cardiorespiratory function in cervical spinal cord injury. Respir Physiol Neurobiol. 2012 ; 180 : 275-82.
PubMed
26) Groot M, Swartz J, Hastings J. Comparison of abdominal compression devices in persons with abdominal paralysis due to spinal cord injury. Spinal Cord Ser Cases. 2019 ; 5 : 35.
PubMed
27) Groomes TE, Huang CT. Orthostatic hypotension after spinal cord injury: treatment with fludrocortisone and ergotamine. Arch Phys Med Rehabil. 1991 ; 72 : 56-8.
PubMed
28) Mukand J, Karlin L, Barrs K, et al. Midodrine for the management of orthostatic hypotension in patients with spinal cord injury : a case report. Arch Phys Med Rehabil. 2001 ; 82 : 694-6.
PubMed
29) Wecht JM, Rosado-Rivera D, Weir JP, et al. Hemodynamic effects of L-threo-3,4-dihydroxyphenylserine (Droxidopa) in hypotensive individuals with spinal cord injury. Arch Phys Med Rehabil. 2013 ; 94 : 2006-12.
PubMed
30) Luciano GL, Brennan MJ, Rothberg MB. Postprandial hypotension. Am J Med. 2010 ; 123 : 281. e1-6.
PubMed
31) Aslan SC, Legg Ditterline BE, Park MC, et al. Epidural spinal cord stimulation of lumbosacral networks modulates arterial blood pressure in individuals with spinal cord injury-induced cardiovascular deficits. Front Physiol. 2018 ; 9 : 565.
PubMed
32) Squair JW, Gautier M, Mahe L, et al. Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury. Nature. 2021 Jan 27. doi : 10.1038/s41586-020-03180-w. Online ahead of print.
 
33) Glickman S, Kamm MA. Bowel dysfunction in spinal-cord-injury patients. Lancet. 1996 ; 347 : 1651-3.
PubMed
34) Krogh K, Nielsen J, Djurhuus JC, et al. Colorectal function in patients with spinal cord lesions. Dis Colon Rectum. 1997 ; 40 : 1233-9.
PubMed
35) 日本大腸肛門病学会, 編. 便失禁診療ガイドライン 2017年度版. 東京 : 南江堂 ; 2017.
 
36) Nino-Murcia M, Stone JM, Chang PJ, et al. Colonic transit in spinal cord-injured patients. Invest Radiol. 1990 ; 25 : 109-12.
PubMed
37) 舘野冬樹, 榊原隆次. ビデオマノメトリーのとり方と読み方. 榊原隆次, 福士審, 編. 神経・精神疾患による消化管障害ベッドサイドマニュル. 1版. 東京 : 中外医学社 ; 2019. p.157-9.
 
38) 乃美昌司, 柳井章宏, 仙石淳. 脊髄損傷. 榊原隆次, 福士審 編. 神経・精神疾患による消化管障害ベッドサイドマニュル. 1版. 東京 : 中外医学社 ; 2019. p.287-95.
 
39) Emmanuel AV, Krogh K, Bazzocchi G, et al. Consensus review of best practice of transanal irrigation in adults. Spinal Cord. 2013 ; 51 : 732-8.
PubMed
40) 脊髄損傷における下部尿路機能障害の診療ガイドライン. 3版 [2019年版] 日本排尿機能学会/日本脊髄障害医学会/日本泌尿器科学会脊髄損傷における下部尿路機能障害の診療ガイドライン作成委員会, 編. 2019.
 
41) Homma Y, Yoshida M, Seki N, et al. Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. Urology. 2006 ; 68 : 318-23.
PubMed
42) Price MJ, Trbovich M. Thermoregulation following spinal cord injury. Handb Clin Neurol. 2018 ; 157 : 799-820.
PubMed
43) M Frohman EM, Wingerchuk DM. Clinical practice. Transverse myelitis. N Engl J Med. 2010 ; 363 : 564-72.
 
44) de Seze J, T Stojkovic T, Gauvrit JY, et al. Autonomic dysfunction in multiple sclerosis : cervical spinal cord atrophy correlates. J Neurol. 2001 ; 248 : 297-303.
 
45) Hennessy A, Robertson NP, Swingler R, et al. Urinary, faecal and sexual dysfunction in patients with multiple sclerosis. J Neurol. 1999 ; 246 : 1027-32.
 
46) Sakakibara R. Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders. Clin Auton Res. 2019 ; 29 : 313-20.
PubMed
47) 榊原隆次. 多発性硬化症に伴う排尿障害. 今月の治療. 2003 ; 10 : 30-2．
 
48) Chia YW, Fowler CJ, Kamm MA, et al. Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction. J Neurol. 1995 ; 242 : 105-8.
PubMed
49) Hinds JP, Eidelman BH, Wald A. Prevalence of bowel dysfunction in multiple sclerosis. A population survey. Gastroenterology. 1990 ; 98 : 1538-42.
PubMed
50) Preziosi G, Raptis DA, Raeburn A, et al. Autonomic rectal dysfunction in patients with multiple sclerosis and bowel symptoms is secondary to spinal cord disease. Dis. Colon rectum. 2014 ; 57 : 514-21.
PubMed
51) Bateman AM, Goldish GD. Autonomic dysreflexia in multiple sclerosis. J Spinal Cord Med. 2002 ; 25 : 40-2.
PubMed
52) Bradl M, Reindl M, Lassmann H. Mechanisms for lesion localization in neuromyelitis optica spectrum disorders. Curr Opin Neurol. 2018 ; 31 : 325-33.
PubMed
53) Yamamoto T, Mori M, Uzawa A, et al. Urinary symptoms and neurological disabilities are differentially correlated between multiple sclerosis and neuromyelitis optica. Clin Exp Neuroimmunol. 2015 ; 7 : 52-8.
 
54) Pohl D, Alper G, Van Haren K, et al. Acute disseminated encephalomyelitis : updates on an inflammatory CNS syndrome. Neurology. 2016 ; 87 : S38-45.
 
55) Sakakibara R, Hattori T, Yasuda K, et al. Micturitional disturbance in acute disseminated encephalomyelitis (ADEM). J Auton Nerv Syst. 1996 ; 60 : 200-5.
 
56) Izumo S1, Goto I, Itoyama Y, et al. Interferon-alpha is effective in HTLV-I-associated myelopathy : a multicenter, randomized, double-blind, controlled trial. Neurology. 1996 ; 46 : 1016-21.
 
57) Hattori T, Sakakibara R, Yamanishi T, et al. Micturitional disturbance in human T-lymphotropic virus type-1-associated myelopathy. J Spinal Disord. 1994 ; 7 : 255-8.
PubMed
P.306 掲載の参考文献
1) Chen Z, Li G, Li J. Autonomic dysfunction in Parkinson's disease : Implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis. 2020 ; 134 : 104700.
 
2) Mendoza-Velasquez JJ, Flores-Vazquez JF, Barron-Velazquez E, et al. Autonomic dysfunction in α-synucleinopathies. Front Neurol. 2019 ; 10 : 363.
 
3) Barone DA, Henchcliffe C. Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies. Clin Neurophysiol. 2018 ; 128 : 1551-64.
 
4) Sakakibara R, Doi H, Fukudo S. Lewy body constipation. J Anus Rectum Colon. 2019 ; 3 : 10-7.
PubMed
5) Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017 ; 18 : 509.
PubMed
6) Cersosimo MG, Raina GB, Pellene LA, et al. Weight loss in Parkinson's disease : the relationship with motor symptoms and disease progression. Biomed Res. 2018 ; 9642524.
PubMed
7) Kalf JG, de Swart BJ, Borm GF, et al. Prevalence and definition of drooling in Parkinson's disease : a systematic review. J Neurol. 2009 ; 256 : 1391-6.
PubMed
8) Bagheri H, Damase-Michel C, Lapeyre-Mestre M, et al. A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol. 1999 ; 22 : 213-5.
PubMed
9) Skjaerbaek C, Knudsen K, Jacob Horsager J, et al. Gastrointestinal dysfunction in Parkinson's disease. J Clin Med. 2021 ; 10 : 493.
PubMed
10) Takizawa C, Gemmell E, Kenworthy J, et al. A systematic review of the prevalence of oropharyngeal dysphagia in stroke, Parkinson's disease, Alzheimer's disease, head injury, and pneumonia. Dysphagia. 2016 ; 31 : 434-41.
 
11) Arai E, Arai M, Uchiyama T, et al. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. Brain. 2012 ; 135 : 1478-85.
PubMed
12) Dutkiewicz J, Szlufik S, Nieciecki M, et al. Small intestine dysfunction in Parkinson's disease. J Neural Transm (Vienna). 2015 ; 122 : 1659-61.
PubMed
13) Niu XL, Liu L, Song ZX, et al. Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease. J Neural Transm. 2016 ; 123 : 1381-6.
PubMed
14) Sakakibara R, Odaka T, Uchiyama T, et al. Colonic transit time and rectoanal videomanometry in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2003 ; 74 : 268-72.
PubMed
15) Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. 2003 ; 2 : 107-16.
PubMed
16) Maeda T, Shimo Y, Chiu SW, et al. Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centers. Parkinsonism Relat Disord. 2017 ; 38 : 54-60.
PubMed
17) Knudsen K, Krogh K, Ostergaard K, et al. Constipation in Parkinson's disease : subjective symptoms, objective markers, and new perspective. Mov Disord. 2017 ; 32 : 94-105.
PubMed
18) Sakakibara R, Kishi M, Ogawa E, et al. Bladder, bowel, and sexual dysfunction in Parkinson's disease. Parkinson's Dis. 2011 ; 2011 : 924605.
 
19) Mishima T, Fukase J, Fujioka S, et al. The prevalence of constipation and irritable bowel syndrome in Parkinson's disease patients according to Rome III diagnostic criteria. J Parkinsons Dis. 2017 ; 7 : 353-7.
 
20) Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015 ; 386 : 896-912.
PubMed
21) Liu B, Sjolander A, Pedersen NL, et al. Irritable bowel syndrome and Parkinson's disease risk : register-based studies. NPJ Parkinsons Dis. 2021 ; 7 : 5.
PubMed
22) Brudek T. Inflammatory bowel diseases and Parkinson's disease. J Parkinson. 2019 ; 9 : S331-44.
PubMed
23) Shen T, Yue Y, He T, et al. The association between the gut microbiota and Parkinson's disease, a meta-analysis. Front Age Neurosci. 2021 ; 13 : 636545.
 
24) McDonald C, Winge K, Burn DJ. Lower urinary tract symptoms in Parkinson's disease : Prevalence, aetiology and management. Parkinsonism Relat Disord. 2017 ; 35 : 8-16.
PubMed
25) Uchiyama T, Panicker JN. Genitourinary manifestations of Parkinson's disease. In ; Randhawa K, Little B, editors : BJUI Knowledge. Wiley, London, DOI 10.18591/BJUIK.0039, Feb 2019.
 
26) Uchiyama T, Sakakibara R, Yamamoto T, et al. Urinary dysfunction in early and untreated Parkinson's disease. J Neurol Neurosurg Psychiatry. 2011 ; 82 : 1382-6.
PubMed
27) Uchiyama T, Yamagichi C, Yamamoto T, et al. Influence of nocturnal polyuria to nocturia in Parkinson's disease. 42st Annual Meeting of International Continence Society (ICS 2012), Beijing. 2012 ; 10 : 15-9.
 
28) Smith M, Seth J, Batla A, et al. Nocturia in patients with Parkinson's disease. Move Dis Clin Pract. 2016 ; 3 : 168-72.
 
29) Malek N, Lawton MA, Grosset KA, et al. Autonomic dysfunction in early Parkinson's disease : results from the United Kingdom tracking Parkinson's study. Mov Disord Clin Pract. 2017 ; 4 : 509-16.
 
30) 内山智之, 榊原隆次, 桑原聡, 他. Parkinson病のlibidoの障害. 神経内科. 2016 ; 84 : 20-5.
 
31) Khemani P, Mehdirad AA. Cardiovascular disorders mediated by autonomic nervous system dysfunction. Cardiol Rev. 2020 ; 28 : 65-72.
PubMed
32) Palma JA, Kaufmann H. Orthostatic hypotension in Parkinson disease. Clin Geriatr Med. 2020 ; 36 : 53-67.
PubMed
33) Palma JA, Redel-Traub G, Porciuncula A, et al. The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension. Parkinsonism Relat Disord. 2020 ; 75 : 97-104.
PubMed
34) Pavelic A, Krbot Skoric M, Crnos ija L, et al. Postprandial hypotension in neurological disorders : systematic review and meta-analysis. Clin Auton Res. 2017 ; 27 : 263-71.
 
35) Umehara T, Nakahara A, Matsuno H, et al. Predictors of postprandial hypotension in elderly patients with de novo Parkinson's disease. J Neural Transm (Vienna). 2016 ; 123 : 1331-9.
PubMed
36) Arici Duz O, Helvaci Yilmaz N. Nocturnal blood pressure changes in Parkinson's disease : correlation with autonomic dysfunction and vitamin D levels. Acta Neurol Belg. 2019 ; https://doi.org/10.1007/s13760-019-01113-7.
 
37) Bordet R, Benhadjali J, Destee A, et al. Sympathetic skin response and R-R interval variability in multiple system atrophy and idiopathic Parkinson's disease. Mov Disord. 1996 ; 11 : 268-72.
 
38) Skorvanek M, Bhatia KP. The skin and Parkinson's disease : Review of clinical, diagnostic, and therapeutic issues. Mov Disord Clin Pract. 2016 ; 4 : 21-31.
PubMed
39) van Wamelen DJ, Leta V, Podlewska, AM, et al. Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson's disease. J Neurol. 2019 ; 266 : 1736-42.
PubMed
40) Asahina M, Mathias CJ, Katagiri A. Sudomotor and cardiovascular dysfunction in patients with early untreated Parkinson's disease. J Parkinsons Dis. 2014 ; 4 : 385-93.
PubMed
41) Xu X, Liao J, Dong Q, Qin F. Clinical utility of SUDOSCAN in predicting autonomic neuropathy in patients with Parkinson's disease. Parkinsonism Relat Disord. 2019 ; 64 : 60-5.
PubMed
42) Antonio-Rubio I, Madrid-Navarro CJ, Salazar-Lopez E, et al. Abnormal thermography in Parkinson's disease. Parkinsonism Relat Disord. 2015 ; 21 : 852-7.
PubMed
43) Jain S, Siegle GJ, Gu C, et al. Pupillary unrest correlates with arousal symptoms and motor signs in Parkinson disease. Mov Disord. 2011 ; 26 : 1344-7.
PubMed
44) Hori N, Takamori M, Hirayama M, et al. Pupillary supersensitivity and visual disturbance in Parkinson's disease. Clin Autonom Res. 2008 ; 18 : 20-7.
 
45) Armstrong RA. Oculo-Visual Dysfunction in Parkinson's Disease. J Parkinsons Dis. 2015 ; 5 : 715-26.
PubMed
46) Coon EA, Cutsforth-Gregory JK, Benarroch EE. Neuropathology of autonomic dysfunction in synucleinopathies. Movement Disorders. 2018 ; 33 : 349-58.
PubMed
47) Metzger JM, Emborg ME. Autonomic dysfunction in Parkinson disease and animal models. Clin Auton Res. 2019 ; 29 : 397-414.
PubMed
48) van Deursen, van den Heuvel, Booji J, et al. Autonomic failure in Parkinson's disease is associated with striatal dopamine deficiencies. J Neurol. 2020 ; 267 : 1922-30.
 
49) Kitta T, Kakizaki H, Furuno T, et al. Brain activation during detrusor overactivity in patients with Parkinson's disease : a positron emission tomography study. J Urol. 2006 ; 175 : 994-8.
PubMed
50) Sakakibara R, Tateno F, Aiba Y, et al. MIBG myocardial scintigraphy identifies premotor PD/DLB during a negative DAT scan period : Second Report. Mov Disord Clin Pract. 2018 ; 6 : 46-50.
PubMed
51) Nakamura T, Hirayama M, Hara T, et al. Role of cardiac sympathetic nerves in preventing orthostatic hypotension in Parkinson's disease. Parkinsonism Relat Disord. 2016 : 20 : 409-14.
 
52) Fedorova TD, Seidelin LB, Knudsen K, et al. Decreased intestinal acetylcholinesterase in early Parkinson disease : An (11) C-donepezil PET study. Neurology. 2017 ; 88 : 775-81.
PubMed
53) Gjerloff T, Fedorova T, Knudsen K, et al. Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET. Brain. 2015 ; 138 : 653-63.
PubMed
54) Pelz JO, Belau E, Fricke C, et al. Axonal degeneration of the vagus nerve in Parkinson's Disease-A high-resolution ultrasound study. Front Neurol. 2018 ; 9 : 951.
PubMed
55) Goldstein DS, Eldadah BA, Holmes C, et al. Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension : independence from levodopa treatment. Hypertension. 2005 ; 46 : 1333-9.
PubMed
56) Fujishiro H, Nakamura S, Sato K, et al. Prodromal dementia with Lewy bodies. Geriatr Gerontol Int. 2015 ; 15 : 817-26.
PubMed
57) Sakakibara R, Ito T, Uchiyama T, et al. Lower urinary tract function in dementia of Lewy body type. J Neurol Neurosurg Psychiatry. 2005 ; 76 : 729-32.
PubMed
58) Taylor JP, McKeith IG, Burn DJ, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020 ; 19 : 157-69.
 
59) Kaufmann H, Kaufmann LN, Palma JA, et al. The natural history of pure autonomic failure : a U. S. prospective cohort. Ann Neurol. 2017 ; 81 : 287-97.
 
60) Coon EA, Singer W, Low PA. Pure autonomic failure. Mayo Clin Proc. 2019 ; 94 : 2087-98.
PubMed
61) Postuma RB, Iranzo A, Hu M, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behavior disorder : a multicentre study. Brain. 2019 ; 142 : 744-59.
PubMed
62) Barone DA, Henchcliffe C. Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies. Clin Neurophysiol. 2018 ; 129 : 1551-64.
PubMed
63) Zitsera J, Muppidi S, Sinn DI, et al. Quantitative sudomotor abnormalities in clinically isolated rapid eye movement sleep behavior disorder. Auton Neurosci. 2020 ; 224 : 102645.
 
P.324 掲載の参考文献
1) Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in case of multiple system atrophy. JNNP. 1969 ; 32 : 28-34.
 
2) Watanabe H, Saito Y, Terao S, et al. Progressive and prognosis in multiple system atrophy : an analysis of 230 Japanese patients. Brain. 2002 ; 125 : 1070-83.
 
3) Watanabe H, Riku Y, Hara K, et al. Clinical and imaging features of multiple system atrophy : Challenges for an early and clinically definitive diagnosis. J Mov Disord. 2018 ; 11 : 107-20.
PubMed
4) Lee YH, Ando T, Lee JJ, et al. Later-onset multiple system atrophy : A multicenter asian study. Mov Disord. 2020 ; 35 : 1692-3.
PubMed
5) Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci. 1989 ; 94 : 79-100.
PubMed
6) Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008 ; 71 : 670-6.
PubMed
7) Stankovic I, Krismer F, Jesic A, et al. Cognitive impairment in multiple system atrophy : a position statement by the Neuropsychology Task Force of MDS Multiple System Atrophy (MODIMSA) study group. Mov Disord. 2014 ; 29 : 857-67.
 
8) Osaki Y, Ben-Shlomo Y, Lees AJ, et al. Validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord. 2009 ; 24 : 2272-6.
PubMed
9) Riku Y, Watanabe H, Mimuro M, et al. Non-motor multiple system atrophy associated with sudden death : pathological observations of autonomic nuclei. J Neurol. 2017 ; 264 : 2249-57.
PubMed
10) Petrovic IN, Ling H, Asi Y, et al. Multiple system atrophy-parkinsonism with slow progression and prolonged survival : a diagnostic catch. Mov Disord. 2012 ; 27 : 1186-90.
PubMed
11) Salazar G, Valls-Sole J, Marti MJ, et al. Postural and action myoclonus in patients with parkinsonian type multiple system atrophy. Mov. Disord. 2000 ; 15 : 77-83.
PubMed
12) Sakakibara R, Hattori T, Uchiyama T, et al. Urinary dysfunction and orthostatic hypotension in multiple system atrophy : which is the more common and earlier manifestation? J Neurol Neurosurg Psychiatry. 2000 ; 68 : 65-9.
PubMed
13) Yamamoto T, Sakakibara R, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in multiple system atrophy. Mov Disord. 2009 ; 24 : 972-8.
PubMed
14) Luciano GL, Brennan MJ, Rothberg MB. Postprandial hypotension. Am J Med. 2010 ; 123 : 281.e1-6.
PubMed
15) Sakakibara R, Panicker J, Simeoni S, et al. Bladder dysfunction as the initial presentation of multiple system atrophy : a prospective cohort study. Clin Auton Res. 2019 ; 29 : 627-31.
PubMed
16) Hahn K, Ebersbach G. Sonographic assessment of urinary retention in multiple system atrophy and idiopathic Parkinson's disease. Mov Disord. 2005 ; 20 : 1499-502.
PubMed
17) Sakakibara R, Panicker J, Simeoni S, et al. Bladder dysfunction as the initial presentation of multiple system atrophy : a prospective cohort study. Clin Auton Res. 2019 ; 29 : 627-31.
PubMed
18) Yamamoto T, Sakakibara R, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in multiple system atrophy. Mov Disord. 2009 ; 24 : 972-8.
PubMed
19) Zhang L, Cao B, Ou R, et al. Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes. Parkinsonism Relat Disord. 2017 ; 35 : 63-8.
PubMed
20) Sakakibara R, Odaka T, Uchiyama T, et al. Colonic transit time, sphincter EMG, and rectoanal videomanometry in multiple system atrophy. Mov Disord. 2004 ; 19 : 924-9.
 
21) Tada M, Kakita A, Toyoshima Y, et al. Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death. Brain. 2009 ; 132 (Pt 7) : 1810-9.
PubMed
22) Benarroch EE. The clinical approach to autonomic failure in neurological disorders. Nat Rev Neurol. 2014 ; 10 : 396-407.
PubMed
23) Cersosimo MG, Benarroch EE. Central control of autonomic function and involvement in neurodegenerative disorders. Handb Clin Neurol. 2013 ; 117 : 45-57.
PubMed
24) Shimohata T, Shinoda H, Nakayama H, et al. Daytime hypoxemia, sleep-disordered breathing, and laryngopharyngeal findings in multiple system atrophy. Arch Neurol. 2007 ; 64 : 856-61.
PubMed
25) Coon EA, Fealey RD, Sletten DM, et al. Anhidrosis in multiple system atrophy involves pre- and postganglionic sudomotor dysfunction. Mov Disord. 2017 ; 32 : 397-404.
PubMed
26) Kihara M, Sugenoya J, Takahashi A. The assessment of sudomotor dysfunction in multiple system atrophy. Clin Auton Res. 1991 ; 1 : 297-302.
PubMed
27) Pellecchia MT, Stankovic I, Fanciulli A, et al. Can autonomic testing and imaging contribute to the early diagnosis of multiple system atrophy? A systematic review and recommendations by the Movement Disorder Society Multiple System Atrophy Study Group. Mov Disord Clin Pract. 2020 ; 7 : 750-62.
 
28) Orimo S, Yogo M, Nakamura T, et al. (123) I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies. Ageing Res Rev. 2016 ; 30 : 122-33.
 
29) Chung EJ, Lee WY, Yoon WT, et al. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy. Mov Disord. 2009 ; 24 : 1650-5.
PubMed
30) Nagayama H, Ueda M, Yamazaki M, et al. Abnormal cardiac [(123) I] -meta-iodobenzylguanidine uptake in multiple system atrophy. Mov Disord. 2010 ; 25 : 1744-7.
PubMed
31) Yamamoto T, Sakakibara R, Uchiyama T, et al. Neurological diseases that cause detrusor hyperactivity with impaired contractile function. Neurourol Urodyn. 2006 ; 25 : 356-360.
PubMed
32) Wenning GK, Ben Shlomo Y, Magalhaes M, et al. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain. 1994 ; 117 (Pt 4) : 835-45.
 
33) Wenning GK, Colosimo C, Geser F, et al. Multiple system atrophy. Lancet Neurol. 2004 ; 3 : 93-103.
PubMed
34) Wenning GK, Geser F, Krismer F, et al. The natural history of multiple system atrophy : a prospective European cohort study. Lancet Neurol. 2013 ; 12 : 264-74.
PubMed
35) Kinoshita K, Fujitsuka T, Yamamura M, et al. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals. Eur J Pharmacol. 1995 ; 274 (1-3) : 65-72.
PubMed
36) Kinoshita K, Watanabe Y, Asai H, et al. Anti-ataxic effects of TRH and its analogue, TA-0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegmental area. Br J Pharmacol. 1995 ; 116 : 3274-8.
PubMed
37) Kinoshita K, Watanabe Y, Yamamura M, et al. TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats. Eur J Pharmacol. 1998 ; 343 (2-3) : 129-33.
PubMed
38) Shimohata T, Nakayama H, Aizawa N, et al. Discontinuation of continuous positive airway pressure treatment in multiple system atrophy. Sleep Med. 2014 ; 15 : 1147-9.
PubMed
39) Jin K, Okabe S, Chida K, et al. Tracheostomy can fatally exacerbate sleep-disordered breathing in multiple system atrophy. Neurology. 2007 ; 68 : 1618-21.
PubMed
40) Lee HJ, Ricarte D, Ortiz D, et al. Models of multiple system atrophy. Exp Mol Med. 2019 ; 51 : 1-10.
PubMed
41) Heras-Garvin A, Weckbecker D, Ryazanov S, et al. Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy. Mov Disord. 2019 ; 34 : 255-63.
 
42) Bassil F, Fernagut PO, Bezard E, et al. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy. Proc Natl Acad Sci U S A. ; 113 : 9593-8.
 
P.331 掲載の参考文献
1) 厚生労働省. 平成29年 (2017) 患者調査の概況 (https://www.mhlw.go.jp/toukei/saikin/hw/kanja/17/index.html).
 
2) Sakakibara R, T Hattori, K Yasuda, et al. Micturitional disturbance after acute hemispheric stroke : analysis of the lesion site by CT and MRI. J Neurol Sci. 1996 ; 137 : 47-56.
 
3) Sakakibara R, T Hattori, T Uchiyama, et al. Urinary function in the elderly with and without leukoaraiosis ; in relation to cognitive and gait function. J Neurol Neurosurg Psychiatry 1999 ; 67 ; 658-60.
PubMed
4) Sakakibara R, T Hattori, K Yasuda, et al. Micturitional disturbance and the pontine tegmental lesion : urodynamic and MRI analyses of vascular cases. J Neurol Sci. 1996 ; 15 : 105-110.
 
5) Andrew J, Nathan PW. Lesions of the anterior frontal lobes and disturbances of micturition and defaecation. Brain. 1964 ; 87 : 233-62.
PubMed
6) DasGupta R, Kavia RB, Fowler CJ, et al. Cerebral mechanisms and voiding function. BJU International 2007 ; 99 : 731-4.
PubMed
7) Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008 ; 9 : 453-66.
PubMed
8) 服部孝道, 安田耕作, 山西友典, 他. 神経疾患による排尿障害ハンドブック. 東京 : 三輪書店 ; 1998.
 
9) Donnellan CA, Fook L, McDonald P, et al. Oxybutynin and cognitive dysfunction. BMJ. 1997 ; 315 : 1363-4.
PubMed
10) Sakakibara R, Uchiyama T, Yamanishi T, et al. Dementia and lower urinary dysfunction : with a reference to anticholinergic use in elderly population. Int J Urol. 2008 ; 15 : 778-88.
PubMed
P.341 掲載の参考文献
1) Yasui Y, Breder CD, Saper CB, et al. Autonomic responses and efferent pathways from the insular cortex in the rat. J Comp Neurol. 1991 ; 303 : 355-74.
 
2) Critchley HD, Mathias CJ, Josephs O, et al. Human cingulate cortex and autonomic control : Converging neuroimaging and clinical evidence. Brain. 2003 ; 126 : 2139-52.
PubMed
3) 梅田聡. 情動を生み出す脳神経基盤と自律神経機能. 自律神経. 2019 ; 56 : 70-5.
 
4) Coon EA, Cutsforth-Gregory JK, Benarroch EE. Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord. 2018 ; 33 : 349-58.
PubMed
5) Kawabe T, Chitravanshi V, Nakamura T, et al. Mechanism of heart rate responses elicited by chemical stimulation of the hypothalamic paraventricular nucleus in the rat. Brain Res. 2009 ; 1248 : 115-26.
PubMed
6) Holstege G. Some anatomical observations on the projections from the hypothalamus to brainstem and spinal cord : an HRP and autoradiographic tracing study in the cat. J Comp Neurol. 1987 ; 260 : 98-126.
 
7) Cersosimo MG, Benarroch EE. Central control of autonomic function and involvement in neurodegenerative disorders. Handb Clin Neurol. 2013 ; 117 : 45-57.
PubMed
8) Saper CB. The central autonomic nervous system : conscious visceral perception and autonomic pattern generation. Annu Rev Neurosci. 2002 ; 25 : 433-69.
PubMed
9) Chamberlin NL. Functional organization of the parabrachial complex and intertrigeminal region in the control of breathing. Respir Physiol Neurobiol. 2004 ; 143 : 115-25.
PubMed
10) Holstege G. Micturition and the soul. J Comp Neurol. 2005 ; 493 : 15-20.
 
11) Jean A. The nucleus tractus solitarius : neuroanatomic, neurochemical and functional aspects. Arch Int Physiol Biochim Biophys. 1991 ; 99 : A3-52.
PubMed
12) Saper CB. The central autonomic nervous system : conscious visceral perception and autonomic pattern generation. Annu Rev Neurosci. 2002 ; 25 : 433-69.
PubMed
13) Dampney RA, Horiuchi J. Functional organisation of central cardiovascular pathways : studies using c-fos gene expression. Prog Neurobiol. 2003 ; 71 : 359-84.
PubMed
14) Morrison SF. RVLM and raphe differentially regulate sympathetic outflows to splanchnic and brown adipose tissue. Am J Phys. 1999 ; 276 (4 Pt. 2) : R962-73.
 
15) Lightman SL, Todd K, Everitt BJ. Ascending noradrenergic projections from the brainstem : evidence for a major role in the regulation of blood pressure and vasopressin secretion. Exp Brain Res. 1984 ; 55 : 145-51.
 
16) Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med. 2008 ; 7 ; 358 : 615-24.
 
17) Ludwig M, Leng G. Dendritic peptide release and peptide dependent behaviours. Nat Rev Neurosci. 2006 ; 7 : 126-36.
PubMed
18) Vita G, Fazio MC, Milone S, et al. Cardiovascular autonomic dysfunction in multiple sclerosis is likely related to brainstem lesions. J Neurol Sci. 1993 ; 120 : 82-6.
PubMed
19) Lensch, E, Jost WH. Autonomic disorders in multiple sclerosis. Autoimmune Dis. 2011 : 803841. doi : 10.4061/2011/803841
 
20) Racosta JM, Sposato LA, Morrow SA, et al. Cardiovascular autonomic dysfunction in multiple sclerosis : a meta-analysis. Mult Scler Relat Disord. 2015 ; 4 : 104-11.
 
21) Tombul T, Anlar O, Tuncer M, et al. Impaired heart rate variability as a marker of cardiovascular autonomic dysfunction in multiple sclerosis. Acta Neurol. Belg. 2011 ; 111 : 116-20.
PubMed
22) Sakakibara R, Mori M, Fukutake T, et al. Orthostatic hypotension in a case with multiple sclerosis. Clin Auton Res. 1997 ; 7 : 163-5.
 
23) Habek M, Crnosija L, Lovri'c M, et al. Sympathetic cardiovascular and sudomotor functions are frequently affected in early multiple sclerosis. Clin Auton Res. 2016 ; 26 : 385-93.
 
24) Arnold AC, Ng J, Raj SR. Postural tachycardia syndrome-diagnosis, physiology, and prognosis. Auton Neurosci. 2018 ; 215 : 3-11.
PubMed
25) Kanjwal, K. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis. Int J Med Sci. 2010 ; 7 : 62-7.
PubMed
26) Magkas N, Tsioufis C, Thomopoulos C, et al. Orthostatic hypotension : from pathophysiology to clinical applications and therapeutic considerations. J Clin Hypertens. 2019 ; 21, 546-54
 
27) Findling O, Hauer L, Pezawas T, et al. Cardiac autonomic dysfunction in multiple sclerosis : A systematic review of current knowledge and impact of immunotherapies. J Clin Med. 2020 ; 9 : 335.
 
28) Krbot Skoric M, Crnosija L, Adamec I, et al. Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue. Clin Auton Res. 2018 ; https://doi.org/10.1007/s10286-018-0563-6
 
29) Flachenecker P, Rufer A, Bihler I, et al. Fatigue in MS is related to sympathetic vasomotor dysfunction. Neurology. 2003 ; 23 ; 61 : 851-3.
 
30) Devos H, Akinwuntan AE, Alissa N, et al. Cognitive performance and cognitive workload in multiple sclerosis : Two different constructs of cognitive functioning? Mult Scler Relat Disord. 2020 ; 38 : 101505.
PubMed
31) Winder K, Linker RA, Seifert F, et al. Cerebral lesion correlates of sympathetic cardiovascular activation in multiple sclerosis. Hum. Brain Mapp. 2019 ; 40, 5083-93.
PubMed
32) Schroth WS, Tenner SM, Rappaport BA, et al. Multiple sclerosis as a cause of atrial fibrillation and electrocardiographic changes. Arch Neurol. 1992 ; 49 : 422-4.
PubMed
33) Juric S, Mismas A, Mihic N, et al. Newly onset sinus bradycardia in the context of multiple sclerosis relapse. Intern Med. 2012 ; 51 : 1121-4.
PubMed
34) Saari A, Tolonen U, Paakko E, et al. Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS. Clin. Neurophysiol. 2004 ; 115 : 1473-8.
PubMed
35) Sanya EO, Tutaj M, Brown CM, et al. Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis patients. Clin Auton Res. 2005 ; 15 : 213-8.
PubMed
36) Fowler CJ, Panicker JN, Drake M, et al. A UK consensus on the management of the bladder in multiple sclerosis. Postgrad Med J. 2009 ; 80 : 470-7.
 
37) Panicker JN, Fowler CJ. Lower urinary tract dysfunction in patients with multiple sclerosis. Handb Clin Neurol. 2015 ; 130 : 371-81.
PubMed
38) Panicker JN, Nagaraja D, Kovoor JM, et al. Lower urinary tract dysfunction in acute disseminated encephalomyelitis. Mult Scler. 2009 ; 15 : 1118-22.
PubMed
39) Charil A, Zijdenbos AP, Taylor J, et al. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis : application to 452 patient data sets. Neuroimage. 2003 ; 19 : 532-44.
 
40) Sakakibara R. Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders. Clin Auton Res. 2019 ; 29 : 313-20.
PubMed
41) 榊原隆次, 内山智之, 服部孝道. 多発性硬化症に伴う排尿障害. 今日の治療 2003 ; 11 : 30-2.
 
42) Nordenbo AM, Andersen JR, Andersen JT. Disturbances of ano-rectal function in multiple sclerosis. J Neurol. 1996 ; 243 : 445-51.
PubMed
43) Nortvedt MW, Riise T, Frugard J, et al. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler. 2007 ; 13 : 106-12.
PubMed
44) Preziosi G, Raptis DA, Raeburn A, et al. Autonomic rectal dysfunction in patients with multiple sclerosis and bowel symptoms is secondary to spinal cord disease. Dis Colon rectum. 2014 : 57 : 514-21.
PubMed
45) Zorzon M, Zivadinov R, Monti Bragadin L, et al. Sexual dysfunction inmultiple sclerosis : a 2-year follow-up study. J Neurol Sci. 2001 ; 187 : 1-5.
 
46) Zorzon M, Zivadinov R, Bosco A, et al. Sexual dysfunction in multiple sclerosis : a case-control study. I. Frequency and comparison of groups. Mult Scler. 1999 ; 5 : 418-27.
PubMed
47) Zivadinov R, Zorzon M, Locatelli L, et al. Sexual dysfunction in multiple sclerosis : a MRI, neurophysiological and urodynamic study. Neuro Sci. 2003 ; 210 : 73-6.
PubMed
48) Giovannoni G. Multiple sclerosis related fatigue. J Neurol Neurosurg Psychiatry. 2006 ; 77 : 2-3.
PubMed
49) Penner IK, Paul F. Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol. 2017 ; 13 : 662-75.
PubMed
50) David Ruban S, Christina Hilt C, Petersen T. Quality of life in multiple sclerosis : The differential impact of motor and cognitive fatigue. Mult Scler J Exp Transl Clin. 2021 ; 24 : 2055217321996040.
 
51) Kos D, Kerckhofs E, Nagels G, et al. Origin of fatigue in multiple sclerosis : review of the literature. Neurorehabil. Neural Repair. 2008 ; 22 : 91-100.
PubMed
52) Pellicano C, Gallo A, Li X, et al. Relationship of cortical atrophy to fatigue in patients with multiple sclerosis. Arch. Neurol. 2010 ; 67 : 447-53.
PubMed
53) Flachenecker P, Rufer A, Bihler I, et al. Fatigue in MS is related to sympathetic vasomotor dysfunction. Neurology. 2003 ; 61 : 851-53.
PubMed
54) Rottoli M, La GS, Frigeni B, et al. Pathophysiology, assessment and management of multiple sclerosis fatigue : an update. Expert Rev Neurother 2017 ; 17 : 373-9.
 
55) Bamer AM, Johnson KL, Amtmann D, et al. Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler. 2008 ; 14 : 1127-30.
PubMed
56) Tachibana N, Howard RS, Hirsch NP, et al. Sleep problems in multiple sclerosis. Eur Neurol. 1994 ; 34 : 320-3.
PubMed
57) Fleming WE, Pollak CP. Sleep disorders in multiple sclerosis. Semin Neurol. 2005 ; 25 : 64-8.
PubMed
58) Zellini F, Niepel G, Tench CR, et al. Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis. Mult Scler. 2009 ; 15 : 1442-9.
PubMed
59) Oka Y, Kanbayashi T, Mezaki T, et al. Low CSF hypocretin-1-orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis. J Neurol. 2004 ; 251 : 885-6.
 
60) Sakai N, Miyajima H, Shimizu T, et al. Syndrome of inappropriate secretion of antidiuretic hormone associated with multiple sclerosis. Intern Med. 1992 ; 31 : 463-6.
PubMed
61) Liamis G, Elisaf M. Syndrome of inappropriate antidiuresis associated with multiple sclerosis. J Neurol Sci. 2000 ; 172 : 38-40.
PubMed
62) Sabatino JJ Jr, Werner JK, Newsome SD. A rare case of hyponatremia from a hypothalamic lesion in a patient with multiple sclerosis. Mult Scler. 2015 ; 21 : 662-5.
 
63) Nakano T, Fujimoto T, Fukuda Y, et al. Neuromyelitis optica with syndrome of inappropriate secretion of antidiuretic hormone and hypersomnia associated with bilateral hypothalamic lesions : a case report. Rinsho Shinkeigaku. 2011 ; 51 : 599-602.
PubMed
64) Saker P, Farrell MJ, Egan GF, et al. Influence of anterior midcingulate cortex on drinking behavior during thirst and following satiation. Proc Natl Acad Sci U S A. 2018 ; 115 : 786-91.
PubMed
65) Martinez-Rodriguez JE, Munteis E, Roquer J. Periodic hyperthermia and abnormal circadian temperature rhythm in a patient with multiple sclerosis. Mult Scler. 2006 ; 12 : 515-7.
 
66) Berti F, Arif Z, Constantinescu C, et al. Hypothermia in multiple sclerosis : Beyond the hypothalamus? A case report and review of the literature. Case Rep Neurol Med. 2018 ; 2018 : 2768493.
PubMed
67) Sinha S, Kataria A, Kolla BP, et al. Wernicke Encephalopathy-Clinical Pearls. Mayo Clin Proc. 2019 ; 94 : 1065-72.
PubMed
68) Maeda H, Kuriyama A, Tanaka T. Prolonged hypotension associated with Wernicke's encephalopathy. Eur J Clin Nutr. 2018 ; 72 : 168-9.
 
69) Goh KY, Conway EJ, DaRosso RC, et al. Sympathetic storms in a child with a midbrain glioma : a variant of diencephalic seizures. Pediatr Neurol. 1999 ; 21 : 742-4.
 
70) Perkes I, Baguley IJ, Nott MT, et al. A review of paroxysmal sympathetic hyperactivity after acquired brain injury. Ann Neurol. 2010 ; 68 : 126-35.
PubMed
71) Lv LQ, Hou LJ, Yu MK, et al. Prognostic influence and magnetic resonance imaging findings in paroxysmal sympathetic hyperactivity after severe traumatic brain injury. J Neurotrauma. 2010 ; 27 : 1945-50.
PubMed
72) 澤本徹, 守田誠司, 梅鉢梨真子, 他. 限局性脳梁血腫を伴った外傷性脳損傷の経過中にparoxysmal sympathetic hyperactivityを呈した1例. 日救急医会誌. 2019 ; 30 : 238-43
 
73) Meyfroidt G, Baguley IJ, Menon DK. Paroxysmal sympathetic hyperactivity : the storm after acute brain injury. Lancet Neurol. 2017 ; 16 : 721-9.
PubMed
74) Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis : case series and analysis of the effects of antibodies. Lancet Neurol. 2008 ; 7 : 1091-8.
PubMed
75) Yan L, Zhang S, Huang X. Clinical study of autonomic dysfunction in patients with anti-NMDA receptor encephalitis. Front Neurol. 2021 ; 5 ; 12 : 609750.
 
P.350 掲載の参考文献
1) Allan LM. Diagnosis and management of autonomic dysfunction in dementia syndromes. Curr Treat Options Neurol. 2019 ; 21 : 38.
PubMed
2) Allan L, McKeith I, Ballard C, et al. The Prevalence of autonomic symptoms in dementia and their association with physical activity, Activities of daily living and quality of life. Dement Geriatr Cogn Disord. 2006 ; 22 : 230-7.
PubMed
3) Allan LM, Ballard CG, Allen J, et al. Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry. 2007 ; 78 : 671-7.
PubMed
4) Horimoto Y, Matsumoto M, Akatsu H, et al. Autonomic dysfunctions in dementia with Lewy bodies. J Neurol. 2003 ; 250 : 530-3.
PubMed
5) Parashar R, Amir M, Pakhare A, et al. Age related changes in autonomic functions. J Clin Diagn Res. 2016 ; 10 : CC11-5.
PubMed
6) Coon EA, Cutsforth-Gregory JK, Benarroch EE. Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord. 2018 Mar ; 33 : 349-58.
PubMed
7) 日本神経学会. 認知症疾患診療ガイドライン 2017. 東京 : 医学書院 ; 2017.
 
8) Beck G, Hori Y, Hayashi Y, et al. Detection of phosphorylated alpha-synuclein in the muscularis propria of the gastrointestinal tract is a sensitive predictor for Parkinson's disease. Parkinson's Dis. 2020 : 4687530.
 
9) Chu CC, Tranel D, Damasio AR, et al. The autonomic-related cortex : pathology in Alzheimer's disease. Cereb Cortex. 1997 ; 7 : 86-95.
PubMed
10) Gudala K, Bansal D, Schifano F, et al. Diabetes mellitus and risk of dementia : A meta-analysis of prospective observational studies. J Diabetes Investig. 2013 ; 4 : 640-50.
PubMed
11) Jeong SM, Han K, Kim D, et al. Body mass index, diabetes, and the risk of Parkinson's disease. Mov Disord. 2020 ; 35 : 236-44.
 
12) Allan LM, Ballard CG, Rowan EN, et al. Incidence and prediction of falls in dementia : a prospective study in older people. PLoS One. 2009 ; 4 : e5521.
PubMed
13) 日本神経治療学会. 標準的神経治療 : 自律神経症候に対する治療. 神経治療. 2016 ; 33 : 655-88.
 
14) Tinetti ME, Williams CS. Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med. 1997 ; 337 : 1279-84.
PubMed
15) Kanagaratnam L, Mahmoudi R, Novella JL, et al. Adverse drug reactions in elderly subjects hospitalized in a specialized dementia management unit. Drugs Aging. 2014 ; 31 : 769-76.
 
16) Bengtsson-Lindberg M, Larsson V, Minthon L, et al. Lack of orthostatic symptoms in dementia patients with orthostatic hypotension. Clin Auton Res. 2015 ; 25 : 87-94.
PubMed
17) Taylor JP, McKeith IG, Burn DJ, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020 ; 19 : 157-69.
 
18) Palma JA, Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord. 2018 ; 33 : 372-90.
PubMed
19) Sakakibara R, Uchiyama T, Asahina M, et al. Amezinium metilsulfate, a sympathomimetic agent, may increase the risk of urinary retention in multiple system atrophy. Clin Auton Res. 2003 ; 13 : 51-3.
PubMed
20) Orme S, Morris V, Gibson W, et al. Managing urinary incontinence in patients with dementia : pharmacological treatment options and xonsiderations. Drugs Aging. 2015 ; 32 : 559-67.
PubMed
P.358 掲載の参考文献
1) Hackett ML, Pickles K. Part I : Frequency of depression after stroke : an updated systematic review and meta-analysis of observational studies. Int J Stroke. 2014 ; 9 : 1017-25.
PubMed
2) Lipsey JR, Spencer WC, Rabins PV, et al. Phenomenological comparison of poststroke depression and functional depression. Am J Psychiatry. 1986 ; 143 : 527-9.
PubMed
3) Robinson RG, Spalletta G. Poststroke depression : a review. Can J Psychiatry. 2010 ; 55 : 341-9.
PubMed
4) Robinson RG, Jorge RE. Post-stroke depression : A review. Am J Psychiatry. 2016 ; 173 : 221-31.
PubMed
5) Lohner V, Brookes RL, Hollocks MJ, et al. Apathy, but not depression, is associated with executive dysfunction in cerebral small vessel disease. PLoS One. 2017 ; 12 : e0176943.
 
6) Krawczyk DC. Contributions of the prefrontal cortex to the neural basis of human decision making. Neurosci Biobehav Rev. 2002 ; 26 : 631-64.
 
7) Berg D, Supprian T, Thomae J, et al. Lesion pattern in patients with multiple sclerosis and depression. Mult Scler. 2000 ; 6 : 156-62.
PubMed
8) Misu T, Fujihara K, Nakashima I, et al. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology. 2005 ; 65 : 1479-82.
PubMed
9) 谷掛万里, 降矢芳子, 形岡博史, 川原誠, 他. 洞機能不全症候群および起立性頻脈症候群をきたした多発性硬化症の1例. Jpn J Rehabil Med. 2008 ; 45 : 535-40.
Medical*Online
10) Schulte LH, May A. The migraine generator revisited : continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016 ; 139 (Pt 7) : 1987-93.
 
11) 榊原隆次. 夜間頻尿 : パーキンソン病を中心に. 神経治療学. 2018 ; 34 : 412-7.
 
12) Kawabe T, Chitravanshi VC, Nakamura T, et al. Mechanism of heart rate responses elicited by chemical stimulation of the hypothalamic paraventricular nucleus in the rat. Brain Res. 2009 ; 1248 : 115-26.
PubMed
13) Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome : clinical and serological observations in 29 cases. Ann Neurol. 2012 ; 72 : 241-55.
PubMed
14) Jones CL, Ward J, Critchley HD. The neuropsychological impact of insular cortex lesions. J Neurol Neurosurg Psychiatry. 2010 ; 81 : 611-8.
PubMed
15) Ibanez A, Gleichgerrcht E, Manes F. Clinical effects of insular damage in humans. Brain Struct Funct. 2010 ; 214 (5-6) : 397-410.
 
16) Meyer S, Strittmatter M, Fischer C, et al. Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex. Neuroreport. 2004 ; 15 : 357-61.
PubMed
17) Yoshihara K, Tanabe HC, Kawamichi H, et al. Neural correlates of fear-induced sympathetic response associated with the peripheral temperature change rate. Neuroimage. 2016 ; 134 : 522-31.
PubMed
P.365 掲載の参考文献
1) Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex. 2006 ; 16 : 916-28.
PubMed
2) Ugawa Y. [Sensory input and basal ganglia]. Rinsho Shinkeigaku. 2012 ; 52 : 862-5.
PubMed
3) Galts CPC, Bettio LEB, Jewett DC, et al. Depression in neurodegenerative diseases : Common mechanisms and current treatment options. Neurosci Biobehav Rev. 2019 ; 102 : 56-84.
PubMed
4) Rickards H. Depression in neurological disorders : an update. Curr Opin Psychiatry. 2006 ; 19 : 294-8.
 
5) Chase TN. Apathy in neuropsychiatric disease : diagnosis, pathophysiology, and treatment. Neurotox Res. 2011 ; 19 : 266-78.
 
6) パーキンソン病診療ガイドライン 2018.
 
7) Dorsey ER, Bloem BR. The Parkinson pandemic-A call to action. JAMA Neurol. 2018 ; 75 : 9-10.
 
8) Reijnders JS, Ehrt U, Weber WE, et al. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord. 2008 ; 23 : 183-9 ; quiz 313.
 
9) Ziropadja L, Stefanova E, Petrovic M, et al. Apathy and depression in Parkinson's disease : the Belgrade PD study report. Parkinsonism Relat Disord. 2012 ; 18 : 339-42.
PubMed
10) Murata M, Okamoto T. [Depression in Parkinson's disease]. Nihon Ronen Igakkai Zasshi. 2013 ; 50 : 752-4.
PubMed
11) Fujise N, Ikeda M. [The relationship between depression and dementia in elderly]. Seishin Shinkeigaku Zasshi. 2012 ; 114 : 276-82.
PubMed
12) 認知症診療ガイドライン 2017.
 
13) Savva GM, Zaccai J, Matthews FE, et al. Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. Br J Psychiatry. 2009 ; 194 : 212-9.
PubMed
14) Starkstein SE, Jorge R, Mizrahi R, et al. The construct of minor and major depression in Alzheimer's disease. Am J Psychiatry. 2005 ; 162 : 2086-93.
PubMed
15) Eriksson M, Asplund K, Glader EL, et al. Self-reported depression and use of antidepressants after stroke : a national survey. Stroke. 2004 ; 35 : 936-41.
PubMed
16) Burvill PW, Johnson GA, Jamrozik KD, et al. Prevalence of depression after stroke : the Perth Community Stroke Study. Br J Psychiatry. 1995 ; 166 : 320-7.
PubMed
17) Ownby RL, Crocco E, Acevedo A, et al. Depression and risk for Alzheimer disease : systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006 ; 63 : 530-8.
PubMed
18) Olafsson E, Ludvigsson P, Gudmundsson G, et al. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification : a prospective study. Lancet Neurol. 2005 ; 4 : 627-34.
PubMed
19) Fiest KM, Dykeman J, Patten SB, et al. Depression in epilepsy : a systematic review and meta-analysis. Neurology. 2013 ; 80 : 590-9.
PubMed
20) Mula M, Sander JW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf. 2007 ; 30 : 555-67.
PubMed
21) Perucca P, Mula M. Antiepileptic drug effects on mood and behavior : molecular targets. Epilepsy Behav. 2013 ; 26 : 440-9.
PubMed
22) Mendez MF, Cummings JL, Benson DF. Depression in epilepsy. Significance and phenomenology. Arch Neurol. 1986 ; 43 : 766-70.
PubMed
23) Filho GM, Rosa VP, Lin K, et al. Psychiatric comorbidity in epilepsy : a study comparing patients with mesial temporal sclerosis and juvenile myoclonic epilepsy. Epilepsy Behav. 2008 ; 13 : 196-201.
PubMed
24) Bell GS, Gaitatzis A, Bell CL, et al. Suicide in people with epilepsy : how great is the risk? Epilepsia. 2009 ; 50 : 1933-42.
PubMed

III章 脳と臓器障害って ?

P.371 掲載の参考文献
1) 頭部外傷治療・管理のガイドライン作成委員会, 編. 頭部外傷治療・管理のガイドライン 第4版. 東京 : 医学書院 ; 2019. p.96-7.
 
2) 山崎信吾, 橋本邦男, 田畑均, 他. 重症頭部外傷急性期の積極的栄養管理. 脳神経外科ジャーナル. 2000 ; 9 : 789-95.
 
3) 日本脳卒中学会 脳卒中ガイドライン委員会, 編. 脳卒中治療ガイドライン 2015 [追補 2019]. 東京 : 協和企画 : 2019. p.8-9.
 
4) Li ZM, Wang LX, Jang LC, et al. Relationship between plasma cortisol levels and stress ulcer following acute and severe head injury. Med Princ Pract. 2010 ; 19 : 17-21.
 
5) Cushing H, Peptic ulcers and the interbrain. Surg-Gynec-obst. 1932 ; 55 : 1-34.
 
6) Kemp WJ, Bashir A, Dababoneh H, et al. Cushing ulcer : Further reflections. Asian J Neurosurg. 2015 ; 10 : 87-94.
 
7) Novak P. Autonomic disorders. The Americal Journal of Medicine. 2019 ; 132 : 420-36.
 
8) Ott L, Young B, Phillips R, et al. Alatered gastric emptying in the head-injured patient : relationship to feeding intolerance. J Neurosurg. 1991 ; 74 : 738-42.
PubMed
9) Garrick T, Mulvhill S, Buack M, et al. Intracerebroventricular pressure inhibits gastric antral and duodenal contractility but not acid secretion in conscious rabbit. Gastroenterology. 1988 ; 95 : 26-31.
 
10) Rimmer DG. Gastric retention without mechanical obstruction. Arch Intern Med. 1966 ; 117 : 287-99.
 
11) Schaller BJ, Graf R, Jacobs AH. Pathphysiological changes of the gastrointestinal tract in ischemic stroke. Am J Gastroenterol. 2006 ; 101 : 1655-65.
 
12) 三宅牧夫. 腸閉塞症 東京 : メジカルビュー社 ; 2017. p.5-12.
 
13) Hang CH, Shi JX, Li JX, et al. alterations of intestinal mucosa structure and barrier function following traumatic brain injury in rats. World J Gastroenterol. 2003 ; 9 : 2776-81.
 
14) Grotz MR, Deitch EA, Ding J, et al. Intestinal cytokine response after gut ischemia : role of gut barrier failure. Ann Surg. 1999 ; 229 : 478-86.
PubMed
15) Al-Diery H, Phillips A, Evennet N, et al. The pathogenesis of NOMI : implications for research and clinical practice. J Intensive Care Med. 2019 ; 34 : 771-81.
 
16) 木所昭夫, 射場敏明. 非閉塞性腸管虚血の病態と治療. 日本集中治療医学会雑誌. 2007 ; 14 : 10-3.
 
P.377 掲載の参考文献
1) Shanahan W. Acute pulmonary edema as a complication of epileptic seizures. NY Med J. 1908 ; 16 : 54-6.
 
2) Weisman SJ. Edema and congestion of the lungs resulting from intracranial hemorrhage. Surgery. 1936 ; 6 : 722-9.
 
3) 西脇公俊. 神経原性肺水腫と肺血管透過性亢進. 現代医学. 2009 ; 56 : 469-75.
Medical*Online
4) Nastasovic T, Milakovic B, Marinkovic JE, et al. Could cardiac biomarkers predict neurogenic pulmonary edema in aneurysmal subarachnoid hemorrhage?. Acta Neurochir. 2017 ; 159 : 705-12.
PubMed
5) Mutoh T, Kazumata K, Ueyama-Mutoh T, et al. Transpulmonary thermodilution-based management of neurogenic pulmonary edema after subarachnoid hemorrhage. Am J Med Sci. 2015 ; 350 : 415-9.
PubMed
P.383 掲載の参考文献
1) Lyon AR, Bossone E, Schneider B, et al. Current state of knowledge on Takotsubo syndrome : a position statement from the task force on Takotsubo syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2016 ; 18 : 8-2.
 
2) Satoh H, Tateishi H, Ushida T, et al. Takotsubo-type cardiomyopathy due to multivessel spasm clinical aspects of myocardial injury : from ischaemia to heart failure (in Japanese). Tokyo : Kagakuhyouronsya Co. 1990. p.56-64.
 
3) Brinjikji W, El-Sayed AM, Salka S. In-hospital mortality among patients with takotsubo cardiomyopathy : a study of the National Inpatient Sample 2008 to 2009. Am Heart J. 2012 ; 164 : 215-21.
PubMed
4) 公益財団法人 日本心臓財団. HEART's Selection 1 たこつぼ症候群 総論 2016年10月号 Vol. 48 No. 10.
 
5) Nunez-Gil IJ, Almendro-Delia M, Andres M, et al ; RETAKO investigators. Secondary forms of takotsubo cardiomyopathy : a whole different prognosis. Eur Heart J Acute Cardiovasc Care. 2016 ; 5 : 308-16.
PubMed
6) Djuric I, Obradovic S, Gligic B. Dynamics of electrocardiographic changes, brain-natriuretic peptide and cortisol levels in a patient with stress (takotsubo) cardiomyopathy--a case report. Vojnosanit Pregl. 2013 ; 70 : 511-5.
 
7) Kosuge M, Kimura K. Clinical implications of electrocardiograms for patients with anterior wall ST-segment elevation acute myocardial infarction in the interventional era. Circ J. 2012 ; 76 : 32-40.
 
8) Singh K, Carson K, Shah R, et al. Meta-analysis of clinical correlates of acute mortality in takotsubo cardiomyopathy. Am J Cardiol. 2014 ; 113 : 1420-8.
PubMed
9) Murugiah K, Wang Y, Desai NR, et al. Trends in short and long-term outcomes for takotsubo cardiomyopathy among medicare fee-for-service beneficiaries, 2007 to 2012. JACC Heart Fail. 2016 ; 4 : 197-205.
 
10) Cataoano JS, Ducruet AF, Frisoli FA, et al. Predictors of the development of takotsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage and outcomes in patients with intra-aortic balloon pumps. J Neurosurg. 2020 4 : 1-6.
 
11) Yalta K, et al. Takotsubo cardiomyopathy : an obscure cause of emerging cardiovascular manifestations in the setting of Bickerstaff's brainstem encephalitis. Neurol Sci. 2020 Sep 25. doi : 10.1007/s10072-020-04749-z.
 
12) Sylvia J, Lehmann BD, Stevens CE. Takotsubo cardiomyopathy-acute cardiac dysfunction associated with neurological and psychiatric disorders front. Neurol. 10 : 917. doi : 10.3389/fneur.2019.00917
 

IV章 こころが出す症状って ?

P.392 掲載の参考文献
1) 融道男, 小宮山実, 大久保善朗, 他監訳. ICD-10 精神および行動の障害-臨床記述と診断ガイドライン. 東京 : 医学書院 ; 2005.
 
2) 高橋三郎, 大野裕, 監訳 : DSM-5 精神疾患の分類と診断の手引き. 東京 : 医学書院 ; 2014.
 
3) 根本隆洋. 器質性精神障害. 今日の治療指針 2018年版. 東京 : 医学書院 ; 2018. p.1004-5.
 
4) 水野雅文, 藤井千代, 佐久間啓, 他編集. リカバリーのためのワークブック 回復を目指す精神科サポートブック. 東京 : 中央法規 ; 2018.
 
5) 根本隆洋. 統合失調症 (初回エピソード). 今日の治療指針 2017年版. 東京 : 医学書院 ; 2017. p.994-5.
 
6) Ito S, Nemoto T, Tsujino N, et al. Differential impacts of duration of untreated psychosis (DUP) on cognitive function in first-episode schizophrenia according to mode of onset. Eur Psychiatry. 2015 ; 30 : 995-1001.
PubMed
7) Leucht S, Tardy M, Komossa K, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia : a systematic review and meta-analysis. Lancet. 2012 ; 379 : 2063-71.
PubMed
8) 根本隆洋. 統合失調症 (維持療法とリハビリテーション). 今日の治療指針 2016年版. 東京 : 医学書院 ; 2016. p.1036-8.
 
9) Mata DA, Ramos MA, Bansal N, et al. Prevalence of depression and depressive symptoms among resident physicians : A systematic review and meta-analysis. JAMA. 2015 ; 314 : 2373-83.
PubMed
10) Drancourt N, Etain B, Lajnef M, et al. Duration of untreated bipolar disorder : missed opportunities on the long road to optimal treatment. Acta Psychiatr Scand. 2013 ; 127 : 136-44.
 
11) 根本隆洋. 統合失調症をめぐる精神科医療の変化-病院から地域, そして早期介入へ-. 臨床精神医学. 2020 ; 49 : 195-202.
Medical*Online
P.397 掲載の参考文献
1) 高橋三郎, 大野裕, 染谷俊幸, 監訳. 身体表現性障害 DSM-IV-TR 精神疾患の診断・統計マニュアル. 東京 : 医学書院 ; 2002. p.467-91.
 
2) 高橋三郎, 大野裕, 監訳. 身体症状症 DSM-5 精神疾患の診断・統計マニュアル. 東京 : 医学書院 ; 2014. p.307-310.
 
3) Creed F, Barsky A. A systematic review of the epidemiology of somatisation disorder and hypochondriasis. Journal of Psychosomatic Research. 2004 ; 56 : 391-408.
 
4) Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies [Comparative Study Meta-Analysis Research Support, Non-U.S. Gov't Review]. Eur Neuropsychopharmacol. 2005 ; 15 : 357-76.
 
5) Kirmayer LJ, Robbins JM. Three forms of somatization in primary care : prevalence, co-occurrence, and sociodemographic characteristics [Research Support, Non-U.S. Gov't]. J Nerv Ment Dis. 1991 ; 179 : 647-55.
 
6) Katon W, Ries RK, Kleinman A. The prevalence of somatization in primary care. Compr Psychiatry. 1984 ; 25 : 208-15.
PubMed
7) Claassen-van Dessel N, van der Wouden JC, Dekker J, et al. Clinical value of DSM IV and DSM 5 criteria for diagnosing the most prevalent somatoform disorders in patients with medically unexplained physical symptoms (MUPS). J Psychosom Res. 2016 ; 82 : 4-10.
PubMed
8) Hauser W, Bialas P, Welsch K, et al. Construct validity and clinical utility of current research criteria of DSM-5 somatic symptom disorder diagnosis in patients with fibromyalgia syndrome. Journal of Psychosomatic Research. 2015 ; 78 : 546-52.
PubMed
9) Kato K, Sullivan PF, Pedersen NL. Latent class analysis of functional somatic symptoms in a population-based sample of twins. J Psychosom Res. 2010 ; 68 : 447-53.
 
10) Levenson JL. Somatic symptom disorder : Assessment and diagnosis. 2020. [Jan 08, 2020]. Available from : https://www.uptodate.com/contents/somatic-symptomdisorder-assessment-and-diagnosis?search=somatic%20symptom&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1.
 
P.399 掲載の参考文献
1) Chijiwa et al. Physiol Behav. 2015 ; 147 : 264-73.
PubMed
2) 加藤久美子, 他. 心療内科を受診した慢性疲労症候群患者の自律神経機能と心身の症状との関連. 第14回日本疲労学会総会・学術集会, 2018.
 
3) Boeckle, et al. NeuroImage. 2016 ; 11 : 606-13.
PubMed
4) Goodkind, M et al. JAMA Psychiatry. 2015 ; 72 : 305-15.
PubMed
P.405 掲載の参考文献
1) 鈴木郁子, 編著. やさしい自律神経生理学 命を支える仕組み. 東京 : 中外医学社 ; 2015. p.1-247.
 
2) 佐藤昭夫, 山中崇. ストレスとは. Clinical Neuroscience. 1994 ; 12 : 14-7.
 
3) 鈴木郁子, 編著. 人間と生活-地球の健康を考える. 東京 : 錦房 ; 2021. p.1-193.
 
4) 佐藤昭夫, 朝長正徳, 編. ストレスの仕組みと積極的対応. 青森 : 藤田企画出版 ; 1991. p.1-443.
 
5) カンデル ER, 他編. 金澤一郎, 宮下保司 (日本語版監修). カンデル神経科学. 東京 : メディカル・サイエンス・インターナショナル ; 2014. p.1-1649.
 
6) 田代信雄, 編. 情動とストレスの神経科学. 福岡: 九州大学出版会 ; 2002. p.1-269.
 
7) Schmidt RF, Lang F, Heckmann M. Physiologic des Menschen : mit Pathophysiologie. 31st ed., Berlin : Springer-Verlag ; 2010. p.1-979.
 
P.411 掲載の参考文献
1) Del Rosso A, Alboni P, Brignole M, et al. Relation of clinical presentation of syncope to the age of patients. Am J Cardiol. 2005 ; 96 : 1431-5.
 
2) Mizumaki K, Fujiki A, Tani M, et al. Left ventricular dimensions and autonomic balance during head-up tilt differ between patients with isoproterenol-dependent and isoproterenol-independent neurally mediated syncope J Am Coll Cardiol. 1995 ; 26 : 164-73.
PubMed
3) Alboni P, Alboni M. Typical vasovagal syncope as a "defense mechanism" for the heart by contrasting sympathetic overactivity. Clin Auton Res. 2017 ; 27 : 253-61.
PubMed
4) Beacher FD, Gray MA, Mathias CJ, et al. Vulnerability to simple faints is predicted by regional differences in brain anatomy. Neuroimage. 2009 ; 47 : 937-45.
PubMed
5) Theodorakis GN, Markianos M, Livanis EG, et al. Hormonal responses during tilt-table test in neurally mediated syncope. Am J Cardiol. 1997 ; 79 (12) : 1692-5.
PubMed
6) Martin A, Probst V, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018 ; 39 : 1883-948.
PubMed
P.416 掲載の参考文献
1) Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016 ; 150 : 1393-407.e1395.
 
2) 機能性消化管疾患診療ガイドライン 2020-過敏性腸症候群 (IBS), 改訂第2版, 日本消化器病学会, 編. 東京 : 南江堂 ; 2020. p.1-107.
 
3) 福土審. 脳腸相関と機能性消化管障害. 日本消化器病学会雑誌. 2020 ; 117 : 834-9.
Medical*Online
4) Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome : a meta-analysis. Clin Gastroenterol Hepatol. 2012 ; 10 : 712-21.e714.
 
5) Whitehead WE, Crowell MD, Robinson J, et al. Effects of stressful life events on bowel symptoms : subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992 ; 33 : 825-30.
PubMed
6) Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritable bowel syndrome-a meta-analysis. Am J Gastroenterol. 2006 ; 101 : 1894-9.
PubMed
7) Enck P, Aziz Q, Barbara G, et al. Irritable bowel syndrome (IBS). Nat Rev Dis Primers 2016 ; 2 : 16014.
PubMed
8) Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med. 2017 ; 376 : 2566-78. Epub 2017/06/29.
 
9) Drossman DA. Functional gastrointestinal disorders : history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016. Epub 2016/05/05.
 
10) Cannon WB. The movements of the stomach studied by means of the Rontgen rays. Am J Physiol. 1898 ; 1 : 359-81.
 
11) Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology. 2011 ; 140 : 761-5.e765.
 
12) Pellissier S, Bonaz B. The place of stress and emotions in the irritable bowel syndrome. Vitamins and hormones. 2017 ; 103 : 327-54.
PubMed
13) Boeckxstaens G, Camilleri M, Sifrim D, et al. Fundamentals of neurogastroenterology : physiology/motility-sensation. Gastroenterology. 2016. Epub 2016/05/05.
 
14) Spencer NJ, Hu H. Enteric nervous system : sensory transduction, neural circuits and gastrointestinal motility. Nat Rev Gastroenterol Hepatol. 2020 ; 17 : 338-51. Epub 2020/03/11.
 
15) Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 2012 ; 9 : 286.
PubMed
16) Craig AD. How do you feel? Interoception : the sense of the physiological condition of the body. Nat Rev Neurosci. 2002 ; 3 : 655-66.
 
17) Mayer EA. Gut feelings : the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011 ; 12 : 453-66.
PubMed
18) Kano M, Dupont P, Aziz Q, et al. Understanding neurogastroenterology from neuroimaging perspective : a comprehensive review of functional and structural brain imaging in functional gastrointestinal disorders. J Neurogastroenterol Motility. 2018 ; 24 : 512.
 
19) Benarroch E. Pain-autonomic interactions. Neurological Sciences. 2006 ; 27 : s130-3.
PubMed
20) Thayer JF, Lane RD. Claude Bernard and the heart-brain connection : Further elaboration of a model of neurovisceral integration. Neurosci Biobehavioral Rev. 2009 ; 33 : 81-8.
 
21) Valenza G, Sclocco R, Duggento A, et al. The central autonomic network at rest : Uncovering functional MRI correlates of time-varying autonomic outflow. Neuro-Image. 2019 ; 197 : 383-90. Epub 2019/05/06.
 
22) Van Oudenhove L, Crowell MD, Drossman DA, et al. Biopsychosocial Aspects of Functional Gastrointestinal Disorders. Gastroenterology. 2016. Epub 2016/05/05.
 
23) Kano M, Van Oudenhove L, Dupont P, et al. Imaging Brain Mechanisms of Functional Somatic Syndromes : Potential as a Biomarker? The Tohoku journal of experimental medicine. 2020 ; 250 : 137-52.
 
24) Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest. 2015 ; 125 : 926-38. Epub 2015/02/18.
 
25) Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis : From motility to mood. Gastroenterol. 2021 ; 160 : 1486-501. Epub 2021/01/26.
 
26) Muller PA, Schneeberger M, Matheis F, et al. Microbiota modulate sympathetic neurons via a gut-brain circuit. Nature. 2020 ; 583 : 441-6. Epub 2020/07/10.
 
27) Fukudo S. IBS : Autonomic dysregulation in IBS. Nat Rev Gastroenterol & Hepatol. 2013 ; 10 : 569.
PubMed
28) Kano M, Yoshizawa M, Kono K, et al. Parasympathetic activity correlates with subjective and brain responses to rectal distension in healthy subjects but not in non-constipated patients with irritable bowel syndrome. Scientific reports. 2019 ; 9 : 1-11.
 
29) Sadowski A, Dunlap C, Lacombe A, et al. Alterations in heart rate variability associated with irritable bowel syndrome or inflammatory bowel disease : A systematic review and meta-analysis. Clin Transl Gastroenterol. 2021 ; 12.
PubMed
30) Ying-Chih C, Yu-Chen H, Wei-Lieh H. Heart rate variability in patients with somatic symptom disorders and functional somatic syndromes : A systematic review and meta-analysis. Neurosci Biobehavioral Rev. 2020 ; 112 : 336-44.
 
31) Stengel A, Tache Y. Corticotropin-releasing factor signaling and visceral response to stress. Exp Biol Med. 2010 ; 235 : 1168-78. Epub 2010/10/01.
 
32) Kano M, Muratsubaki T, Van Oudenhove L, et al. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome. Scientific reports. 2017 ; 7 : 1-11.
PubMed
33) Spiegel BM, Khanna D, Bolus R, et al. Understanding gastrointestinal distress : a framework for clinical practice. Am J Gastroenterol. 2011 ; 106 : 380.
PubMed
34) Kano M, Muratsubaki T, Morishita J, et al. Influence of uncertain anticipation on brain responses to aversive rectal distension in patients with irritable bowel syndrome. Psychosomatic medicine. 2017 ; 79 : 988-99.
PubMed
P.424 掲載の参考文献
1) Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008 ; 9 : 453-66.
PubMed
2) Griffiths D. Neural control of micturition in humans : a working model. Nat Rev Urol. 2015 ; 12 : 695-705.
PubMed
3) Hoeritzauer I, Phe V, Panicker JN. Urologic symptoms and functional neurologic disorders. Handb Clin Neurol. 2016 ; 139 : 469-81.
PubMed
4) 日本排尿機能学会 過活動膀胱ガイドライン作成委員会, 編. 過活動膀胱診療ガイドライン 第2版. 東京 : リッチヒルメディカル ; 2015.
 
5) von Gontard A, Vrijens D, Selai C, et al. Are psychological comorbidities important in the aetiology of lower urinary tract dysfunction-ICI-RS 2018? Neurourol Urodyn. 2019 ; 38 (Suppl 5) : S8-17.
 
6) Charcot JM. Lectures on the Disease of The Nervous System, J. E. Adlard, plate V, London, 1877 ; p.225-45.
 
7) 山西友典, 五十嵐辰男, 高原正信, 他. 心因性尿閉-病因, 病態, 診断, 治療について. 日本泌尿器科學會雑誌. 1985 ; 76 : 1567-72.
 
8) 福井準之助, 山口建二, 仲間三雄, 他. 女性の心因性尿閉の3例. 日本泌尿器科學會雑誌. 1985 ; 76 : 1561-6.
 
9) Phe V, Chartier-Kastler E, Panicker JN. Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol. 2016 ; 13 : 275-88.
PubMed
10) Yamamoto T, Mori M, Uzawa A, et al. Urinary symptoms and neurological disabilities are differentially correlated between multiple sclerosis and neuromyelitis optica. Clin Exp Neuroimmunol. 2016 ; 7 : 52-8.
 
11) Vrijens D, Drossaerts J, van Koeveringe G, et al. Affective symptoms and the overactive bladder-a systematic review. J Psychosom Res. 2015 ; 78 : 95-108.
PubMed
12) Dejerine J, Gauckler E. The Psychoneuroses and their Treatment By Psychotherapy, J B Lippincott, Philadelphia, 1913 ; p.52.
 
13) Sakakibara R, Ito T, Yamamoto T, et al. Depression, anxiety and the bladder. Low Urin Tract Symptoms. 2013 ; 5 : 109-20.
PubMed
P.431 掲載の参考文献
1) 高橋三郎, 大野裕監訳. 身体症状症, DSM-5 精神疾患の分類と診断の手引. 東京 : 医学書院 ; 2014. p.307-10.
 
2) Tomenson B, Essau C, Jacobe F, et al. Total somatic symptom score as a predictor of health outcome in somatic symptom disorders. Br J Psychiatry. 2013 ; 203 : 373-80.
 
3) Kroenke K. Efficacy of treatment for somatoform disorders : a review of randomized controlled trials. Psychosom Med. 2007 ; 69 : 881-8.
PubMed
4) Penzien DB, Rains JC, Andrasik F. Behavioral management of recurrent headache : Three decades of experience and empiricism. Appl Psychophysiol Biofeedback. 2002 ; 27 : 163-81.
PubMed
5) 浜中聡子, 上條吉人. 意識障害をきたす内科疾患 ヒステリー性 (神経) 症. 内科. 2006 ; 97 : 856-9.
 
6) 甲斐智朗. 成人心因性難聴の2例. 耳鼻臨床. 2002 ; 95 : 679-84.
 
7) 三輪徹, 蓑田涼生. 熊本県耳鼻咽喉科における地震後めまい調査についての報告. Equilibrium Res. 2019 ; 78 : 93-101.
 
8) 気賀沢一輝. 心因性視覚障害の診断と治療. 心身医. 2012 ; 52 : 654-60.
Medical*Online
9) 永井哲夫, 宮岡等. 歯科口腔外科領域の心身症. 臨床精神医学講座 6. 東京 : 中山書店 ; 1999, p.457-64.
 
10) 海野智, 舌痛症の精神療法-その治療効果と治療プロセスの検討. 日心内会誌. 2007 ; 11 : 176-81.
 

書評

最近チェックした商品履歴

Loading...